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Summary 
 
Increasing caesarean section rates are a global phenomenon of interest to 
governments, health professionals, and the public.  It is widely believed that many 
procedures are unnecessary and there are many opinions about what (if anything) 
to do about it.  The debate surrounds indications for caesarean section, clinical 
counselling, maternal choice and provision of information, as well as broader 
societal issues.  Attempts to limit the trend, have had little noticeable success. 
This thesis is about reducing caesarean section in labour, and focuses on the concept 
that it can be predicted, and then prevented by induction of labour. 
Patterns of indications for caesarean section over 27 years were described in two 
hospitals in Sydney, Australia.  Most of the increase in primary caesarean section 
rates was explained by increases in emergency caesarean section for slow progress 
in labour, and elective procedures for fetal malpresentation.  Most of the increase in 
the overall caesarean section rate was due to repeat caesarean sections. 
Induction of labour before 40 weeks’ gestational age was found to reduce caesarean 
section rates for slow progress in labour.    Vaginal birth rates varied widely by 
indication for induction.  Neonatal head circumference, cervical length, estimated 
fetal weight, and a combination of biparietal diameter and abdominal 
circumference were associated with caesarean section for slow progress and could 
contribute to its prediction.  Demographic, clinical and ultrasound factors were 
incorporated into a predictive model, in turn incorporated into a protocol for a 
randomised controlled trial of induction of labour at 39 weeks’ pregnancy.   
We concurrently developed a method of creating centile birthweight standards 
which reflect fetal growth described by ultrasounds.  Charts such as these could be 
used as part of a tool to screen for risk of perinatal mortality and enrolment into a 
parallel randomised trial for improving adverse perinatal outcomes. 
The work in this thesis adds to human knowledge by describing precisely how 
caesarean section rates relate to caesarean section indications over time.  It adds to 
the understanding of associations between induction of labour, ultrasound, and 
demographic factors with caesarean section by separately considering slow progress 
in labour, which allows inferences to be made about the mechanisms through which 
induction of labour prevents caesarean sections.  It also adds a new method for 
creating birth weight standards and a protocol for a randomised trial. 
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Chapter 1: Literature review 
Induction of labour and caesarean section 
INTRODUCTION 
This thesis is about the controversial idea that one 
obstetric intervention might be used to reduce 
another.  Ten years ago, in 2007, at a course on 
designing randomised trials, we wrote a protocol to 
test the idea that manual rotation (an obstetric 
intervention) reduces caesarean section (another 
obstetric intervention). 
In this forum, a poster was presented with results 
from the then new Cochrane Systematic Review, 
which showed that induction of labour before the 
pregnancy’s “due date” prevented caesarean 
section.  The authors proposed a randomised trial 
among low risk women.  I was astounded because 
in all my years of obstetric training I had told women 
repeatedly: 
“It’s best if we don’t induce your labour unless we 
really need to, because that will increase your risk 
of caesarean section.  If we wait until the cervix 
becomes more favourable, your chances of 
achieving a normal birth will be better.” 
The proposed trial never occurred because inducing 
women with a normal pregnancy at 39 weeks’ 
pregnancy was considered unnecessary.  Yet the 
possibility remains that the women already at high 
risk of caesarean section – those who have the 
most to gain – could be selectively offered induction 
of labour to improve their chances of a vaginal birth. 
The central idea behind this thesis is that women at 
high risk of caesarean section in labour can be 
identified and that these women might benefit from 
induction of labour.  There is also a potential benefit 
for babies at risk of poor outcomes. 
The bulk of this work is concerned with predicting 
women at risk of caesarean section in labour and 
designing a randomised trial, despite our manual 
rotation multi-centre-headache and a promise to 
“never again!”  
This thesis aims to describe the causes of our high 
caesarean section rates, to improve our ability to 
predict caesarean section in labour, and to write a 
protocol for a randomised trial to test the hypothesis 
that high risk of caesarean section can be reduced 
by inducing labour before 40 weeks’ pregnancy. 
It begins with a traditional literature review which I 
imagine will only be read by my supervisors and 
examiners, but take comfort in its primary purpose – 
to educate the writer.  At the very least it was a 
good way to discover knowledge gaps.  Writing the 
review was like jumping in the deep end of the pool 
with only a vague idea about how to get to the other 
side – and then realising that it was really an 
immense ocean! 
The research component describes the changing 
indications for, and rates of, caesarean section over 
time and looks for predictors of caesarean section 
in labour.  It assesses the association between 
induction of labour and caesarean section for 
different indications and takes a foray into a new 
method for defining small babies who might also 
benefit from induction.  A method of predicting 
women at high risk of caesarean section in labour is 
developed and finally, a protocol for a proposed 
randomised controlled trial is presented. 
The overall hypothesis is that caesarean section in 
labour can be predicted, and then prevented by 
induction of labour. 
But first, the background… 
CAESAREAN SECTION RATES 
In the twentieth century, caesarean section became 
a safe method of reducing maternal and perinatal 
mortality77,78, but rates of caesarean section have 
increased to the point where their necessity has 
been seriously questioned79-81.  In Australia, the 
national rate increased from 3% in 1963 to 33% in 
201464,82. 
Figure 1.1 shows trends in caesarean section rates 
over the last five decades in Australia and in four 
other English speaking high income countries with 
available data.  While there is considerable 
geographic variation (for example the rates were 
25% and 33% in England and Australia respectively 
in 2013) there has been a general upwards trend 
throughout the last half-century with some slowing 
since about 2004. 
Figure 1.2 shows rates of caesarean section over a 
13 year period for 32 Organisation for Economic 
Co-operation and Development (OECD) countries 
showing widely disparate caesarean section rates in 
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2013, ranging from 15% in Iceland to 50% in 
Turkey.  Australia had the 11th highest rate, just 
behind the United States, and the United Kingdom 
had the 21st highest rate. 
Concern about increasing caesarean section rates 
has existed for more than 50 years.  A caesarean 
section  of 4.5% in 1966 in New South Wales led to 
“regular … minority criticism”.64  A decade later, with 
an Australian rate of 12 to 15%, it was considered 
that “the picture of obstetric care … is one of high 
intervention rates, particularly with respect to 
caesarean sections.83 
In 1980, the rising caesarean section rate caused 
the National Institute of Health in the United States 
to commission a consensus on caesarean section 
which assessed rising rates, benefits, harms, 
economic factors and legal considerations79, and in 
1985 the World Health Organisation stated: 
 “Countries with some of the lowest perinatal 
mortality rates in the world have caesarean section 
rates of less than 10%. There is no justification for 
any region to have a rate higher than 10-15%”80 
Thirty years later they re-affirmed that caesarean 
section rates above 10% were not associated with 
reductions in maternal or newborn mortality but 
recommended, more moderately: 
“Every effort should be made to provide caesarean 
sections to women in need, rather than striving to 
achieve a specific rate.”84 
 
In 1999, an Australian national senate report into 
childbirth procedures described the place of 
caesarean section in the Australian community: 
For Australia, data from 1991 to 2014 are for all confinements within Australia1-22, data for 1986 excludes 
Tasmania54, data for 1980 to 1985 are for Western Australia only63, and data for 1963, 1966, 1968, 1969 
and 1977 are for New South Wales only64-66.  For the United States, data are for all confinements within the 
United States68-71.  For the UK, data are for confinements within England and Scotland73.  For Canada, 
data were for all confinements within that country75 
Figure 1.1 
Caesarean section rates per confinement for Australia, England, Scotland, and USA from 1953 to 2015 
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“…Australian women value safety during birth for 
their babies and themselves above all other 
considerations … But while women acknowledge 
the contribution of the medical profession to 
Australia’s low mortality rates they are generally 
concerned by the extent to which childbirth has 
been medicalised. 
The Committee is particularly concerned by the high 
rate of elective Caesarean section in Australia … 
Many midwives lamented the medicalisation of birth 
and the concomitant increase in interventions. Many 
doctors pointed to the record of the medical 
profession in achieving historically low mortality and 
morbidity rates … 
However, many women and many medical and 
midwife professionals recognise that an 
intermediate position is likely to prove most 
beneficial and most acceptable to women.”81 
Today, the caesarean section rate continues to 
attract strong opinions and newspaper headlines, 
often divided into two camps (Figure 1.3).  On this 
background, the concept of using an obstetric 
intervention to reduce caesarean section must be 
approached sensitively and only after carefully 
considering the scientific evidence. 
 
Figure 1.3 
Recent news headlines and quotes 
 
 
 “There’s no doubt women are feeling bullied 
and coerced into caesareans.”44. 
“Is ‘incessant increase’ in caesarean births 
putting first-time mothers’ health at risk?”52 
“‘Mums the losers’ in race to cut C-sections”62 
 “The relentless pressure to reduce caesarean 
section rates has … resulted in major maternal 
trauma to the pelvic floor”62 
 “Mothers-to-be 'are having to beg for the 
procedure as hospitals face pressure to cut 
costs’”72 
“NHS is rationing caesarean births to save 
money, coroner warns”74 
 “Natural childbirth ideology endangers 
mothers and babies where caesarean is 
indicated”76 
Figure 1.2 
Caesarean section rates among OECD countries from 2000 to 201324,25 
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Causes of rising caesarean section rates 
The causes of the rising caesarean section rates 
are not clear.  Potential contributing factors include 
(but are not necessarily limited to): 
• Changing medical practices such as caesarean 
section for breech presentation, multiple 
gestation or suspected fetal compromise85-89 
• Changing maternal characteristics such as 
general increases in maternal age and body 
mass index (BMI), decreases in parity or 
increases in the prevalence of gestational 
diabetes (see pages 6, 11, 10, and 15) 
• Reluctance by women to attempt a vaginal birth 
after a previous caesarean section or by 
medical professionals to recommend it90 
• Fear of litigation by medical professionals90 
• Reluctance by health professionals or inability 
to perform rotational or difficult assisted 
deliveries 91,92 
• Requests by women to avoid labour or its 
perceived complications, fear of labour, or 
personal preference93,94 
• Requests by women or recommendations by 
health professionals for previous complications 
in labour such as psychological trauma and 
anal sphincter injury94,95 
• Convenience for women 
• Convenience or financial incentives for medical 
professionals96 
While many studies describe causes of caesarean 
section, most focus on only one or several of these 
factors.  Descriptive studies tend to be cross 
sectional or cover a short period, limiting the ability 
to discern trends over time. 
On a basic level, caesarean sections can be 
classified as elective or emergency (Figure 1.4) but 
a more detailed breakdown is required to 
understand the potential causes of the rising rates.    
Figure 1.5 shows the rates of elective and 
emergency caesarean section in Australia from 
1991 to 2014.  Both groups contributed to the rise, 
but elective procedures played a greater role, 
especially from 2000 to 2006.  Elective caesarean 
sections increased from 9% in 1991 to 19% in 2014 
1-22,25,29 and emergency caesarean sections 
increased from 8% to 13%.  Estimates for 2013 and 
2014 are slightly lower than for previous years 
because preterm births were excluded25,29. 
Using publicly available data, it is not possible to 
examine subgroups of indications for caesarean 
section within elective and emergency categories, 
but summary statistics for the main indication for 
caesarean section are provided by the Australian 
Institute of Health and Welfare for The Northern 
Territory, Queensland, South Australia, Tasmania, 
and Western Australia (Table 1.1)29. 
The most common primary indications for 
caesarean section in decreasing order of 
prevalence were previous caesarean section (36% 
of all caesarean sections), abnormal progress in 
labour (15%), malpresentation (11%), and ‘fetal 
distress’ (6%).  In a US study of 228,668 births from 
2002 to 2008, more than 31% of caesarean 
sections (11% of births) were for previous uterine 
surgery, and 19% were for multiple gestation or 
malpresentation97. 
Rates of elective and emergency 
caesareans section from 1991 to 2012 are 
for all confinements within Australia.  For 
2013 and 2014, they are for singleton term 
pregnancies (37 completed weeks’ gestation 
or beyond).  Total caesarean section rates 
are for all births from 1991 to 20141-22.  
Figure 1.5 
Elective and emergency caesarean section 
rates in Australia 
 
Emergency caesarean section: a caesarean 
section performed urgently for clinical reasons, 
such as the health of the woman or baby, once 
labour has started. 
Elective caesarean section: a caesarean section 
performed as a planned procedure before or 
following the onset of labour, where the decision to 
have a caesarean section was made before labour 
Figure 1.4 
Definition of emergency and elective 
caesarean section 
27
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In general, the data on indications for caesarean 
are sparse and the underlying causes are less 
clear.  The high rate of elective repeat caesarean 
section suggests that primary (a woman’s first) 
caesarean section is important.  In one US tertiary 
hospital, caesarean section rates increased from 
26% to 36.5% from 2003 to 2009, paralleling 
increases elsewhere98.  Fifty percent of the increase 
was due to previous caesarean section and 50% 
due to primary caesarean sections.  The indications 
for primary caesarean section in 2009 were labour 
arrest disorders (9% of all births), non-reassuring 
fetal heart trace (6%), malpresentation (4%), 
multiple gestation (2%), and others (5%).  Primary 
caesarean sections increased from 18% to 25% of 
which 2% of the increase was for arrest disorders, 
2% for non-reassuring fetal heart traces, 1% for 
multiple gestation and 1% for suspected 
macrosomia.  The greatest relative increase was for 
maternal request which rose from 0.14% to 0.7%. 
Thus, the downstream effect of primary caesarean 
sections causing future repeat procedures appears 
to be a major contributor to overall caesarean 
section rates. 
Elective caesarean section is also commonly 
performed for breech presentation85-87, multiple 
gestation88, suspected macrosomia (to avoid 
shoulder dystocia and arrest disorders)99, and to 
prevent future incontinence and pelvic floor 
prolapse100.  In contrast to absolute indications such 
as major placenta praevia, caesarean section for 
these indications is performed to reduce risks that 
are relatively low101-105. 
Maternal factors such as short stature, increased 
BMI, age, and nulliparity increase the risk of 
caesarean section (discussed on pages 6, 11 and 
12).  In different settings, approximately 22% of 
caesarean sections were attributed to maternal age 
greater than 35 years (discussed on page 7) and 
14% were attributed to maternal obesity106,107.  The 
prevalence of gestational diabetes, in turn linked to 
obesity, maternal age, fetal macrosomia and 
caesarean section is also increasing and may be an 
intervening variable through which increasing 
maternal age and obesity exert their effect108. 
Maternal request for caesarean section has gained 
attention in the popular media, but is not well 
quantified.  In the study by Barber et al, caesarean 
Table 1.1: 
Reported indications for 36,815 caesarean sections among 129,632 births in The Northern Territory, 
Queensland, South Australia, Tasmania, and Western Australia in 201429. 
 n  Proportion of 
all births 
Proportion of 
caesarean sections 
Presumed emergency (based on indication)a     
   Fetal compromise 2,376  2% 6% 
   Slow progress 5,556  4% 15% 
   Unsuccessful attempt at assisted delivery 214  0.2% 1% 
   Unsuccessful induction 448  0.3% 1% 
   Cord prolapse 73  0.1% 0% 
Subtotal 
 
8,667  7% 24% 
Presumed elective (based on indication)a     
   Suspected fetal macrosomia 376  0.3% 1% 
   Malpresentation 3,926  3.0% 11% 
   Placenta praevia 543  0.4% 1% 
   Placental abruption 168  0.1% 0% 
   Vasa praevia 38  0.0% 0% 
   Antepartum/intrapartum haemorrhage 289  0.2% 1% 
   Multiple pregnancy 531  0.4% 1% 
   Previous caesarean section 13,206  10% 36% 
   Previous shoulder dystocia 51  0.0% 0% 
   Previous perineal trauma/4th degree tear 168  0.1% 0% 
   Previous adverse fetal/neonatal outcome 54  0.0% 0% 
   Other obstetric, medical, surgical, psychological 
indications 
5,892  5.0% 16% 
   Maternal choice 2,064  2.0% 6% 
   Subtotal 27,306  21% 74% 
     
   Indication unknown 842  0.6% 2% 
Total 36,815  28% 100% 
a) Data are not categorised as emergency or elective for specific indications 
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section for maternal request increased five-fold from 
2003 to 2009 but still represented less than one 
percent of births98.  Australian data suggest that 2% 
of all births and 6% of all caesareans are for 
maternal choice (Table 1.1). 
Thus, elective repeat caesarean section is the most 
common indication for caesarean section in high 
income countries, and arrest disorders are the 
biggest contributor to the primary caesarean section 
rate.  It follows that reducing caesarean section for 
slow progress in labour will not only reduce the 
primary caesarean section rate but will also have a 
‘flow on’ effect and reduce elective repeat 
procedures. 
PREDICTION OF CASEAREAN 
SECTION 
The primary aim of this thesis is to predict 
caesarean section at a time when induction of 
labour is an option.  Therefore, only predictors 
available before labour are described. 
Demographic predictors 
Maternal age 
In observational studies, maternal age has been 
linked with adverse labour109-119,  perinatal113,114,119-
132, and maternal 
outcomes109,112,113,116,119,121,122,124,130,132-134, and 
obstetric interventions113-116,135.  
Historically, maternal age was seen as a risk factor 
for adverse pregnancy outcomes.  Almost a century 
ago, Schulze45 defined “elderly” as 30 years of age 
but noted that others placed the cut-off at as young 
as 25.  As far back as the 1920s, she described 
rates of caesarean section in nulliparous women 
ranging from 7% at age 30-34 years to 33% at age 
40 to 45 years (Figure 1.6).  “Inadequate pains” in 
the three age groups of women occurred in 21%, 
29% and 36% respectively and their effect on the 
prognosis of labour was “most striking” and 
associated with a “fetal mortality [of] 20.8 per cent, 
which was mainly due, of course, to difficult 
operative deliveries [resulting in nine cervical 
lacerations].”  She concluded:  
“…the development of cervical caesarean section in 
recent years makes it possible, without materially 
increasing the risk to the mother, to await labour, 
observe the type of uterine contractions and then, if 
these seem insufficient to carry the patient through 
successfully, perform caesarean section.  A rather 
high percentage of caesarean sections will probably 
always be necessary, especially in the older 
women…”45 
In 1934, Sterne commented that “All obstetricians 
agree that, after the age of 25, labour becomes 
increasingly difficult, both in primiparae and 
multiparae”136.  He described a caesarean section 
rate of 20% (7/35) among nulliparous women aged 
40 or more who gave birth from 1923 to 1933 in the 
London Hospital.  He summarized 17 papers 
describing 1190 births in nulliparous women older 
than 40.  The caesarean section rate varied from 
0.5% to 33%, was more than 15% in six papers, 
and 7% when the individual data were combined.  
The overall rate of “dead babies” was 14%, much 
higher than in younger women.  He concluded that 
elderly nulliparous women had longer labours, 
“weak pains and unyielding soft parts” and that 
“Caesarean section carries a lower death-rate, both 
for mother and foetus, than labour.” 
Table 1.2 shows reported rates of caesarean 
section of 11% to 44% for older nulliparous women 
in the 1940s and 1950s, most commonly performed 
for slow progress in labour137-139.  In a 1967 
multicentre study in the United States, the 
caesarean section rate among nulliparous women 
increased from 5% of 14,332 women at age 25-26 
years to 9% of 3,215 women at age 31-32 years, 
26% of 722 women aged 39-40 years, and 35% of 
540 women aged 41-42139. 
More recent observational studies consistently 
show a positive correlation between maternal age 
and the overall rate of caesarean section in 
nulliparous109-115,117-121,126,129,135,140-145, parous109,112-
114,117,118,121,126,143, and mixed 
populations116,123,132,145,146.  In a 2010 systematic 
review with 12 studies from high income countries, 
the unadjusted relative risk of caesarean section 
varied from 1.4 to 2.3 for nulliparous women aged 
35 years or older compared with younger women147.  
The unadjusted relative risk was 1.6 to 2.8 for 
parous women among three studies and 1.4 to 1.6  
Figure 1.6 
Caesarean section rate among ‘elderly 
primparas in a US hospital in the 1920s45 
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for women of mixed parity among six studies147, and 
has been similar in subsequent publications123.  The 
authors did not perform a meta-analysis but the 
lower limit of the 95% confidence interval was more 
than one in all included studies.  Studies which 
adjusted for covariates such as birthweight, 
induction of labour, BMI and maternal diabetes 
found similar odds ratios 110,113,120,141,144,117,123,146. 
With few exceptions144, most observational studies 
found increasingly high caesarean section rates 
with increasing maternal age110,113-
115,117,119,121,135,143,145,146,159.  For women older than 
forty, the relative risk of caesarean section was 1.8 
to 4.7109,116,119,121-123,126,127,133,140,144 and for women 
older than forty-five it was 2.1 to 7.3121,122,127,160,161 
compared with women aged below about 35 years.  
The trend extends backwards such that women less 
than 20 years old have lower caesarean section 
rates in most115,117,145,162,163 though not all 
studies110. 
Observational studies which report on caesarean 
section in labour show an odds ratio or relative risk 
of 1.4 to 2.0 for women aged 35 years or 
more110,113,116,118,123 and those which report on 
caesarean section for abnormal progress in labour 
show an odds ratio or relative risk of 1.4 to 
2.0110,111,135,159.  When reported, abnormal progress 
or longer labour overall111, longer first stage110 and 
longer second stage110,129 of labour were also 
increased.  Fetal distress and caesarean section 
due to fetal distress in labour are increased among 
older women in some110,135 but not all132,159 studies. 
Assuming that the relative risk of caesarean section 
for women 35 years or older compared with 
younger women is 2.0 and that 22.1% of women 
who gave birth in Australia in 2015 were 35 years or 
older82, then it can be estimated that 22% of all 
caesarean sections are attributable to advanced 
maternal age164.  This does not account for the 
observation that there is a continuous relationship 
between maternal age and risk of caesarean 
section. 
Possible mechanisms through which maternal age 
exerts its effect on caesarean section include 
inefficient uterine contraction possibly mediated by 
fewer labour induced myometrial gap junctions147 
and fewer myometrial oxytocin receptors147, 
comorbidities such as gestational diabetes and 
hypertension147, lower thresholds for obstetric 
intervention147, closer fetal monitoring147, use of 
anaesthesia during vaginal delivery147, reduced 
voluntary pushing efforts147, reduced pelvic 
Table 1.2 
 Rates of caesarean section in older nulliparous women in the 1940s and 1950s 
Years of 
birth 
Country n Age CS ratea Comparator CS 
rate 
Reference 
Before 
1946 
USA ? 35-45 16% (35-39) 
44% (40-45) 
“clinic average” 4% Hellman 1946 148 
1949-53 USA 154 35-45 21% All births 5% Hofmeister (1955) 149 
1945-53 USA 107 ≥ 35 29% All births 3% Williamson (1955)137 
1941-54 USA 303 ≥ 35 14% All births 3% Arthur (1956) 150 
1935-55 USA 309 ≥ 35 11%  Nil - Fliehr 1956 151 
1947-53 Sweden 408 ≥ 35 14% Nullips (18-25)1 0.3% Frederikson (1958) 152 
1952-56 USA 54 ≥ 35 19% Nilb - di Giulio (1957) 153 
Before 
1957 
USA 313 ≥ 35 25% (35-39) 
29% (40-45) 
Nullips (15-19)1 
Nullips (20-24)1 
Nullips (25-29)1 
Nullips (30-34)1 
3% 
4% 
8% 
12% 
Points (1957) 138 
1941-55 USA 277 ≥ 35 11% All births ≈2% Schmitz (1958)154 
1954-57 Canada 124 ≥ 35 16% (35-39) 
36% (40+) 
All births 2% Legerski (1959) 155 
1942-57 Canada 668 ≥ 36 18% Nullips (15-25)a,c 2% Weaver (1959) 156 
1956-59 USA 42 ≥ 40 33% “overall rate” 3% Posner (1961) 157 
1956-59 USA 50 ≥ 35 14% Nil - Clark (1961) 
1950-60 Sweden 543 ≥ 35 10% (35-36) 
14% (37-37) 
43% (40+) 
Nil - Jacobson 1963 158 
a) Nulliparous women (age in years) 
b) Comparison with caesarean section rates in other hospitals of 0-3% 
c) Matched younger nulliparous women (n = 668) 
Nullips = nulliparous women; CS = caesarean section 
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compliance147, confounders such as fetal 
macrosomia and BMI147, medico-legal concerns147 
and maternal request165.  For older multiparous 
women, there is some evidence that the age at 
index pregnancy is more predictive of subsequent 
caesarean section than age in the current 
pregnancy117.   
Socioeconomic status 
Socioeconomic status incorporates measures of 
income, education, and occupation166. The three 
indicators are interrelated but not fully 
overlapping166.  Studies which examine the 
association between socioeconomic status and 
caesarean section have used family income167,168, 
income adjusted for family size, level of 
education117,168-170, occupation of the father117,171, 
occupation of the mother117,171, private health 
insurance169,170,172,173, geographic area of 
residence167,171,174, immigration status173, wealth170 
or some combination167-169,171.  Unlike other 
predictors of caesarean section such as maternal 
age or height, socioeconomic status is complex and 
prone to measurement error175. 
In poor resource settings, there is a positive 
association between caesarean section and 
socioeconomic status (Figure 1.7a to 1.7c)57.  For 
example, a caesarean section rate of 1% or less is 
often seen in lower socioeconomic groups but is 
considerably higher among women with more 
resources, who can afford this potentially life-saving 
procedure57. 
In a Mexican intervention study, a government 
health care support package of US$15 per month 
with mandatory antenatal care was randomly 
allocated to eligible communities at one of two time 
points 18 months apart with up to US$160 per 
month for schooling.  In 2003, women in families 
who received the support package for 6 months had 
a caesarean section rate of 14.5% compared with 
7.1% in non-recipients, a difference which did not 
change after adjusting for multiple variables176. 
In higher income countries, most of the debate 
surrounds elective caesarean section170.  
Most167,169-173,177 studies found a positive 
association between one or more components of 
socioeconomic status and caesarean section 
overall, but in two studies, there was no association 
after adjusting for explanatory variables such as 
age and parity143,177.  The data for emergency 
caesarean section are sparse and 
contradictory117,123,171.  Some data suggest the 
association between elective caesarean section and 
socioeconomic status is only present in women 
older than 35 (effect modification)112,123.  Only five 
studies controlled for factors such as maternal age 
in a multivariable regression 117,143,169,171,177.  No 
clear patterns have emerged, although at a national 
level, there is evidence that caesarean section rates 
are correlated with gross national product per capita 
(Figure 1.7d)67. 
In Western Australia, the caesarean section rate 
among privately funded women in private hospitals 
rose from 26% in 1996 to 45% in 2008, compared 
with 18% to 28% among women in the public health 
care system178.  However, this marked difference 
was not observed in New South Wales over a 
similar time-frame, potentially due adjusting for 
confounders such as maternal age179.  These 
differences suggest the relationship between private 
health insurance and caesarean section is variable, 
even within the same country, and that predictive 
models using this factor may not be transportable to 
other populations. 
In some South American countries, particularly 
Brazil, qualitative studies indicate that many women 
consider a vaginal birth to be a risky, negative 
experience and believe caesarean sections 
represent the best quality care168.  In the private 
setting, caesarean section rates are as high as 
84%96,170, with as many as 35% of all caesarean 
sections being performed purely for maternal 
choice170.  In the public setting, women describe a 
range of strategies for trying to force the public 
health care system to let them have a caesarean 
section168.  Obstetricians described performing 
caesarean sections for financial and convenience 
reasons, and fear of litigation or losing their patients 
to other practitioners168.  These observations 
suggest that there is potential for the caesarean 
section to continue increasing in high income 
countries such as Australia. 
The possible mechanisms through which higher 
socioeconomic status could be associated with 
caesarean section include: (i) women have more 
ability to pay for essential medical care; (ii) women 
have more ability to pay for non-essential medical 
care which they want168; (iii) private obstetricians 
are more likely to recommend caesarean section for 
financial gain, convenience or fear of litigation168; 
(iv) lower socioeconomic status is associated with 
demographic (eg obesity) or medical (eg diabetes) 
factors which are associated with caesarean section 
180,181; (v) malnutrition could lead to short maternal 
stature and an abnormal bony pelvis predisposing 
to cephalopelvic disproportion182. 
Thus, the relationship between socioeconomic 
status and caesarean section is complicated by  
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Figure 1.7 
Caesarean section and socioeconomic status 
Figures 1.7a to 1.7c show the relationship between socioeconomic status quintile and caesarean section rates grouped 
according to the overall caesarean section rates in each country57.  Figure 1.6d shows the relationship between gross 
national product per capita and caesarean section in 18 Latin American countries67. 
1.7a: Caesarean section rates by wealth quintile 
in selected countries with rates < 2% 
1.7b: Caesarean section rates by wealth quintile 
in selected countries with rates 2 to 4.9% 
1.7c: Caesarean section rates by wealth quintile 
in selected countries with rates ≥ 5% 
1.7d: Gross national product per capita and 
caesarean section in Latin American countries 
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measurement issues, cultural issues, the availability 
of resources, and the scarcity of data on 
intrapartum caesarean section, making 
socioeconomic status an unreliable variable to 
include in predictive models. 
 
Parity  
Compared with women with a previous vaginal 
birth, there is very strong evidence that nulliparity is 
associated with caesarean section after adjusting 
for confounders such as maternal age and 
BMI160,183-185.  In adjusted analyses in observational 
studies, the odds ratio or relative risk of caesarean 
section for nulliparous compared with parous 
women was 3.5 to 5.8160,183,184.  Many observational 
studies limit the population to nulliparous women 
115,120,163 or analyse nulliparous and parous women 
separately117,118,123,143,144,186,187 suggesting that 
investigators believe the two groups are innately 
different. 
It is important to exclude or adjust for previous 
caesarean section because it is a strong predictor 
of caesarean in the current pregnancy and the 
practice of vaginal birth after caesarean section 
varies widely188. 
In one of the few studies which reported on 
caesarean section in labour, the odds ratio was 8.4 
for nulliparous women (95%CI 7.7 – 9.1)185.  This 
higher odds ratio is not surprising given that 
common indications for prelabour caesarean 
section such as breech presentation and placenta 
praevia occur in both nulliparous and parous 
women, and some indications such as previous 
traumatic vaginal birth or previous severe perineal 
trauma are specific to parous women.  Due to the 
paucity of data in the medical literature, US data189 
and Australian summary statistics190 were accessed 
on 27th February 2017.  Only broad statistics were 
available for Australian births but the US dataset 
allowed a more detailed analysis (Table 1.3).  Data 
were analysed using Statistical Analysis Software 
(SAS) version 9.4191.  For term, cephalic presenting, 
singleton live births with no previous caesarean 
section, adjusting for BMI category, maternal age 
category, and maternal height category, the odds 
ratios for nulliparous versus parous women were 
4.2 for all caesarean sections, 2.5 for prelabour 
caesarean sections, and 8.5 for caesarean sections 
in labour (Table 1.3).  Thus, nulliparity was more 
strongly associated with caesarean section in 
labour than caesarean section before labour.  The 
association between nulliparity and caesarean 
section for slow progress in labour is unknown. 
The mechanism of association between parity and 
caesarean section in labour is also unknown.  It is 
not mediated by maternal age or BMI because 
these are positively associated with parity.  Possible 
mechanisms include: (1) women who have a 
vaginal birth in their first pregnancy may have 
underlying attributes just as a large pelvis, ability to 
form a good-functioning placenta, or efficient uterine 
contractions which are still present in subsequent 
pregnancies; (2) slower labours in nulliparous 
women193-196 could allow more time for the fetus to 
become hypoxaemic in labour leading to caesarean 
section for ‘fetal distress’; and (3) physiologic and/or 
anatomic changes such as reduced pelvic floor 
resistance, greater cervical elasticity, or more 
efficient uterine contractions could occur in the first 
labour and confer a greater ability to have a vaginal 
birth in subsequent labours. 
Table 1.3 
Australian (2014) and United States (2015) data on mode of birth and paritya 
Data  n 
(1000’s) 
Outcome Size of effect 
(nulliparous v parous) 
Raw caesarean section rates 
Australian national data, 2014190 254 All caesarean sections 34% v 11% 
US national data 2015189 3,305 All caesarean sections 30% v 15% 
Logistic regression analyses using US national datab 
US national data 2015192 2,796 All caesarean sections ORunadj 3.2 (3.2 - 3.3) 
ORadj    4.2 (4.2 - 4.3) 
 2,565 Caesarean section in labourc ORunadj 6.4 (6.4 - 6.5) 
ORadj    8.5 (8.4 - 8.6) 
 2,555 Prelabour caesarean sectiond ORunadj 1.8 (1.8 – 1.9) 
ORadj    2.5 (2.4 – 2.5) 
a) Women with one or more previous caesarean sections excluded (in all analyses) 
b) Preterm pregnancies (<37 completed weeks’), non-cephalic presentation, stillbirths and neonatal deaths before discharge 
excluded 
c) Prelabour caesarean sections excluded 
d) Caesarean sections in labour excluded 
ORunadj = unadjusted odds ratio (95% confidence interval) 
ORadj = odds ratio adjusted for maternal body mass index group, age group, and height group (95% confidence interval) 
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Body Mass Index 
The impact of maternal obesity on pregnancy 
outcomes has been long recognised197.  
Observational studies have linked obesity to 
adverse pregnancy197-205, intrapartum198,205,206 and 
perinatal outcomes198,200-205,207-211, obstetric 
interventions199,200,204,205,208, and subsequent 
childhood obesity212. 
There are now more obese than starving people in 
the world creating a large disease burden on 
mothers and their infants due to obesity.  In one 
Spanish study, BMI in the upper quartile (>26.1 
kgm-2) was responsible for 9.4% of all caesarean 
sections and 18% of large for gestational age 
infants202.  Other studies in the USA and Sweden 
have estimated that about 14% of caesarean 
sections were attributable to maternal obesity106,107. 
Observational studies consistently show a positive 
correlation between pre-pregnancy or early 
pregnancy maternal BMI and caesarean section in 
nulliparous106,186,201,206,210,213-217, parous186 and 
mixed populations107,183-185,187,198-200,205,209,211,218-226.  
Most of these studies assess early or pre-
pregnancy BMI183-186,199,200,202,205,206,208,210,211,213,216-
224,226,227, sometimes in addition to gestational 
weight gain185,198,208,213,217,218,221,222 but few assess 
BMI near the time of delivery107,187.  The relative risk 
or odds ratio of caesarean section for women with a 
BMI of 30 or more relative to a normal BMI varied 
from 1.8 to 4.0 after adjusting for confounders 
known to be associated with caesarean section 
such as maternal age, parity and 
height106,107,185,187,200,205,209,211,216,218-224,228.  For 
women with a BMI of 40 or more, it varied from 2.5 
to 4.5107,187,200,201,211,220.  When reported, the risk of 
caesarean section progressively increased with 
increasing BMI class through overweight, obese, 
and morbidly obese groups in most187,199-
201,210,211,213,214,218,221,225,229,230, but not all studies206.  
This trend extended to underweight women who 
tend to have lower rates of caesarean section in 
most184,185,210,213,214,216-218,221,223-225,229, but again not 
in all studies209,222.  In a meta-analysis of 33 
observational studies which included caesarean 
section overall or during labour, the unadjusted 
odds ratio of caesarean section was 1.5 (95%CI 1.3 
– 1.6), 2.0 (95%CI 1.9 – 2.3), and 2.9 (95%CI 2.3 – 
3.8) for overweight, obese, and severely obese 
women respectively231.  Two other meta-analyses 
showed similar odds ratios for caesarean section 
overall204,232. 
The observational studies which report on 
caesarean section in labour show a relative risk of 
1.3 to 3.8184,185,187,199,210,214,215,224,227,229 for obese 
women.  In two meta-analyses, the odds ratios of 
emergency caesarean section were 1.6 (95%CI 1.4 
– 1.9) and 2.2 (95%CI 2.1 – 2.4) for obese women 
relative to women with a normal BMI204,232.  One 
study found that obesity was associated with 
caesarean section in labour in nulliparous women 
and with elective caesarean section in parous 
women226.  There is evidence that high pre-
pregnancy BMI is associated with caesarean 
section for failure to progress in 
labour198,205,206,214,221,224,229,233, especially in the first 
stage233, but the evidence for an association with 
caesarean section for suspected fetal compromise 
is conflicting198,214,221,224,227. 
BMI near the time of birth (as opposed to pre-
pregnancy BMI) was also associated with 
caesarean section overall187.  Most studies which 
include both BMI group and gestational weight gain 
in logistic regression models have found that each 
has an independent effect213,218,221,222.  No studies 
were identified which included both BMI near the 
time of birth and gestational weight gain as 
separate covariates.  As BMI near the time of birth 
is the sum of pre-pregnancy BMI and gestational 
BMI gain it is possible that BMI near the time of 
birth is an intervening variable through which the 
other two exert their effect (Figure 1.8). 
High BMI could cause caesarean section by 
increasing birthweight leading to cephalopelvic 
disproportion.   There is a strong relationship 
between BMI and large for gestational age or 
macrosomic infants198-202,205,207,208,216,217,224,225,228, 
and a strong relationship between birthweight and 
caesarean section for failure to progress222.  
However, among studies which adjusted for 
birthweight or macrosomia, the association between 
obesity and caesarean section persisted with 
reported odds ratios of 1.4 to 3.1183,186,209,213.  There 
is much discussion in the literature about “soft 
tissue dystocia” due to altered pelvic tissues in the 
pelvis213,214,222,233 but little direct evidence for it.  
Increasing BMI group is associated with increasing 
length of the first stage of labour which could lead to 
caesarean section for slow progress234.  Finally, 
there is in vitro evidence from myometrial 
specimens collected at the time of elective 
caesarean section that uterine contraction strength 
and frequency are inversely related to BMI233.  This, 
combined with the observation that it is abnormal 
labour progress222,233, particularly in the first 
stage215,233 that is primarily related to maternal BMI 
suggests that caesarean section in obese women is 
mediated more by reduced uterine contraction 
forces than changes in soft tissue anatomy. 
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Gestational weight gain 
While BMI is the standard through which the impact 
of maternal weight on pregnancy is assessed235, 
changes in maternal size are reported as weight 
gain rather than BMI gain235, in line with the U.S 
Institute of Medicine236.  Based on evolving 
evidence, recommended gestational weight gain 
has changed from less than about 9 kg in the early 
twentieth century to 9.1 - 11.4kg from 1970 to 
1990236, and 11.5 to 16 kg from 1990, re-affirmed in 
2009236.  Until 1990, these recommendations 
applied to all women in pregnancy but 
recommendations now vary  by pre-pregnancy BMI 
(Table 1.4)236.  There is evidence of a general 
increase in gestational weight gain over time237-239. 
Table 1.4 
Institute of Medicine Guidelines for gestational 
weight gain236 
Pre-pregnancy BMI 
(kgm-2) 
Recommended weight 
gain (kg) 
< 18.5      12.5 - 18 
18.5 – 24.9      11.5 - 16 
25.0 – 29.9        7    - 11.5 
≥ 30        5    -   9.0 
                                                                              
High or excessive gestational weight gain is 
associated with adverse pregnancy240-245, 
intrapartum241, and perinatal240-244,246-252 outcomes, 
obstetric intervention242,244, postpartum weight 
retention249,253-255, and childhood obesity249,256.  
Conversely, decreased or inadequate gestational 
weight gain is associated with adverse perinatal 
outcomes240,241,243,244,246-251,257.  In one study, the 
attributable risk of caesarean section for gaining 
more than 16kg was 7% of all caesarean 
sections258. 
With few exceptions241, observational studies have 
shown a positive correlation between gestational 
weight gain and caesarean section in nulliparous251, 
parous251, mixed parity241,242,244,248-251,258-260, normal 
weight243, obese240,250,251,260, and/or mixed 
BMI241,242,244,249,259 populations after adjusting for 
pre-pregnancy or early pregnancy BMI.  No studies 
were identified which assessed the association 
between gestational weight gain and caesarean 
section after adjusting for BMI near the time of birth.  
Maternal BMI at the time of birth could be the 
intervening variable through which gestational 
weight gain and pre-pregnancy BMI exert their 
effect (Figure 1.8). 
In observational studies, the odds ratio for 
caesarean section overall for gestational weight 
gain above recommendations compared to within 
recommendations was 1.2 to 2.0 after adjusting for 
BMI242,244,250,251,260 and 1.3 to 1.5 per 10 kg weight 
gain258 after adjusting for factors including parity, 
pre-pregnancy or early pregnancy BMI, maternal 
height and cigarette smoking.  In some studies, the 
odds ratios were higher in nulliparous compared 
with parous women suggesting effect modification 
by parity251.  For emergency caesarean section the 
odds ratio was about 2.2244 and no studies were 
identified which reported on caesarean section for 
slow progress in labour.  The relative risk of 
cephalopelvic disproportion was 1.6 (95%CI 1.4 – 
1.7) and the risk of failed induction was 1.5 (95%CI 
1.4 – 1.6) in one observational study after adjusting 
for multiple confounders243.  When reported, the risk 
of caesarean section overall increased with 
increasing amounts of weight gain243 and 
inadequate weight gain or weight loss was 
associated with a lower rate of caesarean section in 
both obese250 and non-obese243 women. 
One of the mechanisms through which gestational 
weight gain could increase the risk of caesarean 
section is via an increase in maternal BMI at the 
time of birth (Figure 1.8).  In this case, the putative 
mechanisms would be the same as for BMI such as 
soft tissue dystocia243 or abnormal uterine 
contractility243.  If either of these are responsible for 
the association between gestational weight gain 
and caesarean section, then reducing excessive 
weight gain in pregnancy could reduce the risk of 
caesarean section.  As for obesity, gestational 
weight gain could exert part of its effect by 
increasing fetal weight261.  However, with one 
exception244, most observational studies did not 
adjust for birthweight 241-243,249,251,260, and the extent 
to which birthweight is an intervening variable on 
the pathway to caesarean section is unknown.  In 
one study, gestational weight gain was associated 
with caesarean section (especially during labour) 
after adjusting for birthweight244. 
Maternal height 
In the 1940’s it was thought that childhood 
malnutrition led to short maternal stature, bony 
pelvis abnormalities, cephalopelvic disproportion 
and operative delivery182,262.  Table 1.5 shows data 
from Scotland in the 1940s for women of different 
socioeconomic backgrounds who gave birth in 
different institutions262,263.  The distributions of 
heights were strikingly different suggesting that 
short stature was caused by malnutrition earlier in 
life.  The rates of caesarean section for women less 
than 150 cm in height were different at two 
maternity hospitals despite similar rates for taller 
women, potentially due to differences in pelvic 
shape262,263.  The concept was supported by 
evidence of pelvis abnormalities among shorter 
women on X-ray pelvimetry262,264.  Today, it is still 
assumed that nutritional deficiency causes short 
stature and abnormal pelves265,266.  Short maternal 
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stature is also associated with other adverse 
perinatal outcomes182,262,267. 
In low income countries, maternal height is often 
used as a tool to screen for women at high risk of 
caesarean section265,268-273.  Cephalopelvic 
disproportion is a major cause of maternal and 
perinatal mortality and other serious sequelae such 
as genital fistulae, incontinence and sterility264,272.  
Women below a prespecified height may be 
advised against home birth by local health care 
workers or traditional birth attendants and referred 
to a regional hospital268. 
With some exceptions274, observational studies in 
nulliparous227,266,275-277 and mixed parity267,278-281  
populations show an inverse relationship between 
maternal height and caesarean section.  They 
report a relative risk or odds ratio of 1.5 to 3.4 for 
caesarean section for shorter women in univariate 
analyses for a cut-off of 147 to 155 cm267,275-283.  
Others found a lower mean height among women 
undergoing caesarean section for cepalopelvic 
disproportion compared with vaginal births284,285.  
The few studies which adjusted for factors such as 
macrosomia or birthweight, maternal age and parity 
reported an adjusted relative risk or odds ratio of 
1.7 to 2.5 for caesarean section266,281.  Two studies 
in low income countries show relative risks of 2.0 to 
4.9 for women below 155 to 160 cm height268,270, a 
difference similar to higher income countries, 
suggesting that if malnutrition causes abnormal 
progress in labour, it is not commonly due to pelvic 
deformities. 
Observational studies which report on caesarean 
section in labour found a relative risk or odds ratio 
of 2.0 to 3.7 for shorter women266,267,277-281.  Those 
which reported on caesarean section for failure to 
progress show a relative risk or odds ratio of 1.5 to 
2.0275,276,279,280,283.  Only one assessed the 
relationship between maternal height and 
caesarean section for failure to progress in a 
multivariable analysis280.  Shoe size and birthweight 
were independently associated with caesarean 
section for failure to progress, but height, race and 
pelvic assessment were not.  No study was found 
which adjusted for maternal age or BMI. 
In a meta-analysis published in 1996, maternal 
height was associated with caesarean section but 
did not perform well as a diagnostic test272.  There 
was a sensitivity of 51% for a specificity of 81% for 
labour dystocia but an area under the ROC curve 
was not reported272.  The association between 
maternal height and caesarean section for 
cephalopelvic disproportion was similar for African, 
European and Asian populations which would not 
be expected if pelvic abnormalities due to 
malnutrition were a contributing factor272.  In 
agreement with others273, they found that the 
relationship between height and cephalopelvic 
disproportion depended on the background height 
of the maternity population272 and used height 
centiles rather than raw heights to pool results. 
Short maternal height could cause caesarean 
section by increasing cephalopelvic disproportion or 
causing fetal growth restriction.   However, 
most267,273,275,279,282,283 but not all281 studies show a 
positive relationship between maternal height and 
birthweight.  In high income countries, the evidence 
for an association between maternal height and 
adverse perinatal outcomes is unclear267,279,281.  In 
low income countries, perinatal mortality is higher273 
and may be related to cephalopelvic disproportion 
leading to excessively long labours264. 
 
Figure 1.8 
BMI, gestational weight and caesarean 
section 
↑ BMI gain 
↑ BMI at 
birth 
Current view:  
Alternative model: 
Pre-pregnancy BMI and gestational weight gain are 
considered to be independent predictors of 
caesarean section (see Body Mass Index, p11; and 
Gestational Weight Gain, p12).  However, BMI at 
birth is the sum of pre-pregnancy BMI and BMI gain 
and could be the intervening variable through which 
they exert their effect.  Hypotheses about aetiology 
such as soft tissue dystocia or altered uterine 
contractility could be consistent with this alternative 
view. 
↑ Risk of 
caesarean 
section 
↑ BMI 
↑ BMI gain 
↑ BMI 
↑ Risk of 
caesarean 
section 
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Ethnicity 
In comparative observational studies, ethnicity is 
consistently associated with rates of caesarean 
section, but the relationship is complicated by 
cultural and socioeconomic factors.  For example, in 
the United States, studies in the 1980s found little 
difference in caesarean section rates between 
women with African (black) ancestry and women 
from other racial backgrounds167,286,287, but later 
studies consistently report higher rates in black 
women288-299.  In a South African observational 
study of women who gave birth in 1990, black 
women had lower caesarean section rates than 
women from other ‘population groups’300.  In all 
cases, these disparities were attributed or partially 
attributed to a lower average socioeconomic status 
among black women, lower quality care, or racial 
discrimination.  In one observational study in Brazil, 
known to have high caesarean section rates, black 
women who gave birth in 2004 had lower rates of 
caesarean section than white women170.  In the 
United States, black women and their babies are 
more likely to experience adverse obstetric and 
perinatal outcomes including maternal mortality, 
stillbirth, preterm birth, fetal growth restriction, large 
for gestational age, and general obstetric 
morbidity292,301-304. 
In a meta-analysis of 76 observational studies, 
caesarean section was more common in recent 
immigrants from sub-Saharan or ‘unspecified’ Africa 
(odds ratio 2.24 [95% CI 1.63-3.08]), Somalia (1.13 
[95% CI 1.02-1.26]), and South Asia (odds ratio 
1.28 [1.22-1.35]), and less common for Eastern 
European and Vietnamese women to countries with 
a predominantly Caucasian (white) population305.  In 
African/Somalian immigrants, the increased rate 
persisted after adjusting for multiple demographic 
and clinical confounders and was attributed to such 
factors as genital mutilation, pelvic shape, language 
differences, poor maternal health, no antenatal 
care, and low socioeconomic status.  However, 
these observations could be due to complex factors 
such as the ‘immigration effect’ and may not be 
attributable to racial background305.  
Recent observational studies, primarily in the United 
States, consistently show higher adjusted odds 
ratios for caesarean section in black women 
compared with other ethnic groups288,289,291,292,294-
296,299,306.  In most studies there was less difference 
among other ethnic groups including Asian, 
Hispanic, South Asian and white women290,294-
296,298,299 although some found higher rates of 
caesarean section in South Asian304 or Asian 
women307.  Maori women have lower caesarean 
section rates than other New Zealand women308.  
Australian aboriginal women under the age of 35 
have higher caesarean section rates than other 
Australian women, and lower rates if they are 35 
years or older29. 
One well conducted observational study in the 
United Kingdom found that black and South Asian 
women were more likely to have emergency 
caesarean section (adjusted odds ratios 1.49 [95% 
CI 1.41-1.58] and 1.22 [95% CI 1.10-1.34] 
respectively) but no differences in rates of elective 
caesarean section304, but the finding for South 
Asian women was not confirmed in another 
study117.  Others have reported higher rates of both 
caesarean section for slow progress in labour and 
‘fetal distress’ in labour in black women in the 
United States299,309,310. 
Removing race and ethnicity from a Californian 
population based predictive model for primary 
caesarean section that included age, race, ethnicity, 
medical conditions, gestational age, multiple births, 
insurance, nulliparity, complications of pregnancy 
and the trimester in which antenatal care did not 
alter model performance (c statistic 0.76 and similar 
Hosmer Lemeshow test results in both models) and 
the authors suggested that race and ethnicity were 
markers of other model variables311. 
Table 1.5 
Height distribution and caesarean section in Scotland in the 1940’s 262,263 
 Aberdeen nursing 
home I (expensive) 
Aberdeen 
nursing home 2 
(cheaper) 
Aberdeen 
Maternity Hospital 
Glasgow 
Maternity Hospital 
n 377 176 1019 1037 
Height < 150 cm 1.1% 3% 14% 27% 
Height 150 – 157cm 16% 36% 46% 46% 
Height > 158 – 167 cm 59% 48% 34% 24% 
Height ≥ 178 cm 24% 13% 6% 3% 
Caesarean section 
(< 150cm height) 
50% (2/4) - 4% (6/141) 19% (42/216) 
Caesarean section  
(≥ 150cm height) 
2% (6/369) - 1% (8/878) 2% (12/566) 
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Thus, like socioeconomic status, ethnicity is a 
complex variable that may have different 
associations with caesarean section over time and 
geographic location and may be difficult to 
incorporate into a predictive model translatable to a 
range of clinical settings. 
Clinical predictors 
Symphysis-fundus height 
Symphysis-fundal height is the midline surface 
measurement from the superior aspect of the pubic 
symphysis to the uterine fundus312, although 
variations in measurement technique may 
contribute to interobserver error313.  It is commonly 
used to screen for fetal growth restriction and large 
for gestational age fetuses312,314 with varying 
reported sensitivities312,314-317.  The one randomised 
trial found a reduced sensitivity for detecting fetal 
growth restriction when fundal heights were 
measured, compared with when they were not318.  
Others have used regression models incorporating 
fundal height or multiplied fundal height by 
abdominal girth at the level of the umbilicus to 
estimate fetal weight, with no clear additional 
benefit319,320. 
There is a correlation between fundal height and 
birthweight321, but ultrasound measured abdominal 
circumference was a better predictor of both small 
and large for gestational infants in one large 
observational study322. 
One study in Wales, in the 1980’s, described the 
correlation between caesarean section and 
symphysis-fundus height323.  They described 
caesarean section rates of 13%, 7%, 11% and 29% 
among 402 nulliparous women at <10th, 10th-50th, 
50th-90th and > 90th centile lines for fundal height 
respectively.  Rates of labour dystocia or second 
stage delay were 20%, 29%, 36%, and 67% in 
these four groups respectively. 
Thus limited data suggest a relationship between 
symphysis-fundus height and caesarean section. 
Clinical Pelvimetry 
Although clinical measurements correlate poorly 
with X-ray measurements49,324,325, measurements 
such as the external obstetric conjugate, Michaelis 
transverse diagonal and intercrestal diameter were 
associated with caesarean section for slow 
progress in labour and with cephalopelvic 
disproportion326,327.  Other measurements including 
the interspinous diameter estimated on vaginal 
examination and the intertrochanteric diameter 
measured externally were associated with slow 
progress in some, but not all observational 
studies327,328. 
Gestational diabetes 
There is a strong evidence of an association 
between gestational diabetes mellitus and 
caesarean section108,329,330.  In a large multinational, 
well-conducted observational study, serum plasma 
glucose levels were associated with caesarean 
section in women with no previous caesarean with 
odds ratios of 1.38 (95% CI 1.32-1.44), 1.46 (95% 
CI 1.39-1.53), and 1.38 (95% CI 1.32-1.44) per 
0.4mM (one standard deviation) increase in serum 
glucose, for fasting, one hour and two hour post 75g 
glucose load respectively330. The analysis adjusted 
for multiple confounders including BMI, height, and 
infant’s sex, but not parity. 
It remains unclear if control of hyperglycaemia 
during pregnancy reduces the chance of caesarean 
section.  Of two large multicentre randomised trials 
of screening for gestational diabetes and 
subsequent multidisciplinary management, one 
found a reduction in caesarean section331 and the 
other did not332.  Systematic reviews found no 
difference although the confidence intervals almost 
crossed one, with odds ratios of 0.86 (95% CI 0.72-
1.02)333 and 0.90 (95% CI 0.79-1.01)334. 
These data suggest that higher serum glucose 
levels due to less stringent control of gestational 
diabetes, or more severe gestational diabetes is 
associated with caesarean section and that 
gestational diabetes is a candidate risk factor for 
antenatal models for predicting caesarean section. 
Bishop score 
Originally named the “pelvic score”, the Bishop 
score is the sum of five component scores for 
cervical dilatation (cm), effacement (%), station 
(from 3 cm below to 3cm above the ischial spines), 
consistency, and position335.  It was inversely 
correlated with time to delivery and the authors 
proposed it could be used to predict preterm labour, 
corroborate the estimated date of confinement, or 
assist in determining the time of elective caesarean 
section335. 
Decreasing Bishop score is strongly associated with 
emergency caesarean section following attempted 
induction of labour336, but there are few reports of 
its relationship with intrapartum caesarean section 
in a general obstetric population.  In a small 
prospective cohort of nulliparous women planning 
spontaneous onset of labour and a vaginal birth, 
there was a statistically significant increase in 
caesarean section for a Bishop score of ≤ 5 versus 
> 5 at 38 to 40 completed weeks’ gestation337 and 
the areas under the ROC curve were 0.77 and 0.73 
at 37 and 39 weeks respectively. 
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Thus, on the basis of one study, Bishop score is a 
candidate for incorporation into a model to predict 
caesareans section in labour. 
Hyperflexibility 
During parturition, the fetus passes through not only 
the bony pelvis, but also the overlying soft tissues, 
including fatty tissues, muscles such as the 
iliopsoas, the bladder, the muscles of the pelvic 
floor and their anatomical attachments338.  It is 
anatomically plausible that hyperflexibility, 
characterised by soft tissues of greater compliance, 
could be associated with successful vaginal birth.  
Changes in connective tissue collagen, for example,  
could affect the sacroiliac and pubic symphysis 
joints of the pelvis338.  
As far back as the 1800’s, it was thought that the 
pelvic diameters increased during parturition due to 
diastasis of these joints or through a rocking motion 
such that the iliac crests moved towards each other 
as the ischial tuberosities separated to 
accommodate passage of the fetus through the 
pelvic outlet339.  Pelvic moulding is thought to occur 
in labour through movement at the sacroiliac 
joints340. 
One retrospective observational study was 
identified which found that maternal hyperflexibility 
was associated with fully dilated caesarean section 
or operative vaginal vaginal delivery341.    Beighton 
(1969)338 described a simple scoring system which 
assigns one point to (i) passive extension of the fifth 
digit of the hand to more than 90o relative to the 
forearm, bilaterally; (ii) passive apposition of the 
thumb to the anterior aspect of the forearm 
bilaterally; (iii) passive hyperextension of the elbows 
beyond 10⁰ bilaterally; (iv) passive hyperextension 
of the knees beyond 10o bilaterally; and (v) forward 
flexion of the trunk such that the palms of the hands 
are flat on the floor338.  The first four of these score 
up to two points (one for each side of the body) and 
the fifth scores up to one point, for a maximum 
score of nine338.   
Thus, there is insufficient evidence to assess 
maternal flexibility as a predictor of caesarean 
section in labour, but the concept deserves further 
research.  
Imaging predictors 
Pelvimetry 
The invention of clinical radiography in 1895 by 
Wilhem Roentgen338 was followed by descriptions 
of X-ray pelvimetry in 1897338 and 1900342 and later 
by detailed X-ray studies of the morphology and 
dimensions of the female pelvis46,343,344.  In an era 
when cephalopelvic disproportion was dangerous to 
the fetus345-352 and caesarean section was 
associated with high rates of maternal 
complications338, X-ray pelvimetry was studied 
intensely.  From the 1940s onwards, an impressive 
array of publications were devoted to the 
topic46,49,51,342,343,353-360 and an initially skeptical 
obstetric community was for the most part 
converted to the idea that at least for suspected or 
borderline pelvic contraction, pelvimetry could 
predict cephalopelvic disproportion and avoid 
difficult intrapartum operative deliveries342,361,362.  
The basic assumptions were that if X-ray pelvimetry 
could be perfected then (1) emergency caesarean 
section in labour could be predicted allowing 
preemptive elective caesarean; and/or (2) selective 
intrapartum pelvimetry would prevent unnecessary 
caesarean section for presumed cephalopelvic 
disproportion and lead to timely caesarean section 
when it was present.  It was believed that these in 
turn would lead to better maternal and infant 
outcomes362,363. 
In the 1960’s the popularity of X-ray pelvimetry 
declined due to concerns about its safety and 
predictive properties.  Fetuses exposed to ionising 
radiation had an increased risk of malignancy later 
in life364-368.  Although X-ray pelvimetry was clearly 
associated with cephalopelvic disproportion 
49,325,355,357,369,370, there were always at least a few 
cases where women predicted to have 
cephalopelvic disproportion had a normal vaginal 
birth51,370,371.  Thus, using X-ray pelvimetry to select 
for elective caesarean section caused some 
unnecessary operations.  In the meantime, 
cephalopelvic disproportion had become safer for 
the fetus and caesarean section safer for the 
mother creating an environment where a trial of 
labour could safely be considered to be the only 
true pelvimeter372,373, a view which still 
predominates today338.  Under this new paradigm, 
intrapartum pelvimetry was all but abandoned.  One 
author commented: 
“All of us have had the experience of sending a 
patient down to x-ray because of slow progress in 
labour, to find, on her return to the labour ward, the 
head resting on the perineum.  The only value of 
the x-ray in these cases was the additional time 
required to take the film, coupled with the uncertain 
role played by the elevator ride” (Hannah, 1965)372 
 
It was found that antenatal pelvimetry made little 
difference to management decisions58,371,372,374-380 
and the investigation was restricted to indications 
such as vaginal breech delivery or vaginal birth after 
caesarean section.  Additionally, in one small 
randomised controlled trial, X-ray pelvimetry did not 
affect the rate of caesarean section 381. 
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Pelvimetry and ionising radiation on the 
fetus 
An association between antenatal X-ray pelvimetry 
and childhood cancer was first described in a series 
of publications in the 1950’s to 1970’s366,382-387.  In 
large case control studies, the odds ratio of 
childhood leukaemia and malignant solid tumours 
was about 1.5364-368.  Early studies had found no 
difference but were too small to detect an odds ratio 
less than 2388-390.  One larger case control study 
with 1,842 cases of acute lymphoblastic leukaemia 
in childhood found no association (RR 1.1 (95% CI 
0.9-1.2)), possibly because the exposure occurred 
from the 1970s to 1990s when fetal absorbed doses 
of radiation were lower391.  In another case control 
study, comparison of interviewed subjects’ recall 
with actual clinical records revealed that around 
three quarters of X-ray examinations were not 
mentioned in the interview368, raising the possibility 
that recall bias could have influenced the presence 
or size of the estimated association. 
From the 1940s to the 1960s, typical fetal radiation 
doses fell from around 4.6mGy to 2.0mGy per film 
with most women exposed to X-rays having two or 
more films387.  Digital radiography for CT pelvimetry 
reduced fetal doses to 0.1mGy to 0.55mGy for two 
scout views392-398.   A preliminary study using EOS 
imaging sensors reported a reduction in the 
radiation required to 0.08mSv399, biologically 
equivalent to about 0.08mGy400 and preliminary 
images suggested that a further 10-fold reduction to 
less than 0.01mGy was possible399. 
Based on the largest case control study, it has been 
estimated that the 10 year risk of (leukaemia) is 572 
excess cases per million rad years387, although 
observations among survivors of the Hiroshima and 
Nagasaki attacks of World War II suggest the risk is 
lower401.  As the typical fetal radiation dose 
associated with maternal pelvimetry was about 
8.85mGy402, this equated to a 10 year risk of about 
one in 2,000 for an exposed child.  However, as the 
excess risk appears to be linearly related to the 
dose of radiation366, the use of modern techniques 
should in theory reduce this risk.  By extrapolation, 
the risk of excess childhood malignancy following 
an exposure of 0.5mGy would be 1 in 32,000 and 
for an exposure of 0.1mGy would be 1 in 160,000.  
In comparison, the average radiation dose from the 
environment is about 3.0mSv per year403 and fetal 
exposure on a 24 hour flight of 0.14 mSv on a high 
radiation flight path.  These are equivalent to about 
3.0mGy and 0.14mGy respectively403.  Thus, 
pelvimetry could be reintroduced into clinical 
practice if it was demonstrated to be of clinical 
benefit.  Further, the assumption of linear 
association between radiation dosage and risk of 
malignancy is based on fetal doses of 2 mrad or 
more and there may be a threshold dose below 
which there is no additional risk404 in which case 
modern CT pelvimetry could be associated with no 
increased risk at all.  Magnetic resonance imaging 
is not known to be associated with adverse fetal 
effects and is therefore preferred to CT scans, but 
availability and cost restrict its widespread use400. 
The accuracy of pelvimetry has always been 
tempered by knowledge that factors other than the 
size of the fetus or pelvis can lead to failure to 
progress in labour.  Even before widespread use of 
pelvimetry in the 1940's, it was recognised that fetal 
moulding, maternal effort, uterine contractility and 
resistance of the soft tissues in the pelvic floor must 
play an important role324,355,363,405.  While this may 
explain some of the diagnostic inaccuracies of 
pelvimetry, it could still be incorporated into a more 
general predictive model. 
The associations between individual pelvic 
parameters and operative delivery for presumed 
cephalopelvic disproportion are described below: 
Pelvic inlet: 
The pelvic inlet is the most superior aspect of the 
true pelvis338 and is used to define the basic 
morphological subtypes of the human pelvis343.  
Common pelvimetry measurements include the 
anteroposterior (AP) pelvic inlet or shortest distance 
between the symphysis pubis and sacrum in the 
midline338 and transverse pelvic inlet or longest 
distance between ileopectineal lines at a right angle 
to the AP inlet338 (Figure 1.9).  Commonly used 
calculated measurements include the inlet area, 
inlet product (AP pelvic inlet x transverse pelvic 
inlet), inlet sum (AP pelvic inlet + transverse pelvic 
inlet) and inlet volume.  With few exceptions, 
observational studies show a clear association 
between AP pelvic inlet49,58,361,371,406-411, transverse 
pelvic inlet49,361,411, inlet area or 
product48,49,361,407,411,412, inlet sum49,371,413 and inlet 
capacity361,371,407 and evidence of cephalopelvic 
disproportion such as caesarean section or "difficult 
delivery" (Figure 1.10).  Some studies found no 
association between the AP375,413,414 or transverse 
pelvic inlet414 and evidence of cephalopelvic 
disproportion, possibly due to insufficient statistical 
power.  Due to the large number of studies with 
different epidemiologic and imaging methodologies 
it is not possible to comment on which pelvic inlet 
parameters are more strongly associated with 
cephalopelvic disproportion except to say that the 
preponderance of evidence supports a strong 
relationship between pelvic inlet measurements and 
cephalopelvic disproportion. 
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Midpelvis: 
The midpelvis lies between the pelvic inlet and 
pelvic outlet and is most commonly defined by the 
interspinous diameter, the shortest distance 
between the ischial spines, and its AP diameter, a 
straight line extending from the inferoposterior 
aspect of the symphysis pubis through the 
interspinous diameter and to the sacrum in the 
midline338 (Figure 1.9).  Some authors describe the 
AP diameter as the distance sum of two lines 
meeting at an angle subtended from the 
interspinous diameter to the points on the 
symphysis pubis and sacrum closest to this 
diameter361.  Commonly used calculated 
measurements include the midpelvis area, 
midpelvis product (AP midpelvis x interspinous 
distance), midpelvis sum (AP midpelvis + 
interspinous distance), midpelvis circumference and 
midpelvis volume.  As for the pelvic inlet, the 
majority of studies show a clear association 
between the AP midpelvis27,361,371,411,414, 
interspinous distance27,361,371,375,406,407,413, midpelvis 
area or product48,49,361,412,415, midpelvis sum371, 
midpelvis circumference27 and midpelvis volume 
(Figure 1.10).  Recent studies using post-partum 
pelvimetry or MRI have reported promising areas 
under the receiver operator characteristic curve of 
0.78 to 0.88 for predicting caesarean section (Table 
1.6). 
Pelvic Outlet: 
The pelvic outlet is defined by the intertuberous 
distance, the shortest distance between the ischial 
tuberosities transversely, and the AP pelvic outlet, 
the shortest distance from the inferoposterior aspect 
of the symphysis pubis and most inferior aspect of 
the sacrum (figure 1.9).  Most authors describe the 
AP diameter as a straight line but some describe 
two lines meeting at an angle subtended from a line 
drawn between the ischial tuberosities361.   
Commonly used calculated measurements include 
the pelvic outlet area, pelvic outlet product (AP 
pelvic outlet x intertuberous distance), and pelvic 
outlet sum (AP midpelvis + interspinous distance).  
Most studies show an association between the AP 
pelvic outlet361,407,409,413, intertuberous 
distance361,413, pelvic outlet area or product361 and 
pelvic outlet sum371 with evidence of cephalopelvic 
disproportion such as caesarean section or "difficult 
delivery" (Figure 1.10).  Some authors believe the 
pelvic outlet parameters are less associated with 
cepholapelvic disproportion because they can 
increase during parturition to accommodate the 
Figure 1.9  
Pelvic dimensions 
Figure 1.9a (Ince 1940)46 (left) 
Sagittal view of the pelvis 
AB = AP inlet 
XM = AP midpelvis 
YE = AP outlet 
Figure 1.9b (Wolf 1954)47 (above) 
Coronal/transverse view of the pelvis 
A = transverse pelvic inlet 
B = transverse midpelvis (interspinous distance) 
C = transverse pelvic outlet 
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Figure 1.10b: Pelvic inlet, midplane and outlet 
areas inversely associated with labour 
dystocia (Glenn 1954)48 
Figure 1.10a: Pelvic midplane or inlet areas 
< 95 cm2 were associated with high rates of 
labour dystocia (Davis 1958)50 
Figure 1.10d: Interspinous diameter < 
9.4cm was associated with high rates of 
caesarean section (Weinberg 1952)49 
Figure 1.10e: Pelvic inlet product < 85cm2 
was associated with caesarean section 
(Weinberg 195249) 
Figure 1.10 
Examples of pelvic dimensions as predictors of caesarean section 
Figure 1.10f: ROC AUC = 0.88 for 
midpelvis AP diameter and 0.85 for 
midpelvis circumference (Harper 2013)27 
AP = anteroposterior; AUC = area under the curve; ROC = receiver operator characteristic 
Figure 1.10c: Pelvic inlet sum < 22cm 
was associated with high rates of labour 
dystocia (Weinberg 1952)49 
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fetus (pelvic moulding) or are generally larger than 
the midpelvis or pelvic inlet49,416. 
While the relationship between the pelvic outlet 
dimensions and cephalopelvic disproportion may be 
weaker than for the inlet or midpelvis 
dimensions371,411, this has not been tested formally 
and the importance of the pelvic outlet for predicting 
cephalopelvic disproportion remains unclear. 
Pelvimetry using other imaging modalities 
A variety of imaging modalities have been used to 
measure pelvic dimensions and assess their 
potential role as predictors of caesarean section 
overall among women planning a vaginal birth or for 
caesarean section for failure to progress or 
cephalopelvic disproportion.  Magnetic resonance 
imaging is potentially useful and is not associated 
with radiation exposure, but is at this stage is too 
expensive and impractical for general 
use27,361,414,417,418. 
Fetal imaging 
Antenatal ultrasound 
The few retrospective observational studies which 
address the association between antenatal 
ultrasound and intrapartum caesarean section show 
conflicting results419-421.  There is a risk that the 
investigation itself could increase interventions. 
Observational studies are susceptible to bias 
because the underlying factors which led to 
ultrasound examination could also be associated 
with caesarean section419-421.  One Israeli 
observational study of women who had an 
ultrasound within three days of birth found that 
estimated fetal weight was a stronger predictor of 
prelabour caesarean section and caesarean section 
for slow progress than actual birthweight, 
suggesting that ultrasound does lead to 
unnecessary intervention (Figure 1.11)26.  If 
confirmed, this is a potential barrier to routine third 
trimester ultrasound, especially given the propensity 
of ultrasound biometry to over-estimate fetal weight 
when the fetus is large422. 
Fetal biometry 
There are limited data on fetal biometry for 
predicting caesarean section.  These are discussed 
in Chapter 4, Part C. 
Indices of fetal head and maternal pelvis 
Prior to the invention of obstetric ultrasound, 
prelabour diagnosis of cephalopelvic disproportion 
relied on maternal pelvimetry although it was still 
recognised that: 
“Obstetric disproportion means an unfavourable 
relationship of the foetal head to the maternal 
pelvis, and it is therefore illogical to study one 
without the other” (Moir, 1946)356. 
However, fetometry based on X-ray images alone 
was considered unreliable due to factors such as 
the variable position of the fetus and image 
magnification345,356.   
Figure 1.11 
Operative delivery, estimated fetal weight, and actual birthweight 26 
Operative delivery was more strongly related to estimated fetal weight than actual birthweight in this Israeli 
retrospective observational study suggesting the decision for intervention was biased by apparent knowledge 
of fetal macrosomia.  Other studies show conflicting results. 
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To account for the size of both the fetus and the 
maternal pelvis, indices were proposed where fetal 
head measurements are subtracted from those of 
the maternal pelvis (Table 1.7 and Figure 
1.12)53,426,427.  For an X-ray determined “difference 
at the inlet”, Steer (1958) found a caesarean section 
rate of 2%, 13%, 43% and 76% for measurements 
of > 1.7cm, 1.5-1.7cm, 1.1-1.4cm and < 1.1cm 
respectively.  In a small external validation study, 
Mandry426 reported a caesarean section rate of 6%, 
38% and 100% for indices of > 1.82cm, 1.4 – 
1.82cm and < 1.4cm. 
The most studied method is the fetal pelvic index427, 
originally found to be strongly predictive of 
cephalopelvic disproportion with a sensitivity of 0.80 
and a specificity of 0.98427-431.  However, in a 
pooled analysis of 9 studies, Korhonen et al (2015) 
reported a sensitivity of 0.63 for a specificity of 0.82, 
a positive likelihood ratio of 3.5 and an odds ratio of 
8.1432.  In a recent study, areas under the receiver 
operating characteristic curve were 0.69 among 274 
women with cephalic presentation and an indication 
for pelvimetry, 0.85 among 221 nulliparous women 
and 0.83 among 207 women planning a vaginal 
birth after a previous caesarean section423.  The 
latter two figures increased to 0.88 and 0.89 
respectively when maternal race, age, presence of 
medical risk factors, and labour induction were 
included in a multivariable model.  In two study 
populations, the areas under the curve were similar 
when only the AP diameter of the midpelvis was 
used suggesting that the fetal pelvic index performs 
no better than pelvimetry alone27,418,423. 
Cervical imaging 
Cervical length  
Few studies have assessed the relationship 
between cervical length on transvaginal 
ultrasound338,  and intrapartum caesarean section in 
a general obstetric population, although the 
relationship is well studied prior to induction of 
labour369,433-444.  In a meta-analysis of 30 
observational studies and one randomised 
controlled trial, the summary receiver operator 
curves showed a sensitivity of 0.82 for a false 
positive rate of 0.66 and a sensitivity of 0.64 for a 
false positive rate of 0.26 among women 
undergoing labour induction444.  The studies were 
judged to be of mediocre quality and there was 
substantial heterogeneity of the populations and 
estimates of effect444. 
However, women who require induction of labour 
usually have underlying pathology such as pre-
eclampsia, suspected macrosomia, post-dates 
pregnancy, gestational diabetes and other medical 
and pregnancy related conditions1.  It is unknown if 
the relationship between cervical length and 
caesarean section is modified by the requirement 
for induction of labour but such an interaction is 
plausible.  For example, a long, closed cervix could 
be more resistant to cervical ripening agents338 and 
waiting for the cervix to become "more favourable" 
(softer, shorter and more dilated) is commonly 
advocated on this basis338.  The assumption is that 
Table 1.6 
Areas under the receiver operating characteristic (AUC) curve for imaging pelvimetry and fetal head / 
maternal pelvis indices for predicting caesarean section for cephalopelvic disproportion 
Measurement Modality Population Outcome AUC Author 
Midpelvis AP diameter X-ray 
pelvimetry 
Women > 36 
weeks  
CS in women 
planning 
vaginal birth 
0.88 Harper (2013)27 
Fetal pelvic Index U/S and 
X-ray 
pelvimetry 
Nullips and 
TOLAC 
CS in women 
planning 
vaginal birth 
0.85 (nullips) 
0.83 (TOLAC) 
Macones (2013)423 
Borell  
Colcher  
Friedman424 
Mengert425 
Fetal pelvic index 
Midpelvis AP diameter 
Midpelvis AP:HC 
CT Women who 
had a CT < 1 
week post-
partum 
Normal vaginal 
birth v Assisted 
birth for 
cephalon-pelvic 
disproportion 
0.50 
0.52 
0.59 
0.50 
0.67 
0.87 
0.86 
Lenhard (2009)414 
Obstetric conjugate 
Midpelvis AP diameter 
Interspinous distance 
Fetus:Pelvis ratios 
MRI  CS for slow 
progress 
0.65 
0.78 
0.75 
0.64-0.77 
Zaretsky (2005) 418 
AP = anteroposterior; CS = caesarean section; CT =  computerised axial tomography; HC = head circumference; MRI = 
magnetic resonance imaging; nullips = nulliparous women; TOLAC = trial of labour after caesarean; U/S = ultrasound 
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Figure 1.12b: Application of volumetric 
method using fetal head and pelvis volume on 
X-ray (Weinberg 1952)49 
Figure 1.12a: Application of volumetric 
method using fetal head and pelvis volume 
on X-ray (Weinberg 1952)49 
Figure 1.12c: X-ray based volumetric  
attempt to predict CS for CPD using fetal 
head and pelvic inlet (Schwarz 1956)51 
Figure 1.12 d: X-ray based volumteric  
attempt to predict CS for CPD using fetal 
head and midpelvis (Schwarz 1956)51 
Figure 1.12e: AP inlet and birthweight in a 
later publication showing poor prediction of 
CS (Joyce 1975)58 
Figure 1.12 
Examples of fetal-pelvic dimensions as predictors of caesarean section 
Figure 1.12f: X-ray based measurements 
used to find the smallest (cut out) circle that 
fits into the pelvis (Steer 1958)53 
AP = anteroposterior; CPD = cephalopelvic disproportion; CS = caesarean section 
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cervical changes over time will make future 
induction of labour more successful.  Thus, a 
positive relationship between cervical length at the 
time of induction and caesarean section does not 
necessarily translate to a positive relationship if 
induction is delayed (see Figure 1.14). 
Two observational studies found a relationship 
between increased cervical length at 37 weeks' 
gestation and intrapartum caesarean section445,446 
and one did not447.  One study found an association 
when cervical length was measured in the mid-
trimester448.  Thus, the relationship between 
antenatal cervical length and intrapartum caesarean 
section remains unclear. 
An association between cervical length and 
intrapartum caesarean section could be mediated 
through pressure of the presenting part on the 
cervix as it descends into the pelvis near term, 
potentially inducing the release of endogenous 
cervical prostaglandins resulting in cervical change.  
Alternatively, inherent cervical factors such as 
reduced elasticity or responsiveness to hormonal 
stimulation could play a role. 
Fetal position 
Occiput posterior and occiput transverse position (in 
the form of deep transverse arrest) are associated 
with adverse obstetric outcomes449,450.  Fetal 
malposition at birth451-453, and in the second stage 
of labour449,450,454,455 is associated with caesarean 
section, but in the first stage of labour the 
relationship is less clear451,456,457, potentially 
because fetuses commonly rotate into the posterior 
position during the course of labour451,458,459.  
Occiput posterior position prior to induction of 
labour was not related to caesarean section in two 
observational studies459,460 and no studies were 
found that assessed this relationship in a general 
obstetric population.  In a systematic review which 
included 11 observational studies, the authors 
concluded that ultrasound determined fetal position 
in early labour or before labour did not predict 
caesarean section461. 
Fetal station 
Fetal station is estimated on digital vaginal 
examination and is the lowest point of the 
presenting part, where station 0 is at the level of the 
ischial spines.  In Australia, station +3 is 5 cm below 
the spines, defined as the fetal part being visible at 
the introitus without parting the labia, and station -3 
is 5cm above the level of the spines and every unit 
of change therefore represents 1
2
3
 cm. 
Attempts to estimate station sonographically using 
the distance from the fetal head to the sacral tip 
date back to 1977462 but it was not until the last 
decade that more accurate transperineal methods 
were described (Figure 1.13).  With one notable 
exception30, they use a line drawn at right angles to 
the most inferoposterior point of the long axis of a 
midline sagittal section of the symphysis pubis, 
sometimes called the infrapubic line55,61.  Unlike 
vaginal examination and abdominal palpation463, 
they have high interobserver intraclass correlation 
co-efficients and high repeatability23,55,59,464-467. 
Station can be measured perpendicularly from the 
infrapubic line to the leading edge of the fetal skull 
(Figure 1.13a)55 or along the longest visible axis of 
the fetal head minus the estimated 3 cm between 
the infrapubic line and the ischial spines (Figure 
1.13d)59.  Alternatively, it can be inferred from the 
angle of progression, subtended from the long axis 
of the symphysis pubis in the midline and a line 
from the most inferoposterior aspect of the 
Table 1.7 
 Indices of the fetal head and maternal pelvis 
Authors Method Description 
Steer 195853 X-ray cephalopelvimetry (1) Difference at the inlet: diameter of the largest circle 
which fits the pelvic inlet minus FHD 
(2) Difference at the spines: IS diameter minus FHD 
Mandry et al 1983426 X-ray pelvimetry and fetal 
sonography 
Mean of minimum and maximum pelvic inlet diameters 
minus fetal biparietal diameter 
Morgan et al 1986 
(“Fetal pelvic index”)427 
X-ray pelvimetry and fetal 
sonography 
Sum of the two most positive values of: 
PIC* – HC, PIC* – AC, MPC* – HC and MPC* – AC 
 MRI  
AC = fetal abdominal circumference; BPD = fetal biparietal diameter; HC = fetal head circumference; FHD = fetal head 
diameter; IS = interspinous; MPC = midpelvis circumference; PIC = pelvic inlet circumference 
*circumference = transverse dimater + anteroposterior diameter) × 
π
2
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symphysis tangential to the fetal skull (Figure 
1.13c).  This so-called angle of progression 
necessarily increases as the fetal head descends 
but estimates of the angle which correspond with 
station 0 vary from 99⁰ to 119⁰ 59,60,468 suggesting 
problems with calibration.  Potential sources of error 
include reliance on geometric modelling from 
computerised axial tomography scans in non-
pregnant women60, reliance on a single 
computerised axial tomography scan to estimate 
the distance between the infrapubic line and ischial 
spines59, and extrapolation based on 
measurements above the ischial spines468.  Other 
methods include the head-perineum distance from 
the perineum to the fetal presenting part measured 
with the ultrasound probe held transversely with firm 
pressure over the ischial tuberosities with the 
woman in the supine position (Figure 1.13b)30, and 
the fetal head-symphysis distance from the 
inferoposterior symphysis pubis to the nearest part 
of the fetal skull (Figure 1.13f)23. 
Sonographic measurements of fetal station 
correlate well with each other23,469-475 but vaginal 
examination has poor repeatability and varies 
widely for a given ultrasound 
measurement59,60,464,471.  Thus, ultrasound 
measurements are repeatable, provide a 
continuous measurement amenable to statistical 
analysis, and could be a marker of cephalopelvic 
disproportion which would be expected to impede 
descent of the fetus.  Further, there is evidence that 
transperineal ultrasound is less uncomfortable for 
women than digital vaginal examination476,477. 
Two small studies have assessed the association 
between antenatal fetal station and intrapartum 
caesarean section.  Among 100 nulliparous women 
presenting to labour ward at 39 or more weeks’ 
gestation, the median angle of progression was 
104⁰ for women who had a vaginal birth and 90⁰ for 
the 9 women who had a caesarean section478, 
although restriction to women with ultrasound within 
a week of birth was a potential source of bias.  The 
area under the ROC curve for prediction of 
caesarean section was 0.88 suggesting angle of 
progression would be a useful component of a 
model for predicting caesarean section.  In another 
study of 152 women of mixed parity with 
spontaneous prelabour ruptured membranes, 
caesarean section was performed in 4% (4/54) with 
a head-perineum distance < 45 mm and in 15% 
(15/98) women with a distance of 45 mm or more30 
but the analysis for this outcome was not adjusted 
for parity. 
Angle of subpubic arch 
The angle of the subpubic arch has been defined as 
the angle subtended from the apex of the pubic 
symphysis in the midline and the inferior rami of the 
ischia just before they expand into the ischial 
tuberosities344,356.  A narrow angle on X-ray 
pelvimetry has long been associated with difficult 
birth344.  More recently subpubic angle has been 
measured on 3-dimensional transperineal 
ultrasonography479 and a narrower angle was 
associated with operative delivery, after adjusting 
for maternal height480. 
Predictive modelling 
While this is essentially a clinical thesis, the 
research component makes extensive use of 
predictive modelling and logistic regression 
techniques.  Therefore, predictive modelling is also 
reviewed for the benefit of the author (but the 
clinical reader will be forgiven for skimming over this 
section)… 
In medicine, meta-analyses are often used to 
summarise treatment outcomes.  In an analogous 
way, clinical prediction models may be used to 
summarise the effects of predictors of a diagnostic 
or prognostic outcome481.  There are three main 
types of models: (i) regression models - the most 
commonly used in medicine, (ii) classification 
models, and (iii) neural networks482. 
Logistic regression 
Logistic regression is a generalised linear model 
and is the most commonly used regression for 
binary outcomes in medicine, such as caesarean 
section versus vaginal birth482.  The logistic link 
function reduces the range of the outcome variable 
from all real numbers: (-∞,∞) to a probability or 
proportion: (0,1).  The function is: 
 𝑌 = 𝑙𝑛 (
𝑃
1−𝑃
)  
where P is the predicted probability of a positive 
outcome, and (
𝑃
1−𝑃
) is its odds.  We have: 
ln (
𝑃
1−𝑃
) = 𝑙𝑛(𝑜𝑑𝑑𝑠) = 𝛼 + 𝛽1𝑥1 +  𝛽2𝑥2 + ⋯ +  𝛽𝑛𝑥𝑛  
or   
𝑃
1−𝑃
= 𝑜𝑑𝑑𝑠 =  𝑒𝛼+ 𝛽1𝑥1+ 𝛽2𝑥2+⋯+ 𝛽𝑛𝑥𝑛 
=  𝑒𝛼𝑒𝛽1𝑥1𝑒𝛽2𝑥2  … 𝑒𝛽𝑛𝑥𝑛   
It can be seen that increasing a covariate (say 𝑥1) 
by a single unit will result in a predicted odds of: 
𝑒𝛼𝑒𝛽1(𝑥1+1)𝑒𝛽2𝑥2  … 𝑒𝛽𝑛𝑥𝑛 
= 𝑒𝛼𝑒𝛽1𝑥1+𝛽1𝑒𝛽2𝑥2  … 𝑒𝛽𝑛𝑥𝑛 
=  𝑒𝛽1𝑒𝛼𝑒𝛽1𝑥1𝑒𝛽2𝑥2  … 𝑒𝛽𝑛𝑥𝑛   
=  𝑒𝛽1𝑒𝛼+ 𝛽1𝑥1+ 𝛽2𝑥2+⋯+ 𝛽𝑛𝑥𝑛   
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Figure 1.13b: Fetal head-perineum distance 
using a transversely placed probe over ischial 
tuberosities (Eggebo et al 2006)30 
Figure 1.13a: Progression distance 
measured perpendicular to the infrapubic 
line (Dietz et al, 2005)55 
Figure 1.13c: Angle of progression 
relative to midline sagittal axis of pubic 
symphysis (Barbera et al 2009)60 
Figure 1.13d: Progression distance 
measured along the long axis of the fetal 
head from 3cm below the infrapubic line 
(Tutschek et al 2011)59 
Figure 1.13e: Head direction (‘down’ < 0⁰, 
‘horizontal’ 0-<30⁰, ‘up’ ≥ 30⁰ relative to 
midline sagittal axis of symphysis 
pubis)(Henrich et al 2006)61 
Figure 1.13 
Potential predictors of caesarean section on translabial ultrasound 
Figure 1.13f: Fetal head-symphysis 
distance (Youssef et al 2013)23 
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Thus, if we let the linear predictor: 
𝑙𝑝 = 𝛼 + 𝛽1𝑥1 + 𝛽2𝑥2 + ⋯ + 𝛽𝑛𝑥𝑛, then 
𝑜𝑑𝑑𝑠 =  𝑒𝑙𝑝   , and if we then increase 𝑥1 by a single 
unit then: 
𝑜𝑑𝑑𝑠 = 𝑒𝛽1𝑒𝑙𝑝 
Thus, 𝑒𝛽1 is the odds ratio for a single unit increase 
in the covariate, 𝑥1. 
For a binary explanatory variable, 𝑥𝑖 is coded as 0 
or 1, and a change in category from 0 to 1 
represents a single unit increase in 𝑥𝑖 and 𝑒
𝛽𝑖 is the 
odds ratio.  For variables with 𝑛  categories (eg 
country of birth), 𝑛 − 1  dummy variables are 
created, each coded as 0 or 1.  Only one of these 
can take on a value of 1 (as categories are mutually 
exclusive) and all dummy variables equal 0 when 
the referent category is present. 
As for multiple linear regression, logistic regression 
detects interaction by introducing multiplication 
terms such as 𝑥1𝑥2 and testing the null hypothesis 
that the β-coefficient for the term equals zero. 
Logistic regression uses maximum likelihood 
methods to estimate the 𝛽 -coefficients which 
usually require computer algorithms to solve483. 
When the assumed likelihood function is correct, 
large sample properties of maximum likelihood 
estimators include: (i) unbiasedness, (ii) minimum 
variance, and (iii) normal distribution483.  Other 
properties of the maximum likelihood method 
include the ability to test hypotheses using Wald 
statistics and likelihood ratio tests and estimation of 
confidence intervals around regression parameters. 
Adding more explanatory variables to a logistic 
regression model can only increase the amount of 
variability in the outcome attributed to them.  The 
expression −2𝑙𝑛𝐿  (the log-likelihood statistic), 
analogous to 𝑅2 in linear regression, can be used, 
where 𝐿 = the maximum likelihood estimator.  It can 
be shown that the difference in  −2𝑙𝑛𝐿’s between 
two hierarchical models (where 𝑛  variables are 
added to a less complex model) follows a χ𝑛
2  
distribution for large dataset, forming the basis of 
the likelihood ratio test483 which is considered to 
have better statistical properties than the Wald test 
and is generally recommended483. 
Neural networks 
Neural networks are a non-linear extension of 
logistic regression models484.  A typical neural 
network consists of a series of ‘nodes’ arranged in 
three (input, hidden and output) layers connected 
by weighted connections485.  The initial weights are 
randomly allocated and training algorithms are used 
to gradually minimise the difference between the 
predicted output of the system and the known 
values of the outcome variables485.  They are 
susceptible to overfitting although techniques exist 
to reduce this486.  Neural networks have been used 
for clinical prediction modelling but there is no 
apparent advantage compared with multiple logistic 
regression.  In external validation studies, some 
studies found neural networks performed better487, 
some found logistic regression performed better488-
490, and some found no difference491-494. 
CART methods 
Classification and regression tree (CART) methods 
use recursive partitioning to construct binary 
decision trees484.  Subjects are divided into pairs 
with the partition associated with the greatest 
separation with respect to the outcome at the top of 
the tree, the next greatest at the next level and so 
on.  Partitioning occurs until subgroups reach a 
minimum size or the best fitting model is obtained.  
CARTs are believed to be more representative of 
human thinking than other methods such as logistic 
regression but this is not necessarily an 
advantage484.  One advantage is that trees naturally 
incorporate interaction terms but disadvantages 
include the loss of information implicit with dividing 
continuous data into categories, and the risk of 
testimation bias484. 
Other methods 
Other methods of predictive modelling for data with 
a binary outcome are recently developed or still 
under development such as multivariate additive 
regression splines or the use of a support vector 
machine484. 
Measures of model performance 
Nagelkerke’s R2 
In ordinary least squares regression, 
 𝑎𝑑𝑗𝑢𝑠𝑡𝑒𝑑 𝑅2 =
𝑆𝑆𝑟𝑒𝑠/𝑑𝑓𝑟𝑒𝑠
𝑆𝑆𝑡𝑜𝑡/𝑑𝑓𝑡𝑜𝑡
 where 𝑆𝑆𝑟𝑒𝑠  is the sum of 
squares of the residuals and 𝑆𝑆𝑡𝑜𝑡 is the total sum 
of squares around the mean, and 𝑑𝑓𝑟𝑒𝑠  and 𝑑𝑓𝑡𝑜𝑡 
are their respective degrees of freedom.  
𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑 𝑅2  is an unbiased estimated of the 
proportion of variation outcome explained by the 
predictor variables. 
Nagelkerke’s 𝑅2  is an analogous statistic used in 
logistic regression models.  It utilizes the −2𝑙𝑛𝐿 for 
the logistic regression model compared with a null 
model which predicts the average probability of the 
binary outcome495.   
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Brier score 
The Brier score is an alternative to Nagelkerke’s 𝑅2 
for models with binary outcomes495.  It is less 
severe than Nagelkerke’s 𝑅2 at penalising incorrect 
predictions close to 0% or 100%. 
Discrimination and calibration 
Discrimination is the ability to identify subjects with 
or without an outcome495.  Calibration is the level of 
agreement between the predicted and actual 
outcome495.  For example, if we predict 70% 
probability of disease in a group of patients, the 
observed frequency should be 70%495.  
Discriminative ability is more important if the aim of 
a model is to identify a high risk group and 
calibration is more important if the model is used for 
individual patient counselling496. 
At external validation, we can write a recalibration 
equation: 
𝑌𝑛𝑒𝑤 = 𝑎 + 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙?̂?  
for a linear regression model, or 
𝑙𝑜𝑔𝑖𝑡(𝑌𝑛𝑒𝑤) = 𝑎 + 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙?̂?   
for a logistic regression model  
where 𝑌𝑛𝑒𝑤 is the outcome in the external data, and 
?̂? = 𝛼 + 𝛽1𝑥1 + 𝛽2𝑥2 + ⋯ + 𝛽𝑛𝑥𝑛 
Calibration in the large 
Calibration in the large refers to the difference 
between the mean outcome 𝑚𝑒𝑎𝑛(𝑌) and the mean 
predicted outcome 𝑚𝑒𝑎𝑛(?̂?)495.  In a development 
model dataset, 𝑚𝑒𝑎𝑛(𝑌) = 𝑚𝑒𝑎𝑛(?̂?) .  For a new, 
external dataset with outcome 𝑌𝑛𝑒𝑤 , calibration in 
the large is 𝑚𝑒𝑎𝑛(?̂?) − 𝑚𝑒𝑎𝑛(𝑌𝑛𝑒𝑤)  and is 
represented by the intercept in the equation: 
𝑌𝑛𝑒𝑤 = 𝑎 + 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙?̂?. 
Calibration slope 
The calibration slope relates to the strength of the 
predictors in the external dataset relative to the 
prediction model.  It is represented by 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙 in the 
above equation495.  A component of 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙 
represents the amount of shrinkage required at 
internal validation due to overfitting and the 
remainder represents true differences between the 
development and test datasets. 
Other calibration measures 
There are several other calibration measures495.   
For example, Harrell’s E statistic is the absolute 
difference between smoothed observation 
outcomes and predicted probabilities495 
Calibration tests 
For linear regression models, calibration in the large 
may be tested using a one sample T-test of 
𝑚𝑒𝑎𝑛(?̂?) − 𝑚𝑒𝑎𝑛(𝑌𝑛𝑒𝑤)
495.  The model: 𝑌𝑛𝑒𝑤 = 𝑎 +
𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙?̂? may be fitted and used to estimate both 
calibration in the large and the calibration slope. 
Similarly, for logistic regression models, calibration 
in the large can be assessed by testing the null 
hypothesis that 𝑙𝑜𝑔𝑖𝑡(𝑌𝑛𝑒𝑤) − 𝑙𝑜𝑔𝑖𝑡(?̂?) = 0  using a 
Wald or likelihood ratio test495 and the calibration 
slope, 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙  can be estimated by fitting the 
equation 𝑙𝑜𝑔𝑖𝑡(𝑌𝑛𝑒𝑤) = 𝑎 + 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙𝑙𝑜𝑔𝑖𝑡(?̂?). 
Alternatively, the null hypothesis that 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙  = 1 
can be tested by fitting the equation:  
𝑙𝑜𝑔𝑖𝑡(𝑌𝑛𝑒𝑤) = 𝑎 + 𝑏𝑚𝑖𝑠𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛𝑙𝑜𝑔𝑖𝑡(?̂?) + 𝑙𝑜𝑔𝑖𝑡(?̂?)  
where 𝑏𝑚𝑖𝑠𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 is the deviation of 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙 from 
1. 
For linear and logistic regression models, a more 
general recalibration test on two degrees of 
freedom may be done to test the null hypothesis 
that both 𝑎 = 0 and 𝑏𝑜𝑣𝑒𝑟𝑎𝑙𝑙 = 1. 
Area under the receiver operator 
characteristic curve 
The receiver operator characteristic curve is used to 
define different cut-offs of a continuous measure for 
predicting a positive or negative outcome497.  The 
vertical and horizontal axes represent the proportion 
of subjects who have a positive test with and 
without the outcome respectively.  At one extreme 
of the measure, all subjects have a positive test and 
at the other extreme none do.  As the cut-off 
decreases (or increases), the proportion of subjects 
with a positive test necessarily increases for both 
axes.  If the measure is unrelated to the outcome 
then the curve is expected to be a straight line at 45 
degrees from the origin and the area under the 
curve is 0.5.  For a perfect test, the area under the 
curve is 1.  For prediction models, some have 
labelled an area from 0.6 to < 0.7 as ‘poor’, from 0.7 
to < 0.8 as ‘moderate’, an area from 0.8 to < 0.9 as 
‘good’ and an area from 0.9 to 1 as ‘excellent’. 
C-statistic 
For binary outcomes, the c-statistic is the 
proportion: 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑃𝑁 𝑝𝑎𝑖𝑟𝑠 𝑤ℎ𝑒𝑟𝑒 𝑡ℎ𝑒 𝑃 ℎ𝑎𝑑 𝑎 ℎ𝑖𝑔ℎ𝑒𝑟 
𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑒𝑑 𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦 𝑡ℎ𝑎𝑛 𝑡ℎ𝑒 𝑁
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑜𝑠𝑠𝑖𝑏𝑙𝑒 𝑃𝑁 𝑝𝑎𝑖𝑟𝑠
  
where 𝑃  is a positive outcome, 𝑁  is a negative 
outcome, and a 𝑃𝑁  pair is a pair of outcome 
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observations where one is positive and one is 
negative.  For 𝑛 positive outcomes and 𝑚 negative 
outcomes, the number of possible 𝑃𝑁 pairs is 𝑛 ×
𝑚.  The c-statistic is mathematically equivalent to 
the area under the receiver operating curve where 
predicted probabilities are used as diagnostic cut-
offs. 
Goodness of fit 
Goodness of fit relates to how well a model fits a 
given set of data495.  As lack of fit can be due issues 
such as non-linear associations, interactions or an 
inappropriate link function, there may be no single 
suitable test495.  Examples include the Hosmer-
Lemeshow test and Goeman-Le Cessie tests495.  
The Hosmer-Lemeshow test is a 𝜒2 test for binary 
models performed on a 2 × 𝑛 table where the data 
are divided into 𝑛 (usually 10) quantiles of predicted 
probabilities with the expected number and 
observed numbers of the outcome in the columns of 
the table495. 
Discrimination slope 
The discrimination slope is the absolute difference 
in average predictions for subjects with and without 
the binary predicted outcome495.   
Overfitting and optimism 
Overfitting occurs when a model is fitted to 
idiosyncrasies in the data498.  It is a major issue in 
clinical predictive modelling and arises because 
increasing numbers of analyses increase the 
probability that random peculiarities in the data will 
be incorporated into the model.  When the model is 
externally tested, it performs worse than in the 
original data when the new data do not contain 
these chance findings.  The best model fitting 
strategy must strike a balance between detecting 
characteristics of the data that are ‘true’ (in that they 
are present in the parent population) and excluding 
characteristics which are not. 
Optimism is the apparent performance (in the 
sample) minus the ‘true’ performance (in the 
underlying population).  Overfitting leads to 
optimism and is a common problem, particularly in 
small datasets498.  Causes include: 
(i) Testimation bias: occurs when variables are 
screened for inclusion using a test of statistical 
significance.  Variables whose association with the 
outcome is overestimated are more likely to be kept 
in the model, leading to inflated estimates of 
regression coefficients498. 
(ii) Other biases: may occur in the search for the 
best fitting model, such as testing for non-linear 
associations, categorising continuous variables, or 
applying data transformations498. 
(iii) Parameter uncertainty: occurs when on 
average, the higher co-efficients are too high and 
the lower coefficients are too low498 even though 
they are unbiased estimates of the ‘true’ population 
values.  Shrinking the more extreme co-efficients 
towards zero can reduce this problem. 
Coding and transformation of variables 
Decisions such as categorising, transforming or 
ordering data based on their association with the 
outcome can lead to overfitting.  On the other hand, 
making all decisions before looking at the data can 
lead to missing true associations with the outcome 
or violation of model assumptions such as linearity 
between explanatory and outcome variables. 
Categorising variables based on outcome is 
especially associated with overfitting and can lead 
to loss of information.  Transformations using 
restricted cubic splines499 or fractional 
polynomials500 have been advocated.  A method of 
selection of up to second order polynomials has 
been described which aims to find an optimal 
balance between the number of significance tests 
(which ‘use up’ degrees of freedom) and detecting 
the ‘true’ nature of association between a 
continuous variable and the outcome501. 
To reduce the number of predictor variables, similar 
variables can be grouped (eg ischaemic heart 
disease and previous cerebrovascular accident 
combined as “atherosclerotic disease”, or scored 
(eg the number of comorbidities could be coded as 
a sum). 
Selection of variables to include in a clinical 
prediction model 
Ideally, variables are selected without first studying 
their relationship with the outcome502.  Using 
content knowledge, asking experts or even 
performing a systematic review are often 
preferable503.  Exclusion criteria not based on 
examining the data include lack of availability in 
external datasets, data missingness, or presence of 
a very narrow distribution. 
Stepwise selection of variables can cause 
testimation bias.  If used, backward selection is 
generally preferred503.  Advantages of backward 
selection include (i) The effects of all explanatory 
variables can be included in the same model; and 
(ii) correlated variables might be eliminated in the 
forward approach. 
Stopping rules for backward selection include p < 
0.05503.  For generalised linear models, the model 
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with the lowest Aikake information criterion499, or 
Bayesian information criterion503 can be used.  For 
linear regression models, Mallow’s Cp504 has been 
suggested.  The latter three compare models based 
on their fit to the data and penalise for increased 
model complexity, but were not designed to drive 
variable selection499.  Regardless of the method, 
testing for inclusion based on observed association 
with the outcome is associated with both testimation 
bias and a risk of exclusion of important explanatory 
variables. 
Propensity scores 
Propensity scores can be calculated by regressing 
the treatment being assessed on potential 
confounders such that they may be used to predict 
the probability of treatment505.  This probability can 
be used as a summary confounder when assessing 
the impact of treatment on the desired outcome505.  
Simulation studies suggest that propensity scores 
may be beneficial when there are few outcome 
events relative to the number of confounders505. 
Measurement issues 
Regression dilution bias occurs when observer 
measurements or biological variability leads to a 
dilution of the association between an explanatory 
variable and the outcome506. 
Events per variable 
Prediction models which use fewer than 10 events 
per variable tend to be overfitted506 and may 
perform more poorly than a simpler model derived 
from the same dataset.  The number of events per 
variable for reliable selection of predictors from a 
larger set of candidate predictors may be as high as 
50506.  Validation studies may require at least 100 
events505. 
Validation of predictive models 
Internal validation 
Internal validation occurs when a predictive model 
is validated on the development dataset.  It is prone 
to overfitting and optimism. 
(i) Split sample validation:  
The prediction model is developed on a random 
portion of the dataset and tested on the remainder.  
It is inefficient and large sample sizes are 
required507. 
(ii) Cross validation: The data are divided into 
groups, each group serving as a validation dataset 
for models derived from the rest of the data507. 
(iii) Bootstrap validation: Bootstrapping refers to 
resampling from the original dataset with 
replacement and can be used to estimate optimism-
corrected measures of model performance507.  
Rows of data (eg for a single participant) are 
selected at random from the original sample and 
added to the new (bootstrap) sample until it is the 
same size as the original.  There is a theoretical 
and empirical basis to support this approach498 
To estimate optimism-corrected performance, the 
following process is used507: 
1) A model is created in the original data, 
including screening variables for inclusion. 
2) The model is tested in the original sample. 
3) A bootstrap sample the same size as the 
original is created. 
4) A model is created in the bootstrap sample 
using the same model building strategy. 
5) The bootstrap model is tested in the bootstrap 
sample. 
6) The bootstrap model is tested in the original 
sample. 
7) Optimism in measures of model performance is 
estimated by subtracting their value in step 6 
from their value in step 5. 
8) Steps 3 to 7 are repeated in an automated 
process until stable estimates of optimism are 
obtained.  At least 100 and sometimes 
substantially more cycles are required. 
9) Estimates of optimism (step 8) are subtracted 
from the original estimates of model 
performance (step 2) to provide optimism-
corrected estimates. 
This process may be used to estimate optimism-
corrected measures of model performance such as 
𝑅2, the c-statistic and the calibration slope. 
Bootstrap validation adjusts measures of 
performance for testimation bias and parameter 
uncertainty.  Bootstrapping works best to determine 
optimism for a single predefined strategy498. 
External validation 
External validation refers to the validation of clinical 
prediction models in external datasets and relates 
to generaliseability or transportability507.  Examples 
of external validation include:- 
(i) Temporal validation: The development model is 
tested on a dataset from the same source but a 
later time. 
(ii) Geographic validation: The development model 
is tested on a dataset from a place such as another 
institution. 
(iii) Fully independent validation: External validation 
is performed by researchers who did not develop 
the original prediction model.  It provides stronger 
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evidence of generaliseability of a clinical prediction 
model than other forms of validation. 
Missing data 
Missing data can lead to (i) inefficient analysis due 
to failure to use all available data; (ii) difficulties in 
interpretation (eg models with different numbers of 
subjects may not be directly comparable); and (iii) 
bias in regression co-efficients (eg data missing not 
at random) when complete case analysis is used508.  
Missing data may be classified as: 
(i) Missing completely at random: Examples include 
administrative or laboratory errors which occur at 
random.  It does not lead to biased estimation of 𝛽-
coefficients 508. 
(ii) Missing at random: Missingness is related to 
known variables other than the outcome or is 
related to the outcome.  The latter case can lead to 
biased estimates of 𝛽-coefficients508. 
(iii) Missing not at random: Missingness depends on 
the values that are missing.  It does not lead to 
biased estimation of 𝛽-coefficients508. 
In predictive regression, the two main statistical 
approaches for dealing with missing data are a 
maximum likelihood approach and multiple 
imputation508.  There is theoretical and empirical 
support for both, but multiple imputation has been 
preferred in medical applications508. 
Multiple imputation uses a conditional distribution of 
the missing data given the available data508.  When 
there are missing values in the data required to 
impute other data, an iterative data augmentation 
process is used until convergence is obtained508.  A 
new dataset with imputed values drawn from a 
posterior distribution is created.  The process is 
repeated (with different starting values) 𝑚  times 
resulting in 𝑚 datasets, each containing the same 
values as the original, with missing values replaced 
by values drawn from a conditional distribution.  
Each dataset is analysed in the same way as a 
complete case analysis.  Point estimates of 𝛽 -
coefficients and performance estimates are the 
average from each dataset.  Estimates of variance 
are the average of the variance within the 𝑚 
datasets and the variance between them508.  Unlike 
stochastic imputation (𝑚 = 1) , the estimated 
variance in multiple imputation accounts for the 
uncertainty caused by the need to estimate the 
imputation model.  In practice, 𝑚 is usually set to 5 
or 10. 
When defining imputation models, variables not in 
the prediction model may be used in the imputation 
process508.  The outcome must be included in the 
imputation process or the model will be biased508.  
In general, noise variables do not harm the 
imputation process508. 
PREVENTION OF CAESAREAN 
SECTION 
As one of the primary aims of this thesis is to 
assess the role induction of labour could play in 
preventing primary intrapartum caesarean section, 
the review concentrates on induction of labour 
rather than other preventative strategies.  
Prevention of subsequent caesarean section or 
elective caesarean section is beyond the scope of 
this review. 
Induction of labour 
Most observational studies have linked induction of 
labour to intrapartum caesarean section, a 
relationship often assumed to be causative509.  In a 
systematic review, these studies consistently found 
that induction of labour is associated with a higher 
caesarean section rate (OR 1.54 (95% CI 1.23 – 
1.92)509.  However, 24 out of 25 compared induction 
of labour with spontaneous labour but not 
subsequent induction.  Figure 1.14 shows that 
selection bias in these 24 studies can arise because 
women who require later induction of labour (Group 
D in Figure 1.14) are excluded completely from the 
analysis. 
In contrast, RCTs of induction of labour versus 
standard or usual care consistently show that 
induction of labour reduces the risk of caesarean 
section.  The Cochrane meta-analysis excluded 
trials with “high risk” participants such as those with 
gestational diabetes or suspected fetal 
macrosomia510.  The summary relative risk of 
caesarean section in the induction group was 0.89 
(95%CI 0.81 – 0.97) among 8,749 participants and 
21 trials and the I2 was 19% indicating a low level of 
heterogeneity.  In another meta-analysis of 157 
RCTs and 31,085 participants, the summary relative 
risk of caesarean section was 0.88 (95%CI 0.84 to 
0.93) and the I2 was 0% indicating no observed 
heterogeneity of results between studies511.  This 
meta-analysis included high risk populations of 
women with conditions such as gestational 
hypertension, prelabour rupture of membranes, 
suspected fetal macrosomia and suspected 
intrauterine fetal growth restriction; and it included 
comparisons of different methods of induction of 
labour such as prostaglandins plus ARM versus 
ARM only.  Thus, in many of the studies, induction 
of labour occurred in both arms, potentially leading 
to an underestimate of the efficacy of induction of 
labour for reducing caesarean section.  Another 
meta-analysis of 7 RCTs of induction of labour for 
indications other than post-dates or spontaneous 
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ruptured membranes, the summary relative risk of 
caesarean section was 0.82 (95%CI 0.73-0.91), and 
0.82 (95%CI 0.72-0.93) for 12 RCTs of post-dates 
induction, for RCTs rated as high-quality512.  Other 
meta-analyses have found similar results513 
Two recent large observational studies with 
appropriate control groups confirmed that induction 
of labour did not increase the risk of caesarean 
section514,515.  In a retrospective cohort study of 1.3 
million women, Stock et al reported an association 
between induction of labour at 40 to 41 weeks’ 
gestation and reduced risk of caesarean section, in 
agreement with the RCTs - but not at 37 to 39 
weeks514.  Among 132,112 women with a 
“macrosomic” fetus (birthweight 3875 to 4125g) at 
39 completed weeks’ gestation, Cheng et al 
reported an odds ratio of caesarean section of 0.8 
(95%CI 0.75 to 0.95) in the induction group after 
adjusting for maternal weight gain, age and 
ethnicity, also consistent with the RCTs.  However, 
there are several potential sources of bias in these 
studies: (1) women were rounded to the nearest 
gestational week causing some women who went 
into spontaneous labour in the non-induction group 
to be excluded from the analysis514-516; (2) In the 
study by Cheng et al, an increase in birthweight of 
200g per week was assumed when selecting 
women in the non-induction group which may be an 
overestimate beyond 40 weeks’ gestation because 
they relied on a smoothing algorithm to join 
antenatal birthweights and postnatal infant weights 
which eliminated the falling rate of fetal weight gain 
with advancing gestation517; and (3) there is a high 
risk of confounding when considering the 
relationship between induction of labour and 
caesarean section (especially before 40 weeks’ 
gestation) because the intervention is generally 
performed in high risk pregnancies, which could 
bias the observed association in either direction. 
In a more recent large Australian retrospective 
observational study with an appropriate control 
group, the relative risk of caesarean section was 
about 1.1 for induction of labour at 39 completed 
weeks’ gestation and higher at later gestational 
ages and for the outcome of caesarean section for 
slow progress in labour518.  This study had several 
potential biases which could increase this apparent 
association, including adjusting for actual 
birthweight and gestational age (described in more 
detail in Chapter 3, parts B and C). 
The mechanism through which induction of labour 
prevents caesarean section is not known.  It is 
anatomically plausible that smaller fetal size 
reduces cephalopelvic disproportion but there are 
few data to support this.  Figure 1.15 shows a meta-
regression of the 11 RCTs of induction of labour 
versus standard care which reported on mean or 
median birthweights31-41.  It suggests a decrease 
from a relative risk of 0.89 when the birthweight 
difference is 50g to 0.78 when the difference is 
250g implying that earlier induction may be more 
effective as a fetus typically gains about 200g 
weight per week prior to the estimated date of 
confinement42,517.  However, the slope of the 
regression line did not statistically significantly differ 
from zero and the data are far from conclusive. 
Another possible mechanism through which 
induction of labour reduces caesarean section is by 
reducing suspected fetal compromise in labour.  In 
the presence of placental dysfunction, induction of 
labour before the onset of significant hypoxia could 
result in a lower risk of caesarean section for fetal 
indications.  However, the only large RCT not to 
show a reduction in caesarean section with 
induction of labour in the meta-analyses was 
conducted in women with a suspected growth 
restricted fetus suggesting that this is not the 
mechanism519. 
Most RCTs do not report rates of induction of labour 
in the control groups, but those that do have 
reported high rates (Table 1.8).  The indication for 
Figure 1.14 
Observational studies of elective induction 
of labour 
Most observational studies assessing the 
association between induction of labour and 
caesarean section compare group A with 
group C.  As group D is known to have a high 
rate of caesarean section, this would bias the 
results towards a positive association.  The 
correct approach would be to compare group 
A with group B and to adjust for as many 
confounders as possible. 
Women eligible for 
induction of labour 
Group A: 
Labour induced 
Group B: 
Labour not induced 
Group D: 
Later induction of 
labour (eg medical 
indication, post-dates) 
Group C: 
Spontaneous 
labour 
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induction in the control group is often unclear, but 
high rates of treatment in the control arm of a trial 
might cause the treatment effect of induction of 
labour to be underestimated.  For example, in the 
recently published “35-39 Trial”, the rate of 
induction of labour in the treatment group was 78% 
compared with 49% in the control group41.  The 
gestation at delivery was only reported to the 
nearest week, but the difference in mean 
birthweights was only 76g suggesting less than 
three days’ of gestational age difference between 
the two groups41.  If induction of labour reduces 
caesarean section by reducing fetal size, then it 
would not be surprising that this trial found no 
significant difference in the rate of caesarean 
section. 
There is little direct evidence to suggest that earlier 
induction is more effective at preventing caesarean 
section.   The first Cochrane Review published in 
2006 found a relative risk of 0.58 (95% CI 0.34 – 
0.99) for low risk pregnancies induced between 37 
and 40 completed weeks’ gestation520 but the 
updated review distributed the same studies into 
different subgroups (37 to 39 weeks’ and 39 to 40 
weeks’ gestation) neither of which showed a 
statistically significant difference510.  The I2 test for 
subgroup differences was 50% suggesting that 
gestation may modify the efficacy of induction of 
labour for reducing caesarean section510.  However, 
the three studies which contributed to the original 
finding of a relative risk of 0.58 were published 
between 1975 and 1989 in three different 
languages521-523 at a time when the caesarean 
section rate was much lower and their applicability 
today is uncertain. 
It is important to note that masking of treatment 
allocation is not possible in RCTs of IOL, which 
could lead to bias525.  There is also evidence that 
awareness of being studied can lead to changes in 
behaviour which influence the results of studies, 
sometime called the “Hawthorne Effect”526. 
In summary, the highest quality evidence indicates 
a modest treatment effect of elective induction of 
labour for preventing intrapartum caesarean section 
but is unable to distinguish between caesarean 
section for slow progress in labour and caesarean 
section for suspected fetal compromise.  The 
evidence is also insufficient to assess treatment 
efficacy before 40 completed weeks’ gestation. 
SUMMARY 
The caesarean section rate is increasing in high 
income countries and has reached about a third of 
all births in Australia.  Strategies such as 
encouraging external cephalic version for breech 
presentation or offering vaginal birth after previous 
caesarean section have not caused a decline.   
Knowledge of changing patterns in the indications 
for caesarean section would provide insight into the 
Table 1.8 
Rates of actual induction of labour in randomised controlled trials of planned induction of labour 
versus no planned induction 
Population n Induction rate in 
induction group 
Induction rate in 
control group 
Reference 
Post-dates 3,407 66% 32% Hannah (1992) 524 
Gestational diabetes 200 70% 49% Kjos (1994) 33 
 508 85% 31% Heimstad (2007) 38 
Various risk factors 270 58% 22% Nicholson (2008) 39 
Hypertension in pregnancy 559 97% 46% Koopmans (2009) 40 
Suspected fetal growth 
restriction 
572 96% 51% Boers (2010) 519 
Nulliparity and age ≥ 35 years 391 78% 49% Walker (2016) 41 
Figure 1.15 
Randomised controlled trials of planned 
labour induction v no planned induction: 
Weighted linear regression of ln (RR CS) on 
difference in birth weight 31-41. 
 
Ln (RR CS) = natural logarithm of the relative risk of 
caesarean section.  Studies are weighted by their 
standard errors. 
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driving forces behind this change in obstetric 
practice, but this knowledge is generally lacking.  
The available evidence suggests that efforts should 
focus on decreasing primary caesarean sections 
which are most commonly caused by slow progress 
in labour. 
There is high level evidence that induction of labour 
beyond 40 completed weeks’ gestation reduces the 
risk of caesarean section but less evidence for 
pregnancies prior to 40 weeks.  However, induction 
of labour itself is an intervention which many 
women and clinicians want to avoid. 
Induction of labour causes a relative risk reduction 
in caesarean section of 12 to 20% in low risk 
pregnancies.  In high risk pregnancies, the efficacy 
of induction of labour for reducing caesarean 
section varies by risk factor.  If it were possible to 
identify which women are at greatest risk of 
caesarean section in labour then for a given relative 
risk reduction, the absolute risk reduction would be 
higher.  Given observed heterogeneity in 
randomised trials, the relative risk reduction could 
be higher in some subgroups of women. 
The mechanism through which induction of labour 
prevents caesarean section is unknown but 
knowledge of which women would benefit could 
lead to targeted management.  For example, if 
induction prevented cephalopelvic disproportion or 
inadequate uterine contractions then women at high 
risk of slow progress in labour could be offered 
induction.  Thus, describing the impact of induction 
of labour by indication for caesarean section could 
lead to identifying those women most likely to 
benefit. 
Table 1.9 shows a list of antenatal factors which 
could be used to develop models to predict women 
at risk of intrapartum caesarean section.  For many 
of these risk factors, the specific association with 
caesarean section by indication such as for slow 
progress in labour or suspected fetal compromise is 
unknown, representing an important knowledge 
gap.  Filling this gap could lead to identifying 
women whose risk of caesarean section might be 
modified by induction of labour. 
On this background, the general aims of this thesis 
are to describe how indications for caesarean 
section have changed over time, to identify women 
who may benefit from induction of labour, and to 
test the feasibility of conducting a randomised 
controlled trial of induction of labour for preventing 
caesarean section.  The specific aims are: 
(1) To describe the patterns of indications for 
caesarean section in a representative population 
over the period during which the caesarean rate 
increased from less than 20% to more than 30%.   
(2) To describe the association between the 
indication for induction of labour before 40 weeks’ 
gestational age and caesarean section and other 
adverse maternal and perinatal outcomes.  
(3)  To describe the association between induction 
of labour and intrapartum caesarean section for 
different indications, particularly slow progress in 
labour and ‘fetal distress’. 
(4) To identify novel risk factors for caesarean 
section which could be incorporated into models to 
predict increased risk of intrapartum caesarean 
section. 
(5)  Based on the results of aim number (3), to 
develop a model to predict caesarean section for 
slow progress, ‘fetal distress’, or all caesarean 
sections in labour. 
(6) To write a protocol for a multicentre randomised 
controlled trial which recruits those women at high 
risk of caesarean section using the model 
developed in aim number (5).  
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Table 1.9 
Potential variables for an antenatal model to predict caesarean section in labour 
 Comments 
Promising variables 
Maternal age Consistently related to caesarean section overall and caesarean section in labour in 
observational studies.  Continuous relationship from age < 20 years to age > 40 years.  
Related to slow progress in labour. 
Maternal pre-
pregnancy BMI 
(or 3rd trimester) 
Consistently related to caesarean section overall, in labour, and for slow progress.  
Continuous relationship from BMI < 20 kgm-2 through to morbid obesity.  Would be 
convenient to measure BMI at the time of third trimester risk assessment. 
Parity Very strong relationship with intrapartum caesarean section.  Worth considering limiting 
predictive trials to nulliparous women as parous women have very low rates of caesarean. 
Maternal height Consistently related to caesarean section overall, in labour, and for slow progress. 
Gestational 
diabetes status 
Strong evidence of a continuous relationship between caesarean section and increasing 
levels of glucose intolerance in a large multicentre observational study. 
Bishop score Strongly associated with caesarean section in induced labours.  For no planned IOL, 
promising areas under the ROC curve for diagnosing caesarean section in labour.  A 
simple, common examination which is associated with maternal discomfort. 
Fetal biometry 
and estimated 
fetal weight 
Strong evidence of an association between fetal head-pelvis indices and caesarean 
section and between birthweight and caesarean section.  However, fetal biometry and 
estimated fetal weight not well studied.  A common, simple procedure. 
Cervical length 
(transvaginal 
ultrasound) 
Strong evidence of an association with caesarean section for induced labours.  Conflicting 
evidence of an association when there is no planned induction.  A simple, common 
procedure with a single, objective measurement, associated with maternal discomfort. 
Fetal station 
(transperineal 
ultrasound) 
Evidence of an association with caesarean section in two small studies.  Promising area 
under the ROC curve in one study (early labour).  A simple procedure with a single, 
objective measurement, but uncommonly used and some maternal discomfort. 
Possible variables 
Maternal SES Many studies show an association, but difficult to define and the relationship with 
caesarean section may vary with location and time.  
Gestational 
weight gain 
Above recommended weight gain consistently related to caesarean section overall and in 
labour.  Uncertain if effect due to increasing BMI at the time of labour. 
Symphysis-
fundus height 
Limited data suggest a relationship with caesarean section in labour.  Easy to perform, but 
limited interobserver error likely to dilute its predictive properties. 
Clinical 
pelvimetry 
Limited data suggest a relationship with caesarean section in labour, but measurement is 
subjective. 
Flexibility Very limited data suggest a relationship between maternal flexibility and caesarean section 
Pelvimetry Strong relationship with caesarean section and caesarean section for slow progress in 
labour.  Low dose X-rays have theoretical association with childhood cancer, magnetic 
resonance imaging is expensive, and ultrasound measurements not well described. 
Head-pelvis 
indices 
Same disadvantages as pelvimetry (above) and no reason not to include fetal head 
measurements and maternal pelvis measurements in predictive models separately. 
Pubic symphysis 
diastasis 
Not well described in the scientific literature. 
Unlikely variables 
Ethnicity Conflicting difficult to interpret evidence.  Low quality evidence suggests women of African 
descent may be more likely to have a caesarean section, but data are conflicting. 
Fetal head 
position 
No evidence that occiput posterior or transverse positions before labour are associated 
with caesarean section, and positions often change before and during labour. 
BMI = body mass index; IOL = induction of labour; ROC = receiver operating characteristic; SES = socioeconomic status  
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SYNOPSIS 
Chapter 2: Indications for caesarean section. 
This Chapter is divided into two parts, each of which will be submitted to peer reviewed journals.   
Part A is a descriptive study which examines time trends of caesarean section by indication for two 
Sydney metropolitan hospitals.  It describes caesarean section indications in detail including a 
marked increase in caesarean sections for slow progress in labour between 1995 and 2003, and a 
subsequent increase in elective repeat caesarean sections between 2004 and 2016. 
Authors: Morton R, Hyett JA, Phipps H, de Vries BS. 
Contributions to Part A: 
Dr Rhett Morton: Synthesis of the analysis into a first draft of the introduction and discussion and 
formatting the graphs 
Dr Brad de Vries: Study concept and design, analysis, writing the methods, and major contributions 
to the introduction, results, and discussion. 
Dr Hala Phipps: General supervision and contribution to writing the manuscript 
Professor Jon Hyett: Primary supervision and contribution to the writing the manuscript 
  
Part B is a comparative study which quantifies the relative contribution of factors to the recent 
increase in the caesarean section rate.  Most of the increase was explained by changes in the 
distribution of maternal age, body mass index, parity, previous caesarean section, and changes in 
caesarean section rates for malpresentation, multiple gestation, and preterm birth. 
Authors: de Vries BS, Morton R, Phipps H, Hyett JA. 
Contributions to Part B: 
Dr Brad de Vries: Study concept, design, and analysis.  Writing the first draft of the manuscript. 
Dr Rhett Morton: Contribution to the manuscript 
Dr Hala Phipps: General supervision and contribution to writing the manuscript 
Professor Jon Hyett: Primary supervision and contribution to the writing the manuscript 
 Relevance: 
Slow progress in labour was identified as the major contributor to primary caesarean section rates, 
and caesarean section rates in nulliparous women with a term singleton cephalic pregnancy.  This 
was partially attributable to changes in maternal age and body mass index. 
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Chapter 2: Indications for caesarean section  
Part A: Time trends over 27 years 
A description in two Sydney metropolitan hospitals 
 
Introduction 
The incidence of caesarean section has changed 
over time, with global rates increasing in recent 
decades although evidence that a caesarean 
section rate greater than 10% reduces maternal and 
neonatal mortality is lacking527. 
The cause of the increase in caesarean rates and 
the indications for the caesarean sections are not 
well defined. There are several published datasets 
97,528-532, but most are limited by either a short time 
span, or inadequate details about specific 
indications for caesarean section.  The 10-Group 
Classification System developed by Robson56 
presents a uniform and objective strategy to 
categorise caesarean sections to identify areas for 
improvement and to allow comparison across 
different obstetric units. The system does not 
necessarily provide information regarding the 
indication for caesarean section or explain the 
cause of increasing caesarean section rates. 
Describing detailed changes in the indications for 
caesarean section could provide insight into the 
driving forces behind this change in obstetric 
practice. Available evidence suggests that reducing 
the rate of primary caesarean section is the key to 
reducing overall caesarean section rates533, 
sometimes attributed to slow progress in labour or 
labour dystocia. There is also evidence that a large 
proportion of the higher rate of caesarean section is 
due to elective repeat caesarean section532,534. 
The aims of this study were to (i) describe the 
overall incidence of and indications for caesarean 
section and trends over the study period; (ii) 
perform the same descriptive analysis for primary 
caesarean section and caesarean section in 
nulliparous women; and (iii) examine our data within 
the Robson 10-Group classification system. 
Through analysis of these data we aim to elucidate 
potential contributing factors to the increase in 
caesarean section rate. 
Methods: 
Design 
This was a retrospective observational study that 
described rates of caesarean section by indication.  
Population: 
The study population was all births occurring at or 
beyond 24 weeks’ gestational age at Royal Prince 
Alfred Hospital (RPAH) or Canterbury Hospital in 
Sydney, Australia from August 1989 to December 
2004 and from January 2009 to December 2016. 
Due to changes in the database system, we were 
unable to obtain sufficient data for births from 2005 
to 2008 and therefore this period was excluded from 
analysis. RPAH is a tertiary referral hospital and 
one of the largest maternity departments in 
Australia. Canterbury Hospital is a metropolitan 
teaching hospital, and both lie within the Sydney 
Local Health District.  
Outcomes: 
Mode of delivery was categorised as: normal 
vaginal birth, instrumental (assisted) vaginal birth, 
emergency caesarean section, or elective 
caesarean section.  Emergency caesarean section 
was defined as (i) any caesarean section where, at 
the time of onset of labour or attempted induction of 
labour, the woman was planning to have a vaginal 
birth, or (ii) an acute emergency (such as a 
placental abruption or umbilical cord prolapse) 
leading to caesarean section for a woman who had 
been planning a vaginal birth.  Elective caesarean 
section was all other caesarean sections and 
included all deliveries where caesarean section had 
been planned as the mode of birth in the antenatal 
period, even if the woman presented in 
spontaneous labour. 
The primary outcome was caesarean section by 
indication.  For emergency caesarean sections, the 
indication was classified either ‘slow progress’ if it 
was performed for first and second stage arrest 
disorders, failure to establish labour following 
attempted induction or failed attempt at an 
instrumental delivery for slow progress in the 
second stage. The emergency indication of ‘other’ 
was assigned to emergency caesarean sections 
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that were performed for suspected fetal 
compromise, including during spontaneous labour, 
attempted induction or as the reason for attempted 
instrumental delivery. All other emergency 
caesarean sections were classified as ‘other’ 
including acute obstetric emergencies that resulted 
in caesarean section, for example umbilical cord 
prolapse, and placental abruption or intrapartum 
haemorrhage, as well as intrapartum diagnosis of 
malpresentation and intrapartum maternal choice. 
We were unable to classify emergency caesarean 
sections for intrapartum suspected fetal 
compromise independently because this information 
was not always available. 
Indications for elective caesarean section were 
categorised as: maternal choice/request, maternal 
hypertension (hypertensive disorders of pregnancy), 
fetal malpresentation, maternal medical disease 
(non-obstetric/pre-existing) multiple gestation, 
placenta praevia, previous uterine surgery 
(including previous caesarean section or 
myomectomy), previous pregnancy problem 
(including obstetric anal sphincter injury, stillbirth, 
poor perinatal outcome, and traumatic birth 
experience), elective fetal indications (including fetal 
growth restriction, oligohydramnios, abnormal 
doppler flow studies, and abnormal fetal heart rate 
patterns), suspected large fetus, other elective 
(including unexplained antepartum haemorrhage, 
uterine myomas, genital herpes, high presenting 
part, vasa praevia, velamentous cord insertion, and 
uterine rupture), or unknown indication. We 
analysed the proportions of caesarean sections 
performed for these indications for all births over the 
time-period of the dataset, for births to women with 
no previous caesarean sections (primary caesarean 
section), and births to nulliparous women.  
Other outcomes were rates of caesarean section by 
the Robson 10-Group classification system56.  
Finally, a novel ‘modified’ Robson classification was 
developed to describe rates of caesarean section 
for nulliparous and parous women with a cephalic 
presenting term pregnancy and no previous 
caesarean section planning a vaginal birth (similar 
to combining Robson categories 1 and 2a, and 
Robson categories 3 and 4a). We chose these 
groups because induction of labour does not 
increase the risk of caesarean section510-512. Where 
a birth could not be grouped into a classification due 
to missing data, it was labelled as unclassifiable. 
Data: 
Clinical and demographic data were collected from 
our institutional maternity databases which are 
populated by midwives.  The primary indication for 
caesarean section was derived from multiple fields 
within these databases. 
Statistical methods:  
Data were analysed using SAS version 9.4.  
Proportions were expressed as percentages.  Non-
parametric continuous data were expressed as 
medians and interquartile ranges. Where trends 
were plotted over time, rates were interpolated from 
existing data for the missing period of 2005-2008.  
This study obtained ethics approval from the 
Sydney Local Health District (RPAH Zone). 
Results:  
Of 129,145 births at RPA and Canterbury hospitals 
over the study period, 128,430 remained after 
exclusions, including 132 (0.1%) for missing data 
(Figure 2A.1). Of these, 48% were to nulliparous 
and 52% to parous women. There were 31,787 
caesarean sections for an overall rate of 25%.  
From 1989 to 2016 there was an increase in rates 
of overall, emergency, and elective caesarean 
sections from 19% to 31%, 8.6% to 11.5%, and 
10% to 20% respectively. Instrumental deliveries 
increased from 11% to 14% and spontaneous 
vaginal births fell from 69% to 54%.  The trend of 
the overall rate caesarean rate mirrored Australian 
national rates (Figure 2A.2). 
Figure 2A.3 shows the rates of caesarean section 
by indication. Rates across all indications except 
hypertension increased over time.  There was a 
steep rise from 1999 to 2009 which subsequently 
plateaued.  Emergency caesarean section for ‘slow 
progress’ increased from 3.4% to 5.5% of all births 
(a relative increase of 62%), and other emergency 
caesareans increased from 4.9% to 5.8% (a relative 
increase of 18%) from 1989 to 2016.  Most of these 
were for suspected fetal compromise in labour. The 
largest contributor to the increase in elective 
procedures was previous uterine surgery (primarily 
caesarean section) which increased from 4.0% to 
8.9% of all births.  The next most common 
indication was malpresentation which increased 
from 1.1% to 3.6% of all births.  Caesarean section 
for maternal choice alone increased from 0.01 to 
0.9%. 
Primary caesarean sections increased from 15% to 
24% of births to women with no previous caesarean 
section (Figure 2A.4) including an increase in 
emergency caesarean sections from 7.7% to 
12.1%. The rate for slow progress in labour 
increased from 3.3% to 5.7%, and for other 
emergencies from 4.4% to 6.4%. Primary 
caesarean sections for elective indications 
increased from 6.9% to 11.8% including caesarean  
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129,145 births at RPAH and Canterbury Hospital from August 1989 to December 2004 and January 
2009 to December 2016 
- Slow progress 
- Other emergency 
- Choice 
- Hypertension 
- Malpresentation 
- Maternal disease 
- Multiple gestation 
- Other elective 
- Placenta praevia 
- Previous pregnancy problem 
- Previous uterine surgery 
- Fetal indications (elective)  
- Suspected large fetus 
- Unknown indication (elective) 
Robson 10-Group  classification system56  
1    Nulliparous, single, cephalic, 37 weeks, 
spontaneous labour 
2a  Nulliparous, single, cephalic, 37 weeks, 
induced labour 
2b  Nulliparous, single, cephalic, 37 weeks, 
caesarean before labour 
3    Parous, no previous caesarean, single, 
cephalic, 37 weeks, spontaneous labour 
4a  Parous, no previous caesarean, single, 
cephalic, 37 weeks, induced labour 
4b  Parous, no previous caesarean, single, 
cephalic, 37 weeks, caesarean before 
labour 
5    Previous caesarean, single, cephalic, 37 
weeks 
6    Nulliparous, single, breech 
7    Parous, single, breech 
8    Multiple gestation 
9    Abnormal lie 
10  Preterm 
x    Unclassifiable 
Modified classification system 
1    Nulliparous, single, cephalic, 37 weeks, 
planned vaginal birth 
2    Nulliparous, single, cephalic, 37 weeks, 
elective caesarean  
3    Parous, no previous caesarean, single, 
cephalic, 37 weeks, planned vaginal birth 
4    Parous, no previous caesarean, single, 
cephalic, 37 weeks, elective caesarean 
5    Previous caesarean, single, cephalic, 37 
weeks 
6    Nulliparous, single, breech 
7    Parous, single, breech 
8    Multiple gestation 
9    Abnormal lie 
10  Preterm 
x    Unclassifiable 
 
Figure 2A.1: 
Study flow chart 
- Overall caesarean 
- Elective caesarean 
- Emergency caesarean 
- Instrumental vaginal 
- Normal vaginal 
Exclusions: 
- Gestational age <24 weeks (583) 
- Gestational age unknown (122) 
- Mode of delivery unknown (10) 
Analysis of 
mode of 
delivery  
Classified by Robson and modified 
classifications 
Overall 
(128,430) 
No previous 
caesarean 
(115,927) 
Analysis of 
indications 
for 
caesarean 
section  
Nulliparous 
(61,520) 
128,430 births available for analysis 
- Nulliparous 61,520 
 
Denominator 
for primary 
caesarean 
section rates  
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Table 2A.1 
All births by mode of birth and year 
Year All 
caesareans 
Elective 
caesareans 
Emergency 
caesareans 
Instrumental 
births 
Normal vaginal 
births 
Total 
1989 18.8% 145 10.2% 123 8.6% 168 11.8% 987 69.4% 1,423 
1990 19.6% 481 10.9% 380 8.6% 462 10.5% 3071 69.9% 4,394 
1991 19.6% 498 10.7% 410 8.8% 436 9.4% 3,297 71.0% 4,641 
1992 18.2% 437 9.6% 388 8.6% 464 10.2% 3,244 71.6% 4,533 
1993 17.7% 417 9.0% 398 8.6% 467 10.1% 3,335 72.2% 4,617 
1994 18.7% 450 9.6% 425 9.1% 470 10.0% 3,343 71.3% 4,688 
1995 18.4% 407 9.4% 393 9.1% 466 10.7% 3,073 70.8% 4,339 
1996 19.0% 465 9.5% 467 9.5% 516 10.5% 3,446 70.4% 4,894 
1997 19.9% 469 9.8% 486 10.1% 474 9.9% 3,378 70.3% 4,807 
1998 20.4% 415 9.4% 486 11.0% 489 11.1% 3,028 68.5% 4,418 
1999 19.2% 494 9.0% 554 10.1% 588 10.8% 3,825 70.0% 5,461 
2000 21.4% 578 10.8% 572 10.7% 595 11.1% 3,622 67.5% 5,367 
2001 22.2% 580 11.6% 530 10.6% 445 8.9% 3,454 69.0% 5,009 
2002 24.0% 598 12.1% 589 11.9% 541 10.9% 3,219 65.1% 4,947 
2003 25.1% 718 13.3% 641 11.8% 512 9.5% 3,543 65.4% 5,414 
2004 24.8% 671 13.1% 595 11.7% 529 10.4% 3,309 64.8% 5,104 
2009 30.1% 1,196 18.0% 802 12.1% 867 13.1% 3,772 56.8% 6,637 
2010 30.6% 1,235 18.1% 853 12.5% 939 13.8% 3,793 55.6% 6,820 
2011 31.1% 1,363 19.5% 804 11.5% 993 14.2% 3,816 54.7% 6,976 
2012 29.2% 1,263 18.0% 781 11.1% 1021 14.6% 3,941 56.3% 7,006 
2013 29.9% 1,239 18.1% 800 11.7% 916 13.4% 3,875 56.7% 6,830 
2014 30.3% 1,304 19.1% 763 11.2% 958 14.1% 3,791 55.6% 6,816 
2015 30.6% 1,265 19.4% 726 11.1% 932 14.3% 3,592 55.1% 6,515 
2016 31.5% 1,354 20.0% 779 11.5% 964 14.2% 3,677 54.3% 6,774 
           
Figure 2A.2: 
All births by mode of birth, and comparison to national caesarean section rates 
1-22 
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sections for malpresentation which rose from 0.9% 
to 3.6%. 
Primary caesarean sections for suspected fetal 
compromise, previous pregnancy problems, 
multiple gestation, and maternal choice all rose 
substantially from 1989 to 2015 with a combined 
rise from 0.9% to 4.3%.  For all births, the increase 
was from 0.8% to 4.0%. 
Over the 27-year study period, caesarean sections 
among nulliparous women increased from 19% to 
32%, including an increase of 12% to 18% for 
emergencies, 5.8% to 8.8% for slow progress, 6.1% 
to 9.3% for other emergencies and 7.5% to 14% for 
elective procedures (Figure 2A.5). 
Figure 2A.6 shows changes in the obstetric 
population by Robson group over time and Figure 
2A.7 shows caesarean section rates within each 
group (except for groups 2b and 4b which are 
always 100%).  Inductions of labour became more 
common in both nulliparous and parous women: 
there was a decline in group 3 (parous, term, 
cephalic, and no previous caesarean section) from 
33% to 28% of all births, and an increase in group 5 
(term, cephalic, previous caesarean section) from 
5.2 to 11% of all births. 
Figure 2A.7 shows the trend in rates of caesarean 
section by Robson group over the study period.  
Caesarean section rates in term, nulliparous women 
Figure 2A.3: 
Overall caesarean section by indication 
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Figure 2A.4 
Primary caesarean section rates by indication 
 
Figure 2A.5: 
Caesarean section rates in nulliparous women by indication 
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Figure 2A.6: 
Changes in prevalence of Robson categories over time 
 
1 
2a 
2b 
3 
4a 
4b 
5 6 7 
8 9 
10 
Figure 2A.7: 
Data for rates of caesarean section by Robson Groups with overlay of polynomial trend lines 
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with a singleton cephalic presenting fetus 
undergoing induction of labour (group 2a) increased 
from 18% to 29% from 1992 to 2001. Groups 6, 7, 
and 8 (term breech and multiple gestations) had the 
greatest rate of increase over time. All groups 
experienced a general increase in caesarean 
section rates except for group 3 (term, cephalic 
parous women in spontaneous labour).   
Figures 2A.8 and 2A.9 show primary emergency 
and elective caesarean section rates for women 
with a term cephalic pregnancy.  Both nulliparous 
and parous women without a previous caesarean 
section had rates of elective caesarean section 
below 3%, but the rate of caesarean section in 
nulliparous women planning a vaginal birth 
increased from 11% to 21% from 1989 to 2016. 
Discussion 
This study analysed the indications for and trends in 
caesarean sections, from 128,430 births over 27 
years at two institutions within a single health 
district in Sydney, Australia.  Our main findings 
were that the rate of caesarean section increased 
from 19% to 32%, with the greatest rise between 
1999 and 2009.  Most of the increase was due to 
emergency caesarean sections for slow progress, 
elective repeat caesarean sections, and caesarean 
sections for malpresentation (primarily breech 
presentation). Most of the increase in primary 
caesarean section and caesarean section in 
nulliparous women was due to emergency 
procedures for slow progress and elective 
procedures for malpresentation and fetal 
indications.  
These findings are important as they provide a 
comprehensive description of indications for 
caesarean section over a prolonged period when 
overall rates mirrored national Australian data.  
They confirm the large contribution that previous 
uterine surgery makes to the caesarean section 
rate97.  In agreement with Zhang et al97, 9% of all 
births and 28% of all caesarean sections were 
associated with this indication.  However, we 
additionally showed trends in this phenomenon over 
a longer time-period (Figure 2A.2).  Caesarean 
section for slow progress almost doubled between 
1995 and 2003 (from 3.4% to 6.2%) while 
caesarean section for previous uterine surgery was 
relatively stable until 2004 and then rose rapidly to 
almost 9% in 2010.  The time course of these 
changes implies that caesarean sections for slow 
progress led to later increases for previous 
caesarean section. 
In the past decade, Australian national rates of 
caesarean section have not risen as sharply, but 
the trend is still upwards (Figure 2A.2).  In the 
current study, there was an almost identical relative 
rise in overall, primary, and caesarean sections in 
nulliparous women of 11% between 2012 and 2016.  
There was also an increase from 0.8% to 4.0% in 
elective caesarean sections for suspected fetal 
compromise, previous pregnancy problems, 
multiple gestations, and maternal choice from 1989 
to 2016.  Combined, these changes are similar in 
magnitude to the change in caesarean sections for 
slow progress which preceded the increase 
caesarean sections for previous uterine surgery, 
and they could be expected to contribute to future 
caesareans for previous uterine surgery.  Notably, 
caesarean sections for maternal choice alone 
increased almost ten-fold, and despite much debate 
in the media, occurred in less than 1% of all 
pregnancies. 
We also described trends in the proportions of 
women in Robson groups and their respective 
caesarean section rates over time, noting a 
progressive increase in inductions of labour in both 
nulliparous and parous women (groups 2a and 4a), 
a marked decrease in parous women with no 
previous caesarean section (groups 3 and 4a), and 
a coincident increase in parous women with a 
previous caesarean section (group 5)(Figure 2A.6).  
These trends are not surprising given our 
observations about increasing elective repeat 
caesarean sections.  We also noted that caesarean 
sections have increased within every Robson 
group, except for group 3.  The marked increase in 
category 2a (term inductions of labour, cephalic 
presentation, singleton pregnancy in nulliparous 
women) is important because this group 
represented a high proportion (19%) of all births in 
2016. 
The Robson classification allows a standardised 
comparison of caesarean section within different 
risk groups using data which are often readily 
available56.  However, reporting rates of caesarean 
section separately for induced and non-induced 
labours can lead to misleading interpretation.  It is 
especially important not to conclude that reducing 
inductions of labour will reduce the caesarean 
section rate, simply because rates of caesarean 
section are high in group 2a.  Indeed, the results of 
randomised controlled trials show the opposite510-
512,535.  We modified the Robson classification, using 
elective and emergency caesarean section (rather 
than onset of labour) and, more importantly, ignored 
the induction of labour criterion, describing 
caesarean section rates in women with a term 
cephalic singleton pregnancies and no previous 
caesarean section by parity.  This was the 
equivalent of analysing groups 1/2a and 3/4a 
together.  Within these groups, there were 
substantial increases in caesarean sections in 
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nulliparous women over time (Figure 2A.7) but 
relatively small increases in elective caesarean   
sections regardless of parity.  The marked increase 
in caesarean sections among nulliparous term 
women suggest they may benefit from strategies to 
promote vaginal birth.  Possibilities include careful 
diagnosis of slow progress, one on one midwifery 
care, support for changing positions and mobilising 
Figure 2A.8: 
Emergency caesarean section rates by ‘modified’ Robson groups 1 and 3 among women with no 
previous caesarean section planning a vaginal birth (term, cephalic) 
Parous  
Figure 2A.9: 
Elective caesarean sections as a percentage of births among women with no previous caesarean section 
(term, cephalic) 
Nulliparous Parous   
Nulliparous 
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in labour, and induction of labour in selected 
women. 
To our knowledge, no other studies have reported 
on detailed indications for caesarean section over a 
prolonged period.  The time-frame has allowed a 
coherent picture regarding the factors driving trends 
in caesarean section to be built, particularly with 
respect to increases in caesarean section for slow 
progress and the subsequent rise in elective repeat 
procedures, both of which have also been observed 
by others97,98,532,533, and some of which may be 
attributable to caesarean sections for slow progress 
in the passive first stage of labour97,536,537.  
Data from the United States has suggested that 
earlier descriptions of normal labour progress no 
longer apply and that less stringent rules for 
diagnosing slow progress are required533.  For 
example, 6cm cervical dilatation is a suggested new 
criterion for diagnosing the active phase of the first 
stage of labour533.  Others have found that a large 
proportion of women have a caesarean section for 
slow progress prior to 4cm to 6cm cervical dilatation 
and suggest a portion are unnecessary97,537.  In 
view these findings, there is an urgent need to 
examine both definitions of the active first stage of 
labour and the diagnosis of abnormal progress. 
Further, factors such as obesity and maternal age, 
known to be associated with slow progress in 
labour, may play a role (see Chapter 2, Part B).  
Changes in the distribution of maternal BMI and age 
between 1989 and 2016 could help explain some of 
the observed increase in caesarean sections for 
slow progress and there may be a need to 
individualise the management of slow progress in 
labour. 
Several other observations from our data are 
noteworthy.  Caesarean section for malpresentation 
increased from 1.7% to 3.6% from 2000 to 2016, 
likely due to changes in the management of breech 
presentation influenced by the Term Breech Trial101.  
Caesarean section for fetal indications increased 
from 0.4% to 1.7% from 2002 to 2015, possibly due 
to increased use of antenatal ultrasound.  Thus, 
strategies to promote external cephalic version, and 
counselling women about their birth options remain 
important.  Our observation that 28% of caesarean 
sections in 2016 were for previous uterine surgery 
suggests that rates of attempted vaginal birth after 
caesarean section have a major impact on raw 
caesarean section rates. 
Our study has some limitations including those 
inherent in large clinical databases that may be 
susceptible to data entry errors, although we have 
demonstrated the accuracy of a portion (2005 to 
2009) of this database in the past (Chapter 3, Part 
A). There were significant amounts of missing data 
for some years which precluded a separate 
classification of emergency caesareans for 
suspected fetal compromise, and we had to treat 
emergency caesarean sections for indications other 
than slow progress as a single group. Some of the 
fields used in the analysis were derived from 
multiple other fields, including some that were 
allowed free text entry. This could lead to 
misclassification of items such as the indication for 
caesarean section or history of previous caesarean 
section that could bias the findings in any direction. 
The study was undertaken in only two metropolitan 
hospitals, and while some of its findings agree with 
those from other studies, the details of changes in 
indications for caesarean section may not be 
generalisable to other settings.  Lastly this study is 
descriptive in nature, and does not explain 
causation.  
Future research should aim to define causes of 
caesarean sections for slow progress in labour and 
reassess the diagnosis of this condition.  
Subsequent intervention studies of management in 
labour and induction of labour are warranted. 
Conclusions: 
The increase in caesarean sections from 1989 to 
2016 reflects increases in primary caesarean 
sections for slow progress in labour and elective 
procedures for malpresentation and previous 
caesarean sections.  Potential strategies to reduce 
the caesarean section rate include using revised 
criteria for diagnosing and managing slow progress 
in labour, and strategies to encourage vaginal birth 
after caesarean section.  
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Part B:                                                                          
Why has the caesarean section rate changed? 
The impact of changing maternal factors and clinical practice 
 
Introduction 
In Part A, we found that the caesarean section rate 
increased from a relatively stable 18 to 20% in the 
1990’s, went through a period of rapid increase in 
the new millennium and then increased slowly from 
to 30 to 32% from 2009 to 2016, in two Sydney 
metropolitan hospitals.  The pattern of indications 
for caesarean section suggested that the increase 
was at first driven by increases in primary 
caesareans for slow progress in labour and then by 
increases in elective repeat procedures. 
Others have emphasised the importance of primary 
caesarean sections97 but few have attributed 
proportions of the caesarean section rate or its 
increase to factors such as maternal demographics 
or innate changes in the obstetric population.  There 
is much discussion about individual contributors to 
the rising caesarean section rate such as increasing 
caesarean sections in labour or changes in the 
management of breech presentation or multiple 
pregnancies, but quantification of the relative 
contributions of each of these factors has been 
elusive.  
The aims of this study were (i) to assess the 
contribution of demographic and clinical factors to 
changes in the caesarean section rate during the 
time when it increased from less than 20% to more 
than 30%; and (ii) to quantify the proportion of the 
increase in caesarean section rates attributable to 
changes in maternal factors, changes in clinical 
practice, and maternal choices. 
Methods 
Design: 
This was a retrospective observational study which 
compared changes in demographic, clinical and 
obstetric factors between two time periods: (1) 
when the caesarean section rate was ≤ 20% (Group 
A); and (2) when the caesarean section rate was ≥ 
30% (Group B). 
Population: 
The study population was all births occurring at or 
beyond 24 weeks’ gestational age at Royal Prince 
Alfred Hospital (RPAH) and Canterbury Hospital in 
Sydney, Australia.  RPAH is a tertiary referral 
hospital and Canterbury Hospital is a metropolitan 
teaching hospital.  Group A consisted of births from 
August 1989 to December 1999, when the annual 
caesarean section rate ranged from 18 to 20%.  
Group B consisted of births from January 2009 to 
December 2016, when the annual caesarean 
section rate ranged from 30 to 32%. 
Study factors: 
Changes in caesarean section rates were 
compared with respect to parity, previous 
caesarean section, changes in the distribution of 
maternal age and body mass index, plurality and 
fetal malpresentation.  Changes in caesarean 
section rates were also described by Robson 
category56. 
Outcomes: 
The primary outcome was caesarean section.  
Elective and emergency caesarean section were 
defined as in Chapter 2, Part A (page 36). 
Data: 
Clinical and demographic data were collected from 
the maternity database at RPA and Canterbury 
Hospitals. 
Attributing changes in the caesarean section 
rate to maternal and clinical factors: 
To estimate the contribution of maternal factors to 
changes in the caesarean section rate, we stratified 
the dataset as follows: 
Births at ≥ 37 weeks’ gestational age from a 
singleton pregnancy and with cephalic presentation 
were divided into the following groups: maternal age 
was divided into four categories: <25, 25-29, 30-34, 
and ≥35 years.  Maternal body mass index was 
divided into five categories: unknown, <20, 20-24, 
25-29, and ≥30 kgm-2.  Parity was divided into three 
categories: nulliparous, parous with no previous 
caesarean section, and parous with a previous 
caesarean section.  Thus, there were 60 
subcategories of women (= 4 x 5 x 3) with a unique 
combination of these three factors. 
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102,589 births with available data 
453 excluded for < 24 weeks’ gestational age 
Group A (1989 to 1999) 
   48215 births 
 
Figure 2B.1: 
Participant flow chart 
Missing data: 
   115 missing data for gestational age 
   8 unknown mode of birth 
 
102,712 births meeting inclusion criteria 
•  August 1989 to December 1999 
• January 2009 to December 2016  
 
   103,165 births at RPAH or Canterbury Hospital: 
 
Group B (2009 to 2016) 
   54374 births 
  
Multiple pregnancies (at all gestational ages), 
malpresentation at ≥ 37 weeks’ gestation, and 
singleton pregnancies at < 37 weeks’ gestation 
were each divided into two groups – women with 
and without a previous caesarean section, creating 
six more subcategories.  Women who could not be 
classified were assigned to a separate category.  
Thus, the study cohort was divided into 67 (= 60 + 6 
+ 1) distinct subcategories for further analysis. 
Within Group A, the caesarean section rate was 
calculated separately for each of the 67 
subcategories.  These rates were then applied to 
the equivalent subcategories in Group B to estimate 
what the caesarean section rate “would have been” 
in Group B had it consisted of exactly the same 
distribution of age, body mass index, parity, rate of 
previous caesarean section, multiple pregnancies, 
malpresentations, and preterm births.  Comparing 
this predicted caesarean section rate with the actual 
caesarean section rate in Group B allowed 
calculation of the proportion of the increase in 
caesarean section due to these factors.  This 
process was repeated for individual factors 
(maternal age, body mass index and parity) 
separately to estimate the individual contribution of 
these factors separately. 
A post-hoc decision was made to assess the 
additional contribution of elective caesarean 
sections for indications that had increased in 
prevalence between the two time-periods (see 
Chapter 2, Part A).  These indications were: 
maternal choice (in the absence of a medical 
indication), suspected fetal compromise, previous 
pregnancy issues (such as previous anal sphincter 
injury), and suspected large fetus. 
A sensitivity analysis was performed with exclusion 
of the 67th (unknown) subcategory.  Differences in 
raw caesarean section rates between Group A and 
Group B were also described by Robson group. 
Statistical methods:    
Data were analysed using SAS version 9.4.  
Proportions were expressed as percentages.  Non-
parametric continuous data were expressed as 
medians and interquartile ranges. 
A logistic regression was performed for the outcome 
of caesarean section, using the following 
explanatory variables: time-period (Group A or 
Group B), maternal age, maternal body mass index, 
parity group (nulliparous, parous, or parous with ≥ 1 
previous caesarean sections), gestational age, 
malpresentation (cephalic or other presentation), 
and plurality (singleton or higher order pregnancy).  
Continuous variables were tested for linearity with 
the logit function of the outcome by categorising 
and plotting the beta-coefficients against the 
midpoints of each group, and categorised if the 
relationship was not linear. 
This study obtained ethics approval from the 
Sydney Local Health District (RPAH Zone). 
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Results: 
Demographics and caesarean section rates 
There were 103.165 births in the study periods, 
including 102,712 after exclusions for pregnancies < 
24 weeks’ gestational age (Figure 2B.1).  123 
(0.1%) were excluded for missing data. 
Table 2B.1 shows baseline clinical and 
demographic variables in Group A and Group B.  
There were missing data for 15% of women for BMI, 
2.2% for parity, and < 0.01% for maternal age.  The 
raw caesarean section rates were 19% and 30% in 
the two time-periods.  Women in group B had a 
mean age of 1.9 years older and a median BMI of 
0.7 kgm-2 higher.  Group B consisted of more 
nulliparous women (50% v 46%), and more women 
with a previous caesarean section (24% v 14% of 
births to parous women, or 12% v 7.5% of all 
births), and more inductions of labour (Robson 
groups 2a and 4a). 
Over the two time-periods, elective caesarean 
section increased from 9.7% to 19% and 
emergency caesarean section increased from 9.4 to 
11.6% (Table 2B.2).  The rate of caesarean section 
in women with no previous caesarean increased 
from 15% to 23% and the rate in nulliparous women 
increased from 20% to 30%. 
Table 2B.3 shows changes in the proportion of 
births in each Robson group and the caesarean 
section rate within each group.  There was a 
combined reduction in categories 3 and 4a (term, 
singleton, cephalic, parous women) from 39% to 
32% and an increase in category 5 (term, cephalic, 
previous caesarean section) from 5.6 to 10.6% of all 
births.  There were substantial increases in 
caesarean section rates for categories 1, 2a, 5, 6, 7, 
8, and 10. 
Logistic regression on caesarean section 
In the logistic regression on caesarean section, 
there was evidence of interaction between time-
period (Group A or B), and cephalic/term birth, 
malpresentation, multiple gestation, and preterm 
birth; and separate logistic regressions were 
performed for each of these four groups (Table 
2B.4).  Body mass index and maternal age were not 
linearly related to the outcome and were 
categorised. 
For cephalic presenting term pregnancies, adjusting 
for age group, BMI group, and parity group 
(nulliparous, parous, or parous with previous 
caesarean section) resulted in a reduction in the 
unadjusted relative risk of caesarean section in 
Group B compared with Group A from 1.85 (95% CI 
1.80-1.91) to an adjusted risk of 1.52 (95% CI 1.36-
1.71).  Age group and BMI group were associated 
with caesarean section after adjusting for the other 
variables. 
Estimations of attributable risk 
Based on the difference between the adjusted and 
unadjusted relative risk in term, cephalic, singleton 
pregnancies (Table 2B.4), we estimated that 39% of 
the increase in caesarean sections in this group 
was due to changes in the distribution of maternal 
age, body mass index, parity, and previous 
caesarean section. 
We were unable to allocate 1,211 births (1.3%) into 
a stratified group, based on the available data, 
including 366 in group A and 845 in Group B, and 
these were allocated into a separate stratum.  
Based on stratification of the data and calculation of 
Table 2B.1 
Baseline demographic and clinical factors 
 Group A 
(1989-2004) 
Group B 
(2009-2016) 
n 48,215 54,374 
GA (weeks)a 
(median [IQR]) 
39(+4/7) 
(38(+3/7), 40(+4/7)) 
39+4 
(38(+4/7), 40(+4/7)) 
Age (years) 
(SD) 
Age group 
(years) 
   < 25 
   25-29 
   30-34 
   ≥ 35 
30.3 (5.5) 
4 missing 
 
 
8,455 (18) 
14,355 (30) 
15,337 (32) 
10,064 (21) 
32.2 (5.2) 
4 missing 
 
 
4,944 (9.1) 
13,145 (24) 
29,946 (37) 
16,335 (30) 
BMI (kgm-2) 
 
 
 
BMI group  
      < 20 
   20-24 
   25-29 
   ≥ 30 
22.0 
(20.1, 24.7) 
7,061 (15%) 
missing 
 
9,749 (24) 
21,920 (53) 
6,535 (16) 
2,950 (7.2) 
22.7 
(20.5, 25.8) 
8,321 (15%) 
missing 
 
8,752 (19) 
23,419 (51) 
9,181(20) 
4,701 (10) 
Parity 
   Nulliparous 
   Parous 
   Unknown 
 
22,041 (46) 
25,798 (54) 
376 (0.8) 
 
27,177 (50) 
26,269 (48) 
928 (2) 
Previous CS  3,622 (14)a 6,356 (24)a 
a) the denominator is all parous women 
BMI= body mass index; SD = standard deviation 
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subcategory caesarean section rates for Group A 
and the distribution of maternal and pregnancy 
factors in Group B, we estimated that 39% of the 
increase in caesarean sections were due to 
changes in the distribution maternal age, body 
mass index, parity and history of previous 
caesarean section, for all births (Table 2B.5).  21% 
was associated with changes in parity and previous 
caesarean section, 12% was associated with 
changes in age, and 6% was associated with 
Table 2B.2 
Caesarean section rates overall, by history of previous caesarean section, and in nulliparous women 
 Group A 
(1989-2004) 
Group B 
(2009-2016) 
Number of births (all births) 
All caesarean sections 
   Emergency 
      Slow progress 
      Other indications 
      Unknown indication 
      Total emergency 
   Elective 
      For previous uterine surgery 
      For fetal malpresentation 
      Other indications 
      Total elective 
n = 48,215 
9,188 (19) 
 
   1,895 (3.9) 
   2,488 (5.2) 
   127 (0.3) 
4,510 (9.4) 
 
   1,785 (3.7) 
   688 (1.4) 
   2,205 (4.6) 
4,678 (9.7) 
n = 54,374  
16,527 (30) 
 
   3,228 (5.9) 
   3,010 (5.5) 
   70 (0.1) 
6,308 (12) 
 
   4,725 (8.7) 
   1,747 (3.2) 
   3,747 (6.9) 
10,219 (19) 
Number of births (no previous caesarean section)    
Primary caesarean sections 
   Emergency 
      Slow progress 
      Other indications 
      Unknown indication 
      Total emergency 
   Elective 
      For fetal malpresentation 
      Other indications 
      Total elective 
n = 44,580  
6,487 (15) 
 
   1,663 (3.7) 
   1,940 (4.4) 
   88 (0.2) 
3,691 (8.3) 
 
   996 (2.2) 
   1,800 (4.0) 
2,796 (6.3)  
n = 47,990 
11,181 (23) 
 
   2,934 (6.1) 
   2,894 (6.0) 
   61 (0.1) 
5,889 (12) 
 
   1,621 (3.4) 
   3,671 (7.6) 
5,292 (11) 
Number of births (nulliparous women) 
Caesarean sections in nulliparous women  
   Emergency 
      Slow progress 
      Other indications 
      Unknown indication 
      Total emergency 
   Elective 
      For fetal malpresentation 
      Other indications 
      Total elective 
n = 22,041 
4,428 (20) 
 
   1,442 (6.5) 
   1,381 (6.3) 
   44 (0.2) 
2,867 (13) 
 
   395 (1.8) 
   1,166 (5.3) 
1,561 (7.1) 
n = 27,177 
8,210 (30) 
 
   2,619 (9.6) 
   2,388 (8.8) 
   31 (0.1) 
5,038 (19) 
 
   1,077 (4.0) 
   2,095 (7.7) 
3,172 (12) 
Table 2B.3 
Distribution of Robson groups and caesarean section rates 
Robson groupa Proportion of all births Caesarean section rate 
 Group A Group B Group A Group B 
1) Nullip, single cephalic, ≥ 37 weeks, spont 14,207 (29) 13,982 (26) 1,278 (9.0) 1,997 (14) 
2a) Nullip, single, cephalic, ≥ 37 weeks, IOL 4,107 (8.5) 8,604 (16) 970 (24) 2,731 (32) 
(1 + 2a) 18,314 (38) 22586 (42) 2,248 (12) 4,728 (21) 
2b) Nullip, CS before labour 579 (1.2) 1,433 (2.6) 579 (100) 1,433 (100) 
3) Parous, single cephalic, ≥ 37 weeks, spont 15,343 (32) 12,773 (23) 311 (2.0) 337 (2.6) 
4a) Parous, single, cephalic, ≥ weeks, IOL  3,573 (7.4) 4,370 (8.0) 122 (3.4) 281 (6.4) 
(3 + 4a) 18,916 (39) 17,143 (32) 433 (2.3) 618 (3.6) 
4b) Parous, CS before labour 522 (1.1) 865 (1.6) 522 (100) 865 (100) 
5) Previous CS, single, cephalic, ≥ 37 weeks 2,724 (5.6) 5,767 (11) 1,915 (70) 4,771 (83) 
6) Nullip, breech (incl < 37 weeks) 1,055 (2.2) 1,121 (2.1) 831 (79) 1,073 (96) 
7) Parous, breech (incl previous CS, < 37 
weeks) 
976 (2.0) 769 (1.4) 664 (68) 712 (93) 
8) All multiple pregnancies 916 (1.9) 838 (1.5) 442 (48) 615 (73) 
9) Single, abnormal lie (incl previous CS) 213 (0.4) 173 (0.3) 192 (90) 168 (97) 
10) Single, cephalic, < 37weeks 3,488 (7.2) 2,790 (5.1) 1,037 (30) 1,132 (41) 
Unable to classify 512 (1.1) 889 (1.6) 325 (63) 477 (54) 
CS = caesarean section; IOL = induction of labour; incl = including; nullip = nulliparous; spont = spontaneous 
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changes in body mass index.  We estimated that a 
further 5% was due to changes in caesarean 
sections for malpresentation, 3% to changes in 
caesarean sections for multiple gestation, and 6% 
to changes in caesarean sections for preterm birth. 
When combined, 55% of the increase in caesarean 
section was associated with maternal or pregnancy 
factors.  In a post-hoc analysis, the prevalence of 
elective caesarean section for maternal choice 
increased from 0.20% to 0.64% of all births, elective 
caesarean section for suspected fetal compromise 
increased from 0.33 to 1.36%, elective caesarean 
section for a previous pregnancy issue (such as 
anal sphincter injury, pelvic floor trauma, or difficult 
birth) increased from 0.0% to 0.66% and elective 
caesarean sections for suspected large fetus 
increased from 0.24% to 0.55%.  When these were 
added to the analysis, 62% of the increase in 
caesarean section rate from 19% to 30% was 
explained (Table 5). 
We performed a sensitivity analysis which excluded 
the 1.3% of births with insufficient data to stratify 
into a group.  Omitting this group changed the 
estimated proportions of the increase in caesarean 
section explained by any given factor by less than 
1% in all cases. 
Discussion: 
Our main finding was that most of the steep rise in 
the caesarean section rate from 19% to 30% 
between 1999 to 2009 was explained. More than a 
third of the rise was explained by changes in 
maternal age, body mass index, history of previous 
caesarean section, and parity; more than 50% was 
explained when changes in rates of caesarean 
section for malpresentation, multiple gestation, and 
preterm birth were additionally considered; and 
finally, a further 8% was explained by increases in 
elective caesarean section for maternal choice, 
suspected fetal compromise, previous pregnancy 
issues, and a suspected large fetus.  Less than two 
percent of the rise could be attributed to maternal 
choice alone representing 0.2% of all births. 
These findings are important because the changes 
in the rate of caesarean section over time mirrored 
Australian national rates, and our more detailed 
institutional data may provide insight into the 
causes of the rise.  We found an increase in primary 
caesarean section rates from 15% to 23%, and in 
Table 2B.4 
Univariable and multivariable logistic regression on caesarean section 
Analysis group Unadjusted RR  Adjusted RRb 
 
(i) Cephalic presentation ≥ 37 weeks’ gestation 
   Group A 
   Group B 
Parity Group 
   Parous 
   Nulliparous 
   Parous, previous caesarean section 
Age group (years) 
   < 25 
   25 – 29 
   30 – 34 
   ≥ 35 
BMI group (kgm-2) 
   < 20 
   20 – 24 
   25 – 29 
   ≥ 30 
 
1.0 
1.85 (1.80-1.91) 
 
1.00 
2.69 (2.61-2.78) 
6.36 (6.31-6.40) 
 
1.00 
1.40 (1.32-1.48) 
1.76 (1.67-1.85) 
2.34 (2.24-2.45) 
 
1.00 
1.32 (1.27-1.38) 
1.85 (1.77-1.94) 
2.20 (2.09-2.30) 
 
1.0 
1.52 (1.36-1.71) 
 
1.00 
3.04 (2.95-3.13) 
6.33 (6.27-6.37) 
 
1.00 
1.38 (1.30-1.47) 
1.72 (1.62-1.82) 
2.33 (2.21-2.45) 
 
1.00 
1.25 (1.19-1.31) 
1.74 (1.66-1.84) 
2.08 (1.96-2.20) 
(ii) Malpresentations ≥ 37 weeks gestation 
   Group A 
   Group B 
 
1.00 
1.25 (1.22-1.28) 
 
1.00 
1.08 (1.04-1.12) 
(iii) Multiple gestationsb 
   Group A 
   Group B 
 
1.00 
1.52 (1.41-1.65) 
 
1.00 
1.11 (1.06-1.16) 
(iv) < 37 weeks’ gestation 
   Group A 
   Group B 
 
1.00 
1.26 (1.20-1.33) 
 
1.00 
1.11 (1.06-1.17) 
a) Unable to classify 22 women into one of these groups 
b) Adjusted for maternal age, maternal BMI, and parity group (nulliparous, parous with no previous caesarean section, and 
parous with ≥ 1 previous caesarean sections). 
c) All multiple gestations are in this group 
RR = relative risk 
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nulliparous caesarean section rates from 20% to 
30%.  This, coupled with an approximate doubling 
in Robson category 5 from 5.6% to 10.6%, and an 
increase in caesarean section rates within this 
category (representing fewer vaginal births after 
caesarean section), confirm the findings of others 
that the increase in the caesarean section rate is 
being driven by an increase in primary caesarean 
sections533.  Our finding that caesarean section for 
slow progress in labour increased from 3.7% to 
6.1% suggests that this group should be the target 
of future strategies to promote vaginal birth. 
Our finding that age, body mass index, parity and 
previous caesarean section all contributed to the 
increase in caesarean sections is consistent with 
the scientific literature (see Chapter 1).  Others 
have estimated that 14% of caesareans were due to 
maternal obesity106,107 and 7% were due to 
gestational weight gain258, but few studies report on 
the population based impact of maternal factors on 
caesarean section rates.  We reported on the 
relative impacts of a variety of maternal factors.  
More than one fifth (21%) of the increase in the 
caesarean section rate from 19% to 30% was 
explained by changes in the distribution of parity 
and previous caesarean section (Table 5).  The 
next most important factor was changes in the 
distribution of maternal age which explained 12% of 
the increase – more than changes in caesarean 
section rates for malpresentation, multiple 
pregnancy, and preterm birth combined. 
The attributable proportions estimated in Table 5 
can be used to estimate what the caesarean section 
rate “would have been” if only certain changes had 
occurred.  For example, given that the caesarean 
section rate increased from 19.1% (Group A) to 
30.4% (Group B) over the two time-periods, and 
39% of caesarean sections were due to a 
combination of parity, previous caesarean section, 
body mass index and maternal age, we can say that 
had the obstetric population been the same in about 
1995 (Group A) as it was in about 2012 (Group B) 
then the caesarean section rate would have 
changed from 19.1% to 23.5% with no changes in 
care.  With additional changes in caesarean section 
rates for malpresentation, multiple pregnancy, 
malpresentation and preterm birth, it would have 
increased to 25.1%, and with changes to rates of 
elective caesarean section for the indications listed 
in Table 5, it would have increased to 26.4%. 
Despite much discussion in the popular media, only 
1.5% of the increase in the caesarean section rate 
could be explained purely by the choice to have a 
caesarean section (after changes in maternal and 
pregnancy factors had been considered) 
representing only 0.2% of all births.  The theoretical 
maximum reduction in caesarean section that could 
be achieved by not performing caesarean section 
Table 2B.5 
Factors which can explain the increase in caesarean sections between 1999 and 2009  
Factor 
 
‘Explained’ proportion of 
the increase in the 
caesarean section rate 
Proportion of all births 
Changes in the distribution of maternal factors 
(presumed unrelated to changes in management) 
   Nulliparity or previous caesarean section 
   Maternal age 
   Maternal body mass index 
Subtotal 
 
 
   21% 
   12% 
   5.9% 
39% 
 
 
   2.4% 
   1.3% 
   0.7% 
4.4% 
Changes in caesarean section rate for: 
(presumed related to changes in management) 
   Malpresentation (mainly breech) 
   Multiple gestation 
   Preterm birth 
Subtotal 
 
 
   5.1% 
   3.3% 
   6.2% 
15% 
 
 
   0.6% 
   0.4% 
   0.7% 
1.7% 
Post-hoc assessment of elective caesareansa: 
(presumed related to changes in management) 
   Maternal choice 
   Suspected fetal compromise 
   Previous pregnancy issue 
   Suspected large fetus 
Subtotal 
 
 
   1.5% 
   2.1% 
   3.4% 
   1.1% 
8.1% 
 
 
   0.2% 
   0.2% 
   0.4% 
   0.1% 
0.9% 
Combined total 62% 7.0% 
a) For the post-hoc assessment, maternal and pregnancy factors were first considered.  Thus, the attributable proportions 
shown here are lower than they would have been had only the indication for elective caesarean section been considered.  
For example, caesarean sections for maternal choice increased from 0.20% to 0.66% of all births, representing 5% of the 
increase in caesarean sections (from 19% to 30%), but only 1.5% was attributed to maternal choice, because factors such as 
maternal age and plurality were considered first. 
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for maternal request alone was 0.66% - the 
proportion of all births in 2009 to 2016 (Group B) for 
which a caesarean section was performed for this 
reason.  However, the actual reduction would be 
less as a substantial proportion of caesarean 
sections would have been performed for other 
indications. 
These findings can be used to direct future efforts to 
improve care in pregnancy.  We found a substantial 
increase in caesarean sections for slow progress in 
labour and while the change appears to be 
influenced by changes in maternal age, body mass 
index and parity the trend is concerning.  More 
research about the management and diagnosis of 
prolonged labour, and the best time to intervene is 
required.  It is unclear if changes in labour 
management policies533 will impact on this trend.  
Induction of labour has been shown to reduce 
caesarean section510-512,535, and in the future it 
would be worthwhile considering a randomised trial 
of women at high risk of caesarean section for slow 
progress for preventing this outcome. 
Our study has limitations.  Large clinical databases 
may be susceptible to data entry errors, although 
we have demonstrated the accuracy of a portion 
(2005 to 2009) of this database in the past (Chapter 
3, Part A).  Some of the fields used in the analysis 
were derived from multiple other fields, including 
some which allowed free text entry.  This could lead 
to misclassification of items such as the indication 
for caesarean section or history of previous 
caesarean section which could bias the findings in 
any direction.  15% of the data were missing for 
body mass index.  The data come from only two 
institutions in one city and our findings may not be 
generalisable to other settings. 
Our study also has several strengths.  We had 
almost complete data for factors such as maternal 
age and mode of birth which reduces selection bias.  
The large dataset allowed subdivision into many 
subcategories and a stratified analysis which would 
not have been possible in smaller datasets.  Unlike 
national databases, our institutional database 
contained sufficient data fields to allow us to 
subdivide our outcome into indications for 
caesarean section, and Robson categories. 
Conclusions: 
Much of the increase in the caesarean section rate 
between 1999 and 2009 is explained by changes in 
maternal demographics and history of caesarean 
section and a significant proportion is explained by 
changes in the route of delivery for multiple 
pregnancies, malpresentations, and preterm births.  
Maternal choice had minimal impact. 
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SYNOPSIS 
Chapter 3: Induction of labour. 
This Chapter is divided into three parts.  Parts A and C have been submitted to peer reviewed 
journals, and Part B has been published.   
Part A is a descriptive study which examines caesarean section rates for slow progress, ‘fetal 
distress’ and other indications among nulliparous women induced at 38 to 39 weeks’ gestational 
age.  Caesarean section rates and the indications for caesarean section, varied widely by indication 
for induction of labour. 
Authors: de Vries BS, Tooher J, Phipps H, Wong E, McGeechan K, Barratt A, Hyett JA. 
Contributions to Part A: 
Dr Brad de Vries: Study concept and design, analysis, and drafting the manuscript. 
Prof Alexandra Barratt: Contribution to study design, analysis, and writing the manuscript. 
Dr Kevin McGeechan: Contribution to study design, analysis, and writing the manuscript. 
Dr Jane Tooher: Data collection and contribution to writing the manuscript. 
Dr Ebony Wong: Data collection and contribution to writing the manuscript. 
Dr Hala Phipps: General supervision, ethics applications, contribution to writing the manuscript. 
Dr Adrienne Gordon: Neonatal advice and contribution to writing the manuscript. 
Professor Jon Hyett: Primary supervision and contribution to the writing the manuscript. 
  
Part B is a letter to the ANZJOG which describes the biases inherent in observational studies of the 
association between induction of labour and caesarean section. 
Reference: de Vries BS. Re: Intrapartum intervention rates and perinatal outcomes following 
induction of labour compared to expectant management at term from an Australian perinatal centre.  
ANZJOG 57: E9-E13, 2017. 
Part C was a comparative study which assessed the association between induction of labour at 38 to 
39 completed weeks’ gestational age and caesarean sections for different indications, in nulliparous 
women.  It showed different associations with caesarean for slow progress and caesarean section for 
other indications, strongly suggesting that induction of labour reduces caesarean section by 
reducing slow progress in labour and not by preventing ‘fetal distress’. 
Authors: de Vries BS, McGeechan K, Barratt A, Tooher J, Wong E, Phipps H, Gordon A, Hyett JA. 
Contributions to Part C: 
The description of authors’ contributions is the same as for Part A. 
 Relevance: 
Differences in indications for induction of labour could be responsible for heterogeneity of findings 
in randomised controlled trials of induction of labour for preventing caesarean section.  Induction of 
labour probably prevents caesarean section by preventing slow progress in labour. 
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Chapter 3: Induction of labour 
Part A: Outcomes by indication 
 
Introduction 
In Australia, induction of labour (IOL) increased 
from 25% to 28% of all pregnancies between 2004 
and 20149,29.  IOL is associated with complications 
such as uterine hyperstimulation, uterine rupture, 
‘fetal distress’, restricted mobility and adverse 
labour experience538,539.  Conversely, it is also 
associated with a decrease in adverse maternal and 
perinatal outcomes such as caesarean section, 
severe pre-eclampsia, and stillbirth510-512,514. 
Knowledge of the impact of IOL on these outcomes 
is important when counselling women about their 
delivery options and choices, yet the evidence to 
inform such counselling is limited and mixed. For 
example, randomised trials show that IOL can 
reduce caesarean section rates510-512, yet 
observational studies, at high risk of bias, found that 
IOL increases the risk of caesarean section509,540.  
More recent, well conducted observational studies 
had mixed results514,515,518,541. Furthermore, 
outcomes may vary when IOL is performed for 
different indications such as gestational diabetes, 
hypertension, or suspected fetal compromise.  Few 
studies report mode of birth by indication for IOL, 
and those that do tend to have a small sample size, 
only a few indications, and a wide range of 
gestational ages542-545.  Therefore, current and more 
comprehensive information on outcomes according 
to indications for IOL is needed to help inform 
women about their options. 
Aims 
(i) To describe rates of caesarean section for 
nulliparous women with a singleton pregnancy, 
following IOL from 38(+0/7) to 39(+6/7) by clinical 
indication for IOL. 
(ii) To describe other adverse maternal and 
perinatal outcomes. 
Methods: 
This was a retrospective descriptive observational 
study where the primary study factor was indication 
for IOL and the primary outcome was mode of birth. 
To avoid confusion, we used the term ‘suspected 
fetal compromise’ when IOL was performed for 
concerns about fetal well-being, and ‘fetal distress’ 
when a caesarean section was performed for 
concerns about fetal well-being. 
Population: 
The study population was nulliparous women with 
IOL at 38(+0/7) to 39(+6/7) weeks’ gestational age at 
Royal Prince Alfred (RPA) Hospital, a tertiary 
hospital; and Canterbury Hospital, a metropolitan 
teaching hospital in Sydney, Australia from January 
2009 to December 2016.  Outcomes for women 
planning a vaginal birth who did not undergo IOL 
were also described. 
Exclusion criteria were birth before 38 completed 
weeks’ gestation, elective (pre-labour) caesarean 
section, parity > 0 (any previous birth ≥ 20 
completed weeks’ gestation), multiple gestation and 
non-cephalic presentation. 
Data: 
Clinical and demographic data were collected from 
our institutional maternity database maintained by 
midwives. 
The main indication for IOL was categorised as: 
antepartum haemorrhage, cholestasis of 
pregnancy, maternal choice, reduced fetal 
movements, gestational diabetes mellitus, pre-
existing diabetes, hypertension in pregnancy, 
suspected fetal macrosomia, spontaneous 
(prelabour) ruptured membranes with clear amniotic 
fluid, spontaneous ruptured membranes with 
meconium stained amniotic fluid, suspected fetal 
compromise, post-dates pregnancy, or ‘other’.  
Midwives were asked to enter the main indication 
for IOL into the obstetric database using a drop-
down menu or free text.  Almost all free text entries 
contained only one indication for IOL and were 
reviewed individually by an author (BdV) and 
assigned to one of the above categories. 
Mode of birth was classified as: vaginal (normal 
vaginal birth or instrumental delivery), or caesarean 
section (for slow progress, ‘fetal distress’, or other 
indications).     Maternal outcomes were: post-
partum haemorrhage > 1L (estimated by the 
midwife), third or fourth degree perineal trauma, 
epidural in labour, length of maternal admission, 
and time from birth to maternal discharge.  Perinatal 
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outcomes were: abnormal arterial cord blood gases 
(pH < 7.1, base excess < -12 mM, and/or lactate > 
8mM)546-548, five-minute Apgar score < 7, neonatal 
intensive care unit (NICU) admission, NICU 
admission for respiratory distress, shoulder dystocia 
(with McRoberts or other manoeuvres), perinatal 
mortality (stillbirth or neonatal death within six 
weeks of birth).  Core outcome sets were 
considered549, but selection of outcomes was 
limited by the available data fields.   
Caesarean section for slow progress in labour and 
for ‘fetal distress’ were as defined by the obstetric 
team.  Until 2014, gestational diabetes was 
diagnosed on 75g glucose load with a fasting blood 
glucose ≥ 5.5mM, one hour ≥ 10mM or two-hour ≥ 
8mM.  From January 2015, Australasian Diabetes in 
Pregnancy Society criteria were used550.  
Hypertension in pregnancy was a systolic blood 
pressure ≥ 140 mmHg or diastolic ≥ 90 mmHg on at 
least two occasions.  Suspected fetal compromise 
was any concern about fetal well-being leading to 
IOL including suspected growth restriction, reduced 
amniotic fluid index, increased umbilical artery 
resistance, reduced middle cerebral artery 
resistance, reduced cerebral placental index, and 
cardiotocograph abnormalities.  Records with 
birthweight > 6,000kg or < 1,000kg were considered 
implausible and excluded28.  Records with missing 
mode of birth or gestational age ≥ 44 completed 
weeks were excluded.  For describing baseline 
characteristics, actual birthweight was adjusted to 
an expected fetal weight  at 38(+0/7) weeks gestation 
by calculating birthweight centile using methods 
described elsewhere551.  This allowed an 
approximate comparison of baseline differences in 
fetal weight at the time a decision for IOL or 
continued pregnancy was made. 
Clinical practice 
IOL procedures were: cervical ripening with 0.3 
mg/h slow release intravaginal dinoprostone over 
12 hours for a Bishop score <7.  From 2012, if the 
Bishop score was still <6, a Cook®, a cervical 
ripening balloon was inserted into the cervix, each 
balloon filled with 60-80mL water, and removed 
after another 12 hours.  IOL was by artificial rupture 
of the membranes then oxytocin infusion.  Before 
2013, infusion commenced at 1mU/min and 
changed 30 minutely by 1mU/min to a maximum 
32mU/min. From January 2013 to October 2015, 
infusion started at 4mU/min and changed 30 
minutely by 2mU/min to a maximum 40mU/min.  
Subsequently, oxytocin commenced at 1.5mU/min 
and adjusted 30 minutely, to 2.5mU/min, 5mU/min, 
then by 5mU/min to a maximum of 40mU/min. The 
dose was titrated, aiming for four to five uterine 
contractions every 10 minutes. 
Vaginal examinations were approximately four-
hourly in the first stage of labour, two-hourly from 
eight to 10 cm dilatation, and then hourly. The 
loading dose for epidural analgesia was 0.125% 
marcaine with 2ug/mL fentanyl and infusion of 
0.125% ropivacaine with 5ug/mL fentanyl at 6–8 
mL/hour and boluses as required. Augmentation 
was considered for cervical dilatation < 2 cm in 4 
hours or poor contractions during the active phase 
of labour. 
Analysis 
Analysis was with SAS version 9.4®.  Proportions 
were expressed as percentages with 95% 
confidence intervals.  Non-normally distributed 
continuous data were expressed as medians and 
interquartile ranges. 
Ethics: 
Ethics approval was obtained from the Sydney 
Local Health District (RPA Hospital Zone), Protocol 
No X17-0144. 
Results: 
Of 56,162 births 21,750 remained after exclusion 
criteria were applied and a further 33 were excluded 
for unknown or unrealistic data, leaving 21,717 
available for analysis (Figure 3A.1).  There were 
3,330 women who underwent IOL at 38(+0/7) to 
39(+6/7) weeks’ gestation, 6,431 who went into 
spontaneous labour at this gestation, and 11,956 
who gave birth ≥ 40(+0/7) weeks’ gestation. 
Women undergoing IOL at 38(+0/7) to 39(+6/7) weeks’ 
gestation had similar age, body mass index, and 
birthweight adjusted to 38 weeks’ gestation to 
women not induced at this gestational age (Table 
3A.1).  Women with diabetes in pregnancy and 
women born in South Asia were more likely to be 
induced than other women.  Women born in South 
East Asia were more likely to go into spontaneous 
labour at 38(+0/7) to 39(+6/7) weeks’ gestation and 
women born in Australia or New Zealand were more 
likely to progress beyond 40 completed weeks’ 
gestation. 
Following IOL from 38(+0/7) to 39(+6/7) weeks’ 
gestation, rates of vaginal birth ranged from 54% for 
IOL for suspected large fetus to 82% for IOL for 
suspected fetal compromise (Table 3A.2, Figure 
3A.2).  Caesarean section for slow progress ranged 
from 3.4% for IOL for suspected fetal compromise 
to 36% for suspected large fetus.  Caesarean 
section for ‘fetal distress’ ranged from 2.7% for 
elective (maternal choice) IOL to 20% for 
antepartum haemorrhage or pre-existing diabetes.  
74% of women with IOL at 38(+0/7) to 39(+6/7) weeks, 
75% of women whose pregnancy progressed 
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56,162 births at RPAH or Canterbury 
Hospital from January 2009 to 
December 2016 
21,717 women with available data 
Exclusionsa: 
   9,112 births ≤ 38 weeks’ gestation 
   7,590 elective caesarean sections 
   17,633 births to parous women 
   68 multiple gestations 
   9 breech births 
3,330 inductions of 
labour at 38(+0/7) to 
39(+6/7) weeks’ gestation 
Figure 3A.1: 
Participant flow chart 
6,431 spontaneous labours 
at 38(+0/7) to 39(+6/7) weeks’ 
gestation 
    
11,956 with no induction 
at 38(+0/7) to 39 (+6/7) 
weeks’ gestation 
    
Unknown or unrealistic dataa: 
   6 unknown mode of birth 
   8 ‘post-dates’ induction of labour < 40 weeks’ gestation 
   4 births with gestational age ≥ 44 weeks 
   15 unrealistic birthweight (< 1000g or > 6000g)b  
    
21,750 planned vaginal births 
meeting inclusion criteria 
a) These numbers are hierarchical.  For example, there were 7,590 elective caesarean sections after the 9,112 births ≤ 
38 weeks’ gestation had been excluded 
b) Birthweight criteria used by Alexander et al 199628 
RPAH = Royal Prince Alfred Hospital 
beyond 39(+6/7) weeks, and 88% of women who 
went into spontaneous labour at 38(+0/7) to 39(+6/7) 
weeks’ gestation had a vaginal birth. 
Postpartum haemorrhage > 1L and anal sphincter 
injury occurred with similar frequency in all IOL 
subgroups (Table 3A.3).  Epidural use ranged from 
48% for IOL for suspected fetal compromise to 82% 
for IOL for suspected large fetus.  The median 
length of stay was 12 hours longer for women with 
IOL compared with women who gave birth after this 
gestation, and the median time from birth to 
discharge was 6 hours longer. 
Perinatal outcomes following IOL at 38(+0/7) to 
39(+6/7) weeks’ gestation were similar in all 
subgroups except for IOL for pre-existing diabetes 
where 44% (11/25) of infants were admitted to the 
NICU and 7.9% had a five-minute Apgar score less 
than seven (Table 3A.4).  Overall, 8.9% of infants 
were admitted to the NICU when the labour was 
induced at 38(+0/7) to 39(+6/7) weeks’ gestation, 5.0% 
when the woman went into spontaneous labour at 
38(+0/7) to 39(+6/7) weeks’ gestation, and 6.4% for all 
pregnancies ≥ 40(+0/7) weeks’ gestational age. 
Discussion: 
Main Findings 
Our main finding was that among women induced at 
38 or 39 weeks’ gestational age, rates of vaginal 
birth varied widely by indication for IOL.  82% of 
women induced for suspected fetal compromise 
achieved a vaginal birth compared with only 54% 
when the indication was suspected large fetus.  
Indications for caesarean section also varied widely.  
When the indication for IOL was suspected fetal 
compromise, 72% of all caesarean sections were 
for ‘fetal distress’ compared with only 13% when the 
indication was suspected large fetus. 
Significance 
These findings are useful for counselling women.  
Nulliparous women could be informed that the rate 
of vaginal birth was about the same if labour was 
induced at 38 or 39 weeks’ gestation compared with  
58 Chapter 3: Impact of induction of labour 
 
 
 
 
 
 
 
Table 3A.1: 
Demographic and clinical characteristics among nulliparous women with a singleton pregnancy intending to 
have a vaginal birth 
 IOL at 
38(+0/7) - 39(+6/7) 
SOL at 
38(+0/7) - 39(+6/7) 
SOL or IOL ≥ 40(+0/7) 
n 3,330 6,431 11,956 
Maternal age (years)a 31 (28,34) 30 (27,34) 31 (28,34) 
Pre-pregnancy BMIa,b 23 (21,27) 
(n = 2,598) 
21 (20,24) 
(n = 4,357) 
22 (20,25) 
(n = 8,195) 
Maternal place of birth 
   Australia or New Zealand 
   South East Asia 
   South Asia 
   Europe, Canada or United States 
   Other 
 
1,380 (41%) 
774 (23%) 
685 (20%) 
276 (8%) 
215 (6%) 
 
2,512 (39%) 
1,966 (31%) 
838 (13%) 
654 (10%) 
461 (7%) 
 
5,833 (49%) 
2,509 (21%) 
1,283 (11%) 
1,434 (12%) 
897 (8%)  
Diabetes mellitis 898 (27%) 613 (10%) 664 (6%) 
Estimated fetal weight at 38(+0/7) weeks (kg)a,c 3.0 (2.7,3.3) 3.0 (2.8,3.3) 3.0 (2.8,3.3) 
a) Median (interquartile range) 
b) Calculated from measured maternal height and self-reported pre-pregnancy weight.  6,565 BMIs were missing 
and 10 were considered implausible (< 12 or > 70) and excluded. 
c) Estimated by calculating birthweight centile and assuming the fetus was on the same centile at 38(+0/7) weeks’ 
gestation, and using birthweight data described in Chapter 5 Part A 
IOL = induction of labour; SOL = spontaneous onset of labour 
SROM = spontaneous (preterm) ruptured membranes 
Figure 3A.2: 
Mode of birth for nulliparous women induced from 38
(+0/7)
to 39
(+6/7)
 weeks’ gestation by indication for 
induction 
  
82% 81% 81% 77% 76% 74% 74% 73% 71% 67% 56% 54% 
Vaginal birth: 
(blue) 
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TABLE 3A.2: 
Mode of birth for nulliparous women induced from 38(+0/7) - 39(+6/7) weeks’ gestation by indication, and all 
other women planning a vaginal birth ≥ 38(+0/7)weeks 
 
Indication for IOL n NVB 
(%) 
AVB 
(%) 
Total vaginal 
birth  
(%) (95%CI) 
CS 
for SP 
(%) 
CS for ‘fetal 
distress’ (%) 
CS 
other 
(%) 
Total CS 
(%) 
Suspected fetal compromise 443 57 25 82 (79-86) 3.4 13 1.6 18 (14-21) 
Maternal choice 37 57 24 81 (68-94) 14 2.7 2.7 19 (6-32) 
Cholestasis of pregnancy 47 51 30 81 (70-92) 11 8.5 0.0 19 (18-30) 
Reduced FMs 167 47 29 77 (70-83) 9.0 11 3.6 23 (17-30) 
Hypertensive disorders 385 43 33 76 (72-80) 10 12 2.3 24 (20-28) 
SROM, clear liquor 829 47 28 74 (71-77) 14 9.4 2.3 26 (23-29) 
Other indications 457 44 30 74 (70-78) 14 10 2.0 26 (22-30) 
SROM, meconium liquor 55 44 29 73 (61-85) 11 13 3.6 27 (15-39) 
Gestational diabetes 789 44 27 71 (68-74) 15 12 2.3 29 (26-32) 
Antepartum haemorrhage 46 35 33 67 (52-80) 8.7 20 4.4 33 (20-48) 
Pre-existing diabetes 25 24 32 56 (37-75) 16 20 8.0 44 (25-73) 
Suspected large fetus 50 28 26 54 (39-68) 36 6.0 4.0 46 (32-61) 
Total for IOL at 
38(+0/7) - 39(+6/7) weeks 
3,330 46 28 74 (73-76) 12 11 2.3 26 (24-27) 
All births ≥ 40(+0/7) weeks 
gestation 
11,956 47 29 75 (75-76) 13 9.8 2.1 25 (24-25) 
Spontaneous labour at 
38(+0/7) – 39(+6/7) weeks 
6,431 65 23 88 (87-89) 4.8 4.2 3.1 12 (11-13) 
AVB = assisted vaginal birth; CS = caesareans section; FMs = fetal movements; GDM = gestational diabetes; IOL = induction 
of labour; NVB = normal vaginal birth;  SP = slow progress; SROM = Spontaneous rupture of membranes 
TABLE 3A.3: 
Birth outcomes for nulliparous women induced from 38(+0/7) - 39(+6/7) weeks’ gestation by indication and women 
planning a vaginal birth not induced at this gestation 
 
Indication for IOL n PPH 
>1L 
(%) 
3rd/4th 
degree 
perineal 
trauma (%) 
Epidural 
in labour 
(%) 
Length of stay 
(hours)a,b 
Time from 
birth to 
discharge 
(hours)a,b 
Suspected fetal compromise 443 3.8 3.6 48 105 (79,137) 84 (57,104) 
Maternal choice 37 2.7 0.0 59 86 (71,122) 72 (47,104) 
Cholestasis of pregnancy 47 2.1 6.4 64 119 (88,142) 76 (58,98) 
Reduced FMs 167 3.4 7.8 66 100 (77,137) 77 (56,99) 
Hypertensive disorders 385 5.5 6.0 55 125 (100,157) 94 (72,116) 
SROM, clear liquor 829 3.6 5.7 59 100 (77,125) 85 (63,110) 
Other indications 457 5.9 5.0 61 108 (84,137) 87 (65,109) 
SROM, meconium liquor 55 3.8 5.5 67 96 (70,121) 84 (61,109) 
Gestational diabetes 789 3.7 6.0 59 122 (97,148) 88 (66,109) 
Antepartum haemorrhage 46 4.3 8.7 72 104 (87,133) 92 (70,109) 
Pre-existing diabetes 25 2.4 12 68 142 (125,154) 104 (89,120) 
Suspected large fetus 50 4.0 2.0 82 122 (96,149) 91 (68,109) 
Total for IOL at 
38(+0/7) - 39(+6/7) weeks 
3,330 4.0 5.5 59 108 (82,140) 87 (64,109) 
All births ≥ 40(+0/7) weeks 
gestation 
11,956 4.9 6.3 53 96 (71,121) 81 (57,101) 
Spontaneous labour at 
38(+0/7) – 39(+6/7) weeks 
6,431 2.9 6.4 34 84 (60,106) 76 (53,96) 
a) Median (interquartile range) 
b) missing data on length of stay and time from birth to discharge for two women  
IOL = induction of labour 
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pregnancies reaching 40 weeks’ gestational age 
(about 75% in our study), but higher if spontaneous 
labour occured before 40 weeks.  Importantly, 
women can be given more detailed estimates of 
their chances of achieving a vaginal birth based on 
the indication for their IOL.  This is especially 
relevant when delivery is recommended for 
suspected fetal compromise and the woman is 
deciding between IOL and elective caesarean 
section. 
Other outcomes 
While adverse maternal and perinatal outcomes 
were similar across all groups, there were some 
differences.  Epidural rates were higher with IOL, 
suggesting induced labours are more painful or 
longer.  Women with pre-existing diabetes mellitus 
had more anal sphincter injuries and more infants 
with low five-minute Apgar scores, potentially due to 
small sample size (n = 25).  IOL at 38 or 39 weeks’ 
gestation was associated with admission to the 
NICU, but the rate of respiratory distress syndrome 
was the same.  This could be due to our policy of 
routinely admitting infants < 2,200g or at risk of 
hypoglycemia (poor maternal glycemic control, 
birthweight ≥ 95th centile, hypoglycemia symptoms 
with blood glucose ≤ 2.5mmol/L, and low 
percentage body fat measured by PEA-POD®).  We 
observed similar rates of perinatal death, shoulder 
dystocia, five-minute Apgars < 7, and abnormal 
arterial cord blood gases, but our sample size may 
have been too small to detect differences in these 
outcomes.  Others have found that IOL is 
associated with less perinatal mortality, but a small 
increase in shoulder dystocia514. 
Other literature 
To our knowledge this is the first study to describe 
pregnancy and perinatal outcomes by specific IOL 
indication before 40 weeks’ gestation.  Several 
smaller studies recruiting women of mixed parity 
induced at any gestation542,543 or from 37 weeks 
onwards544 reported mixed findings for mode of 
birth following IOL for “fetal indications”.  A 
secondary analysis of an existing observational 
study found higher rates of vaginal birth among 
1,834 term nulliparous women when the birthweight 
was below the tenth centile compared with larger 
infants (odds ratio 1.47 [95% CI 1.14-1.91] after 
adjusting for obesity).  Our data support the finding 
that IOL for suspected fetal compromise is not a risk 
factor for caesarean section. 
Our results could help explain heterogeneity in the 
findings of randomised controlled trials of IOL for 
preventing caesarean section.  Most trials show that 
IOL reduces caesarean section but few were 
performed at this relatively early gestational 
age510,535.  Some trials in specific populations such 
as fetal growth restriction, maternal age > 35 years, 
and gestational diabetes found no difference in 
caesarean section rates41,519,552, possibly due to 
small sample size, study design, or effect 
modification due to the mechanism through which 
IOL exerts its preventative effect.  For example, 
based on our findings, if IOL prevents caesarean 
section by reducing cephalopelvic disproportion 
then it would not be expected to prevent caesarean 
section for fetal growth restriction, which is 
consistent with the findings of the Digitat Trial519.  
Similarly, the 35/39 Trial showed no difference in 
caesarean section rates, which would be expected 
if IOL prevents caesarean section by reducing 
cephalopelvic disproportion, given the difference in 
mean birthweight was only 76g, equivalent to less 
than three days’ gestational age. 
Limitations 
Limitations included retrospective analysis and data 
entry by many different clinicians which could lead 
to data inaccuracy.  For example, the midwife who 
recorded the indication for IOL may have been 
unaware of all the considerations which led to the 
decision to induce.  We previously demonstrated 
high accuracy of this dataset from 2005 to 2009 for 
variables including indication for caesarean section 
but did not do so for indication for IOL553.  It is 
important to note that these data are descriptive, 
and, in the absence of intervention trials powered to 
detect effects according to IOL indication, no strong 
inferences can be made about how a decision to 
induce labour will affect birth outcomes.  For 
example, while IOL at 38 or 39 weeks’ gestation for 
a suspected large fetus was associated with only a 
54% rate of vaginal birth, it is not known whether a 
decision not to induce the labour will increase or 
decrease this rate. 
Strengths 
These included prospective data collection, large 
sample size and few exclusions for missing or 
inadequate data (< 0.2%).  This would result in 
lower risk of misclassification of IOL indication, 
narrower confidence intervals, and low risk of 
selection bias.  We were also able to describe 
outcomes according to indication for caesarean 
section which is often unavailable in large datasets. 
Future research 
Future research should investigate the association 
between IOL and caesarean section for slow 
progress and ‘fetal distress’ and aim to determine if 
IOL preferentially prevents caesarean section for 
each of these indications.  This could lead to a 
model to predict women who are at high risk of 
caesarean section who may benefit from IOL near 
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term and ultimately to a randomised trial of IOL in 
women at high risk for reducing caesarean section. 
Conclusion 
Rates of vaginal birth in nulliparous women 
following IOL at 38 or 39 weeks’ gestation vary by 
indication for IOL.  Rates of maternal and perinatal 
complications are similar to births from 40 weeks’ 
gestation onwards.  This information is useful for 
counselling women and could be incorporated into 
information pamphlets or decision aids.  
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Part B: Letter to ANZJOG 
Re: Intrapartum intervention rates and perinatal 
outcomes following induction of labour 
 
Dear Editor, 
I would like to congratulate Zhao et al518 on their 
excellent paper published in the February issue of 
ANZJOG.  They found that induction of labour (IOL) 
was associated with emergency caesarean section 
(CS) after adjusting for multiple confounders.  I was 
glad to see them divide elective caesarean section 
into ‘failure to progress’ and ‘non-reassuring fetal 
status’ because this could provide insight into the 
mechanisms through which IOL alters mode of 
delivery. 
However, despite good quality design, this type of 
study is susceptible to bias.  Firstly, the choice of 
comparator – women induced on or after the week 
of IOL would over-estimate any positive association 
between IOL and emergency CS.  This comparator 
would be appropriate for a woman induced at 
38(+0/7) weeks’ gestation, but a woman induced at 
38(+6/7) will be compared with women who went into 
spontaneous labour at an earlier gestational age.  
Unfortunately, the alternative– women induced after 
the gestational week of IOL would under-estimate 
the association.  In the paper by Stock et al, both 
approaches were used.  For IOL at 40 weeks’ 
gestation they found adjusted odds ratios of 0.83 
(95%CI 0.79 to 0.88) and 1.08 (95%CI 1.03 to 1.13) 
for these two comparators respectively - completely 
opposite results from the same dataset!514 
Secondly, adjusting for birthweight would also over-
estimate any positive association between IOL and 
emergency CS.  Ideally, fetal weight at the time of 
induction would be used, but this is not possible.  In 
the non-IOL group, the fetus will continue to grow 
and, as there is a positive correlation between 
birthweight and CS, more CSs will be attributed to 
birthweight in the regression model - and fewer 
attributed to the decision not to induce the labour.  
Birthweight could be extrapolated back to the 
gestation at which the induction occurred in the 
study group, although this relies on the assumption 
that all fetuses grow at approximately the same 
rate. 
Thirdly, adjusting for diabetes and hypertension as 
‘yes/no’ variables will bias the study towards a 
positive association between IOL and emergency 
CS because the women whose labour was induced 
will have more severe disease.  For example, 
women with pre-existing diabetes or on high doses 
of insulin are more likely to be induced at 38 weeks’ 
gestation and those with diet controlled gestational 
diabetes are more likely to be conservatively 
managed. 
Finally, and perhaps most importantly, it is not 
possible to account for unknown confounders.  
There are many reasons for offering IOL which are 
often not recorded in maternity datasets.  At earlier 
gestations, we tend to offer induction of labour only 
when there is a strong maternal or fetal indication, 
many of which predispose to emergency CS.  Thus, 
if IOL at 38 weeks’ gestation protects against 
emergency CS, observational studies will tend to 
underestimate this effect.  While elective IOL is a 
contentious topic, it is important to know what risks 
and benefits it confers so that women can be 
appropriately informed about all their management 
options and ultimately, randomised controlled trials 
are the least biased way to gain this information. 
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Part C: 
Observational study and sensitivity analysis 
Induction of labour at 38 to 39 weeks: does it 
prevent caesarean section for slow progress? 
 
Introduction 
In Australia, almost a third of babies are born by 
caesarean section and 28% of labours are 
induced29.  The background rate of caesarean 
section increased from less than 20% to more than 
30% between 1996 and 2006 and is still rising7,17,82.  
Among women who are having their first caesarean, 
the most common indication is slow progress in 
labour82,98. 
Randomised trials show that induction of labour 
(IOL) reduces caesarean section, but until recently, 
few trials were conducted prior to 40 weeks’ 
gestational age in low risk pregnancies510.  A large 
randomised trial, currently published in abstract 
form, recruited 6,106 low risk nulliparous women 
and found that induction of labour at 39(+0/7) to 
39(+4/7) weeks’ gestational age reduced caesarean 
section from 22.2% to 18.6%554.  Several recent 
well conducted observational studies found that IOL 
before 40 weeks’ gestation does not increase the 
risk of caesarean section and decreases perinatal 
mortality514,555.  Another recent observational study 
found an increase in caesarean section518.  Despite 
the evidence for an association between IOL and a 
reduced rate of caesarean section, the mechanism 
of this association is unknown and it is unclear 
which groups of women might benefit. 
The aims of this study were: 
(i) to assess the efficacy of IOL at 38(+0/7) to 39(+6/7) 
weeks’ gestation for reducing caesarean section for 
slow progress in labour, caesarean section for 
suspected fetal compromise, and caesarean section 
overall. 
(ii) to assess the association between IOL and 
adverse maternal and perinatal outcomes 
(iii) to describe the impact of choice of comparator 
for assessing the association between IOL and 
caesarean section. 
Methods: 
This was a retrospective observational study where 
the primary study factor was IOL resulting in birth at 
38(+0/7) to 39(+6/7) weeks’ gestation and the primary 
outcomes were caesarean section for slow progress 
in labour, caesarean section for suspected fetal 
compromise, and caesarean section for any 
indication.  The paper is reported using STROBE 
guidelines556.   
Population: 
The study population was nulliparous women with 
IOL at Royal Prince Alfred Hospital (RPAH) or 
Canterbury Hospital in Sydney, Australia from 
January 2009 to December 2016.  RPAH is a 
tertiary referral hospital and Canterbury Hospital is 
a metropolitan teaching hospital. 
Exclusion criteria were birth before 38 completed 
weeks’ gestation, elective (planned pre-labour) 
caesarean section, parity > 0 (any previous birth ≥ 
20 completed weeks’ gestation), multiple gestation, 
non-cephalic presentation, and IOL at 38(+0/7) to 
39(+6/7) weeks’ gestation for spontaneous ruptured 
membranes. 
Intervention: 
The intervention was induction of labour as outlined 
for the descriptive study in Chapter 3, Part A (page 
55) 
Comparator: 
Choosing a comparison group consisting of women 
who gave birth beyond either 38(+0/7) or 39(+6/7) 
weeks gestational age (the lower and upper limits of 
our study group) could have resulted in over or 
underestimation of any positive relationship 
between IOL and caesarean section respectively514.  
Thus, we chose a comparison group of women who 
gave birth beyond the median gestational age at 
birth in the study group.  The median gestational 
age in the study group was 39(+1/7), and 
consequently our comparison group consisted of all 
women with IOL or spontaneous onset of labour 
who gave birth at ≥ 40(+0/7) weeks gestation plus all 
women who went into spontaneous labour from 
39(+2/7) to 39(+6/7) weeks.  We performed a sensitivity 
analysis using two alternative comparators: (1) all 
women with IOL or spontaneous onset of labour at 
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≥ 40(+0/7) weeks’ gestation; and (2) the same as (1) 
plus all women with spontaneous onset of labour 
from 38(+0/7) to 39(+6/7) weeks’ gestation.  These two 
comparators are equivalent to those used by other 
investigators514. 
Outcomes: 
The primary outcomes were caesarean section for 
slow progress in labour, caesarean section overall, 
and caesarean section for suspected fetal 
compromise.  Other outcomes were: instrumental 
delivery, third or fourth degree perineal trauma 
(assessed by clinicians), post-partum haemorrhage 
> 1L (as estimated by the midwife at birth), length of 
hospital stay, abnormal arterial umbilical cord gases 
(pH < 7.1, base excess < -12 mM or lactate > 8 
mM), five-minute Apgar score < 7, admission to the 
neonatal intensive care unit (NICU), and admission 
to NICU for respiratory distress syndrome. 
Data: 
Clinical and demographic data were collected from 
the maternity database as described in Chapter 3A. 
Statistical methods: 
Data were analysed using SAS version 9.4®.  A p-
value of <0.05 was considered statistically 
significant. We adjusted for the following variables 
known to be associated with caesarean section 
based on our previous studies, the medical 
literature and available data fields: maternal age, 
booking BMI, height, gestational diabetes, and 
birthweight (corrected to 38(+0/7) weeks’ gestation).  
Multiple imputation was used for missing data using 
20 iterations.   For the outcome of caesarean 
section overall, binomial logistic regression was 
performed on each of the 20 datasets, and 
summary odds ratios and 95% confidence intervals 
reported.   Explanatory variables were tested for 
linearity by grouping into four to six clinically 
relevant categories and plotting the beta-
coefficients against the mid-points of each group.  
Non-linearly associated variables were analysed by 
group.   For separate outcomes of caesarean 
section by indication (slow progress, ‘fetal distress’, 
and ‘other’), multinomial regression was used and 
all explanatory variables were categorised.  Effect 
modification was assessed by creating the 
interaction terms: IOL x maternal age and IOL x 
BMI as these were considered physiologically 
plausible, with a cut-off of 0.05 for inclusion of the 
term.  Colinearity was considered present when the 
variance inflation factor was > 10.  The equality of 
odds ratios describing the association of IOL with 
cesarean section for slow progress and cesarean 
section for suspected fetal compromise was 
assessed by testing the equality of regression 
coefficients in the multinomial regression model.  A 
formal sample size calculation was not performed. 
Ethics 
Ethics approval was obtained from the Sydney 
Local Health District (RPA Hospital Zone), Protocol 
No X17-0144. 
Results 
Data were available for 17,786 (99.8%) of 17,817 
eligible mother-infant pairs and of these, 2,415 were 
induced from 38(+0/7) to 39(+6/7) weeks’ gestation and 
15,371 were in the comparison group (Figure 3C.1).  
Data were missing for pre-pregnancy body mass 
index for 5,439 (31%) women, and five-minute 
Apgar scores for 13 (0.1%) infants. 
Baseline characteristics are outlined in Table 3C.1.  
Women born in South Asia were more likely to be 
induced at 38(+0/7) to 39(+6/7) weeks’ gestation.  
Women with gestational diabetes on insulin were 
more likely to be induced at 38(+0/7) to 39(+6/7) weeks, 
consistent with our local policies.  Maternal age, 
BMI and birthweight adjusted to 38(+0/7) weeks 
gestation were similar in both groups.  The median 
actual birthweight was 267g higher in the 
comparison group than for infants of mothers 
induced at 38(+0/7) to 39(+6/7). 
Most maternal and perinatal outcomes were similar 
for inductions of labour from 38(+0/7) to 39(+6/7) 
weeks’ gestation (IOL group) compared with 
pregnancies ≥ 40(+0/7) weeks (Table 3C.2).  Twenty-
six percent of women in the IOL group and 22% of 
women in the comparison group had a caesarean 
section.  8.5% of infants in the IOL group and 6.1% 
in the comparison group were admitted to the 
neonatal intensive care unit.  5.4% of women in the 
IOL group and 6.3% in the comparison group had 
an anal sphincter injury.  After excluding inductions 
for fetal death in utero in the IOL group and all 
congenital anomalies, there were no perinatal 
deaths in the IOL group and 27 (0.2%) in the 
comparison group (Table 3C.2). 
Binomial logistic regression for induction of 
labour on caesarean section overall 
There was interaction between IOL and maternal 
age group (p = 0.002).  The odds ratios for the IOL 
group compared with the comparison group was 
higher among women aged < 25 years (OR 1.63 
[95%CI 1.17 – 1.27]) than for women in older age 
groups after adjusting for BMI group, height group, 
birthweight centile group and gestational diabetes 
type (Table 3C.3). 
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Multinomial logistic regression for 
induction of labour on caesarean section  
(i) For slow progress in labour 
There was no interaction.  The odds ratio for the 
IOL group compared with the comparison group 
was 0.93 (95%CI 0.79 – 1.09) after adjusting for 
BMI group, height group, age group, gestational 
diabetes type, and birthweight group (corrected to 
38(+0/7) weeks’ gestation) (Table 3C.2).   
(ii) For suspected fetal compromise 
There was interaction between IOL and maternal 
age group (p = 0.004).  The odds ratios for the IOL 
group compared with the comparison group 
progressively decreased from 1.94 (95% CI 1.18-
2.89) for women aged < 25 years to 0.99 (95% CI 
0.73-1.36) for women aged ≥ 35 years (Table 3C.3). 
Comparison between caesarean section for 
slow progress and ‘fetal distress’ 
There was strong evidence (P=0.009) of a 
difference in the odds ratio for cesarean section for 
suspected fetal compromise and the odds ratio for 
cesarean section for slow progress. Women who 
underwent IOL had greater odds of cesarean 
section for suspected fetal compromise relative to 
vaginal birth (OR 1.23 (1.05-1.44)), while the odds 
of cesarean section for slow progress was similar to 
that for vaginal birth (OR 0.93 (0.79-1.09)). 
Multivariable analyses for other outcomes 
After adjusting for multiple covariates, the IOL group 
was associated with fewer anal sphincter injuries 
(OR 0.80 [95%CI 0.65-0.99]), more admissions to 
the neonatal intensive care unit (OR 1.27 [1.07-
1.51]) and fewer perinatal deaths (OR 0.07 [95%CI 
0.01-0.80])(Table 3C.2).  No difference was found 
for assisted vaginal birth, post-partum haemorrhage 
> 1L, shoulder dystocia, NICU admission for 
respiratory distress, Apgar score < 7, or abnormal 
arterial cord blood results. 
Sensitivity analysis 
Table 3C.4 shows the results of the planned 
sensitivity analysis.  The odds ratios for all primary 
outcomes were higher when the comparison group 
consisted of births ≥ 40(+0/7) weeks’ gestation and 
lower when spontaneous births from 38(+0/7) to 
39(+6/7) weeks’ gestation were included in the 
comparison group. 
Adjusting for raw birthweight instead of expected 
birthweight at 38(+0/7) weeks’ gestation changed the 
odds ratio for caesarean section overall from 1.06 
(95% CI 0.94-1.19) to 1.61 (95%CI 1.27-2.04), and 
adjusting for both raw birthweight and gestational 
age increased it to 2.00 (95%CI 1.70-2.36). 
Table 3C.1: 
Demographic and clinical characteristics among nulliparous women with a singleton pregnancy intending to 
have a vaginal birth 
 IOL at 
38(+0/7) - 39(+6/7) 
Comparison groupa 
n 2,415 15,371 
Maternal age (years)b 31 (28,35) 31 (28, 34) 
Pre-pregnancy BMIb,c 23 (21,27) 
(n = 1,868) 
22 (20, 24) 
(n = 10,479) 
Maternal place of birth (%) 
   Australia or New Zealand 
   South East Asia 
   South Asia 
   Europe, Canada or United States 
   Other 
 
1,027 (43) 
518 (21) 
509 (21) 
207 (8.6) 
154 (6.4) 
 
7,239 (47) 
3,513 (23) 
1,678 (11) 
1,696 (12) 
1,151 (7.5) 
Gestational diabetes 
   Diet controlled 
   Insulin treated 
   Unknown type 
   Total 
 
189 (7.8) 
524 (22) 
142 (5.9) 
855 (35) 
 
694 (4.5) 
199 (1.3) 
122 (0.8) 
1,015 (6.6) 
Estimated fetal weight at 38(+0/7) weeks (kg)b,d 3.0 (2.7,3.3) 3.0 (2.8, 3.3) 
a) IOL ≥ 40 (+0/7) weeks’ gestation and SOL ≥ 39(+2/7) weeks’ gestation 
b) Median (interquartile range) 
c) 10 BMIs < 12 or > 70 were considered implausible and excluded 
d) This was estimated by calculating birthweight centile and assuming the fetus was on the same centile at 38(+0/7) weeks’ 
gestation, using methods described in Chapter 5 Part A 
BMI = body mass index; IOL = induction of labour; SOL = spontaneous onset of labour 
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Discussion 
Main findings 
Our main finding was that the association between 
IOL and caesarean section depended on the 
indication for caesarean section (p = 0.009).  
Specifically, IOL was associated with an increase in 
caesarean section for suspected fetal compromise 
(‘fetal distress’), and no difference in caesarean 
section for slow progress in labour, with estimated 
odds ratios in opposite directions.   IOL was most 
strongly associated with caesarean section for ‘fetal 
distress’ in younger women. 
Significance 
These findings are important because little is known 
about how IOL reduces the risk of caesarean 
section.  Meta-analyses of randomised trials show 
that term IOL reduces caesarean section, with odds 
ratios varying from 0.82 to 0.89 depending on which 
studies were included510-512.  Our study provides 
insight into the mechanisms of this association and 
suggests that IOL prevents some caesarean 
sections by preventing fetal growth in utero leading 
to less cephalopelvic disproportion.  Our results do 
not support the hypothesis that IOL prevents 
caesarean section by reducing fetal compromise 
due to placental dysfunction which becomes more 
prevalent or severe with gestational age. 
Our finding that the association between IOL and 
caesarean section for suspected fetal compromise 
was modified by maternal age was unexpected and 
important.  We speculate that younger women, 
known to have higher vaginal birth rates117,147, may 
contract more efficiently and are more susceptible 
to uterine hyperstimulation, leading to umbilical cord 
compression, fetal acidaemia, and caesarean 
section.  If this were true then slower oxytocin 
infusion or aiming for less frequent contractions in 
Table 3C.2 
Maternal and perinatal outcomes 
 IOL Groupa 
n (%) 
Comparison 
Groupb 
ORunadj  
(95% CI)c 
ORadj 
(95% CI)d 
n 2,415 15,371   
Maternal outcomes     
Mode of birth 
   Normal vaginal 
   Assisted vaginal 
   Total vaginal 
   CS-slow progress 
   CS-‘fetal distress’ 
   CS-other indications 
   Total CS 
 
1,120 (46) 
683 (29) 
1,803 (75) 
283 (12) 
275 (11) 
54 (2.2) 
612 (25) 
 
7,713 (50) 
4,275 (28) 
11,988 (78) 
1,722 (11) 
1,332 (8.7) 
329 (2.1) 
3,383 (22) 
 
 
 
1.00 
1.09 (0.95-1.25)e 
1.37 (1.20-1.58)e 
1.09 (0.81-1.46)e 
1.23 (1.11-1.36)f 
 
 
 
1.00 
0.93 (0.79-1.09)e 
1.23 (1.05-1.44)e,g 
1.07 (0.78-1.47)e 
1.06 (0.94-1.19)f,g 
Post-partum haemorrhage > 1L 103 (4.3) 695 (4.5) 0.94 (0.76-1.16)f 0.96 (0.76-1.22)f 
Anal sphincter injury 130 (5.4) 963 (6.3) 0.85 (0.70-1.02)f 0.80 (0.65-0.99)f 
     
Perinatal outcomes     
Perinatal deathh 
   Stillbirth 
   Neonatal death 
   Total 
 
0 (0.0) 
0 (0.0) 
0 (0.0) 
 
22 (0.1) 
5 (0.0) 
27 (0.2) 
 
 
 
0.12 (0.01-1.90)i 
 
 
 
0.07 (0.01-0.80)j 
Shoulder dystocia 22 (0.9) 167 (1.1) 0.84 (0.54-1.31)f 0.83 (0.50-1.37)f 
Admission to NICU 206 (8.5) 933 (6.1) 1.44 (1.23-1.69)f 1.27 (1.07-1.51)f 
Admission for RDS 71 (2.9) 436 (2.8) 1.04 (0.81-1.34)f 0.95 (0.71-1.25)f 
Apgars < 7k 61 (2.5) 342 (2.2) 1.14 (0.86-1.50)f 1.12 (0.83-1.52)f 
Abnormal arterial cord blood 
results 
26 (1.1) 123 (0.8) 1.35 (0.88-2.06)f 1.28 (0.80-2.04)f 
a) IOL from 38(+0/7) to 39(+6/7) weeks’ gestation 
b) SOL 39(+2/7) to 39(+6/7) weeks or SOL/IOL ≥ 40(+0/7) weeks’ gestation 
c) Unadjusted odds ratios for IOL group versus comparison group 
d) Odds ratios for IOL group versus comparison group adjusted for maternal diabetes status, maternal age, body mass index, 
height, and birthweight adjusted to 38(+0/7). 
e) Multinomial logistic regression 
f) Binomial logistic regression 
g) Adjusted ORs for CS-‘fetal distress’ and total CS should be interpreted carefully as they vary by maternal age group (Table 
3C.3) 
h) Excludes IOLs for fetal death in utero in IOL Group, and congenital anomalies 
i) 0.5 was added to each cell of the 2x2 table557 
j) Using Firth’s penalised likelihood method558 
k) Five-minute Apgar score missing for 13 infants 
CI = confidence interval; CS = caesarean section; CS – ‘fetal distress’ = caesarean section for suspected fetal compromise; 
IOL = induction of labour; NICU = neonatal intensive care unit; SOL = spontaneous onset of labour; OR = odds ratio 
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younger women whose labour was induced could 
reduce their risk of caesarean section. 
Other literature 
Our findings could explain heterogeneity in 
randomised trials of IOL.  For example, the Hypitat 
trial found a reduction in caesarean section from 
19% to 14%, due to fewer caesarean sections for 
slow progress40, but the Digitat trial recruited 
women with growth restricted fetuses and found no 
difference519.  These findings are consistent with the 
observation that most caesarean sections following 
IOL for suspected fetal compromise are for ‘fetal 
distress’ in labour (Chapter 3, Part A).  The ‘35/39 
Trial’, found no difference in caesarean section, but 
49% of women in the non-IOL group had an IOL 
and the mean difference in birthweight was only 
76g, consistent with less than three days’ difference 
in gestational age between the two groups41.  If IOL 
prevented caesarean section by preventing 
cephalopelvic disproportion, this is not surprising. 
Our results were very sensitive to the choice of 
comparison group highlighting potential bias in 
observational studies540.  Women induced at a 
given gestational age should be compared with 
women who give birth beyond this gestation, not 
just those with spontaneous labour509,514.  Thus, 
women induced at 38(+0/7) weeks and women 
induced at 39(+6/7) weeks’ gestation have different 
ideal comparators, and we selected a comparison 
group who gave birth beyond the median 
gestational age of our IOL group.  A large well 
conducted observational study in Scotland showed 
that for IOL at 40(+0/7) to 40(+6/7) weeks’ gestation, 
using comparators at the end and beginning of this 
gestational age window produced completely 
opposite results with odds ratios of 0.83 (95%CI 
0.79-0.88) and 1.08 (95%CI 1.03-1.13) 
respectively514.  We observed this same 
phenomenon, and our choice of comparison group 
produced odds ratios approximately half way 
between these extremes (Table 3C.4).  We believe 
this approach is more accurate, but it is not possible 
when using large datasets which round gestational 
age to the nearest week. 
Our results could explain discrepancies in the 
findings of recent observational studies with 
appropriate comparison groups509,514,518,541.  Others 
have adjusted for birthweight and/or gestational 
age514,518 which would bias towards a positive 
association between IOL and caesarean section, 
and the one study which adjusted for these 
variables found that IOL was strongly protective 
against caesarean section541.  This bias occurs 
because birthweight and gestational age are 
associated with caesarean section and are directly 
influenced by IOL.  They could even be on the 
causative pathway from IOL to caesarean section.  
In the regression models, caesarean section is then 
incorrectly attributed to increased birthweight or 
gestational age in the comparison (non-IOL) group 
when it should be attributed not inducing the labour.  
Our finding of an increase in odds ratio for 
caesarean section from 1.06 (95% CI 0.94-1.19) to 
2.00 (95%CI 1.70-2.36) when these variables were 
added to the model is an example of this bias. 
Other outcomes 
We found a decrease in perinatal mortality following 
IOL at 38(+0/7) to 39(+6/7) weeks’ gestational age, and 
a decrease in maternal anal sphincter injury, 
consistent with other observational data514,555.  A 
meta-analyses of randomised trials also showed a 
reduction in perinatal mortality (OR 0.31[95%CI 
0.12-0.81])510.  Our finding of an increase in 
neonatal admissions agrees with some 
observational studies514, but not others541 and is not 
supported by the Cochrane review (OR 0.90 
[95%CI 0.78-1.04])510. The rate of admissions to the 
NICU following spontaneous onset of labour at 
38(+0/7) to 39(+6/7) weeks’ gestation was 5.0% in our 
cohort (Chapter 3A), suggesting that the difference 
Table 3C.3 
Association between induction of labour at 38(+0/7) to 39(+6/7) and caesarean section overall and caesarean 
section for indications other than slow progress in labour by maternal age groupa 
 n ORadj (95% CI)b,c 
CS-overall 
ORadj (95% CI)b,d 
CS-‘fetal distress’ 
Maternal age group (years)    
< 25 2,167 1.63 (1.17-2.27) 1.94 (1.23-3.05) 
25 - <30 5,208 1.13 (0.91-1.40) 1.44 (1.07-1.94) 
30 - <35 6,721 0.99 (0.82-1.19) 1.11 (0.86-1.43) 
≥ 35 3,690 0.91 (0.72-1.14) 0.99 (0.73-1.36) 
a) Comparison group was SOL 39(+2/7) to 39(+6/7) weeks or SOL/IOL ≥ 40(+0/7) weeks’ gestation 
b)  Odds ratios for IOL group versus comparison group adjusted for maternal diabetes status, body mass index, height, and 
birthweight adjusted to 38(+0/7) 
c) Binary logistic regression 
d) Multinomial logistic regression 
CS-‘fetal distress’ = caesarean section for suspected fetal compromise; CS-overall = caesarean section for any indication; 
IOL = induction of labour; ORadj = adjusted odds ratio; SOL = spontaneous onset of labour 
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in this outcome was not due to the timing of 
induction of labour and may have been related to 
the underlying indication or influenced by our NICU 
admission policies with respect to birthweight and 
gestational diabetes. 
Limitations 
Limitations included: (i) data entry by many different 
clinicians which could lead to data inaccuracy, 
although we previously demonstrated the accuracy 
of this dataset from 2005 to 2009553; (ii) ‘high risk’ 
pregnancies could be associated with both 
caesarean section and the indication for IOL which 
could bias the study towards showing a positive 
association;  and (iii) like other observational 
studies, we assumed planned IOL or planned non-
induction of labour based on gestational age and 
mode of onset of labour, which could bias the 
results in either direction. 
Strengths 
Strengths included: (i) multiple imputation of 
missing data which reduces bias; (ii) estimation of 
fetal growth and expected fetal weight at the time of 
IOL using centile curves from the same 
institution551, avoiding the bias associated with 
using actual birthweights but allowing adjustment 
for approximate fetal weight; (iii) selection of an 
appropriate comparison group; and (iv) preselection 
of known confounders which reduces overfitting due 
to variable selection strategies498. 
Future research 
Future research should aim to confirm our findings 
prospectively.  Given the difficulties with 
observational studies, this would ideally be 
achieved in a randomised controlled trial.  One 
recent large trial recruiting 6,106 low risk nulliparous 
women found that induction of labour from 39(+0/6) to 
39(+4/7) weeks’ gestational age reduced the rate of 
caesarean section from 22.2% to 18.6%535.  While 
routinely offering IOL for women with low risk 
pregnancies may be controversial, an alternative 
would be to screen for (i) risk of caesarean section 
for slow progress in labour, and/or (ii) risk of 
adverse perinatal outcomes, using predictive 
modelling.  This approach would minimise 
unnecessary IOLs, and for a given relative risk 
reduction, be associated with a lower number 
needed to treat. 
Finally, our finding that IOL is associated with 
caesarean section for suspected fetal compromise 
in labour in younger women could lead to future 
research directed towards assessing uterine 
hyperstimulation and oxytocin infusion protocols in 
younger women. 
Conclusion: 
Induction of labour at 38(+0/7) to 39(+6/7) weeks’ 
gestational age in nulliparous women is associated 
with an increase in caesarean section for suspected 
fetal compromise, particularly in younger women, 
and may be associated with a decrease in 
caesarean section for slow progress.  There was 
evidence of a reduction in perinatal mortality.  There 
is potential to develop models to predict caesarean 
section for slow progress in labour or adverse 
perinatal outcomes and offer induction of labour to 
women at high risk of these outcomes. 
 
 
  
Table 3C.4 
Sensitivity analysis 
Comparator OR (95% CI) 
CS-overall 
OR (95% CI) 
CS-progress 
OR (95% CI) 
CS- ‘fetal distress’ 
IOL ≥ 40(+0/7) or SOL ≥ 38(+0/7) 1.20 (1.07-1.34)a 1.10 (0.94-1.28) 1.42 (1.22-1.65)a 
IOL ≥ 40(+0/7) or SOL ≥ 39(+2/7) b  1.06 (0.94-1.19)a 0.93 (0.79-1.09) 1.23 (1.05-1.44)a 
IOL ≥ 40(+0/7) or SOL ≥ 40(+0/7) 0.91 (0.81-1.02)a 0.78 (0.66-0.92) 1.06 (0.91-1.24)a 
a) These ORs should be treated with caution due to evidence of interaction (they vary by maternal age group) 
b) This was the main comparison group 
CS-overall = caesarean section for any indication; CS-‘fetal distress’ = caesarean section for suspected fetal compromise in 
labour; CS-progress = caesarean section for slow progress in labour; IOL = induction of labour; SOL = spontaneous onset of 
labour 
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SYNOPSIS 
Chapter 4: Predictors of caesarean section. 
This Chapter is divided into three parts which have all been published in peer reviewed journals.   
Part A is a comparative study which assessed the association of neonatal head circumference with caesarean section 
for slow progress and for other indications in labour in term pregnancies.  Larger head circumference was associated 
with caesarean section for both of these. 
Reference: de Vries B, Bryce B, Zandanova T, Ting J, Kelly P, Phipps H, Hyett JA.  Is neonatal head circumference 
related to caesarean section for failure to progress?  ANZJOG 56: 571-7, 2016. 
Contributions to Part A: 
Dr Brad de Vries: Study concept and design, analysis, major contributions to writing the manuscript. 
Dr Bianca Bryce: Data collection, and drafting the first version of the manuscript. 
Dr Tatiana Zandanova: Data collection and contribution to writing the manuscript. 
Dr Jason Ting: Data collection and contribution to writing the manuscript. 
Dr Patrick Kelly: Statistics advice and contribution to writing the manuscript. 
Dr Hala Phipps: General supervision and contribution to writing the manuscript. 
Professor Jon Hyett: Primary supervision and contribution to the writing the manuscript. 
 
Part B is a comparative study which found that longer ultrasound measured cervical length at 37 weeks’ gestational 
age was associated with caesarean section in labour. 
de Vries B NR, McGeechan K, Santiagu S, Vairavan R, Burke M, Phipps H, Hyett J. Is sonographically measured 
cervical length at 37 weeks’ gestation associated with intrapartum cesarean section? A prospective cohort study. Acta 
Obstet Gynecol Scand 97(6): 668-676, 2018 
Contributions to Part B: 
Dr Brad de Vries: Study concept and design, analysis, major contributions to writing the manuscript. 
Dr Rajit Narayan: Performed most of the ultrasounds, drafted the introduction and discussion. 
Dr Stanley Santiago: Data collection and contribution to writing the manuscript. 
Dr Kevin McGeechan: Recommended type of, and assisted in the analysis, contribution to writing the manuscript. 
Dr Ramesh Vairavan: Performed ultrasounds, ethics application, and contribution to writing the manuscript. 
Dr Minke Burke: Performed ultrasounds and contribution to writing the manuscript. 
Dr Hala Phipps: General supervision and contribution to writing the manuscript. 
Professor Jon Hyett: Primary supervision and contribution to the writing the manuscript. 
 
Part C was a comparative study which found that fetal biometry at 37 weeks’ gestation was associated with caesarean 
section for slow progress in labour. The best predictors were estimated fetal weight or a combination of abdominal 
circumference and biparietal diameter. 
Reference: Yang J, Hyett JA, McGeechan K, Phipps H, de Vries BS.  Is ultrasound measured fetal biometry predictive 
of intrapartum caesarean section for failure to progress? ANZJOG doi: 10.1111/ajo.12776. Epub ahead of print, 2018. 
Contributions to Part C: 
Dr Jenny Yang: Data linkage and drafted the manuscript. 
Dr Brad de Vries: Study concept and design, data analysis, and major contributions to writing the manuscript. 
Dr Kevin McGeechan: Statistics advice, assistance with the analysis, and contribution to writing the manuscript. 
Dr Hala Phipps: General supervision and contribution to writing the manuscript. 
Professor Jon Hyett: Primary supervision and contribution to the writing the manuscript. 
 
Relevance: 
Factors were identified which can contribute to a model for predicting caesarean section for slow progress in labour. 
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Chapter 4: Predictors of intrapartum 
caesarean section 
Part A: Head circumference 
Does neonatal head circumference predict 
intrapartum caesarean section? 
Introduction 
There is global concern about rising caesarean 
section rates throughout the world and ongoing 
debate about the causes559.  In high income 
countries, factors such as increasing maternal age, 
maternal body mass index (BMI) and gestational 
diabetes are associated with an increased risk of 
caesarean, and changes in these demographics 
may in part be driving these rates296,446,448,560.  
Other factors include changing attitudes towards the 
management of breech and twin births561,562 and 
midcavity instrumental deliveries91,563. 
There have been many attempts to quantify the risk 
of caesarean section in a general obstetric 
population using logistic regression models but 
none have been introduced into widespread clinical 
use296,446-448,560,564-566.  A model would need to have 
a high positive predictive value if it was to be used 
to select women at high enough risk to be offered 
elective caesarean section445,446,560.  An alternative 
approach would be to screen for high risk of 
caesarean section with the aim of offering induction 
of labour to improve the chances of a vaginal 
birth510. 
That fetal head circumference (HC) could be a 
predictor of caesarean section for failure to 
progress makes anatomical sense as the underlying 
abnormality is assumed to be cephalopelvic 
disproportion (CPD)567.  We chose to assess 
measured neonatal HC as this is performed for all 
neonates at our institution. 
Our aim was to describe the association between 
neonatal HC and caesarean section for failure to 
progress in labour and for intrapartum caesarean 
section overall. 
Methods 
This was a retrospective cohort study.  The study 
factor was HC quartile and the primary outcomes 
were caesarean section for failure to progress in 
labour and intrapartum caesarean section overall.  
Data were extracted from the obstetric database 
used by Royal Prince Alfred (RPA) Hospital, a 
tertiary referral hospital in Sydney Australia with 
about 4,500 births per year. 
The database included information for all births over 
20 weeks' gestation at RPA Hospital from January 
2005 and is contemporaneously updated by the 
midwives involved in the women's care.  Women 
with a singleton, cephalic live birth at 37 or more 
completed weeks' gestation with entries for the 
following variables were included: neonatal HC, 
birthweight, place of birth, height, age, booking BMI 
(<  20 weeks' gestation), cigarette smoking during 
the current pregnancy ('yes', 'no', 'unknown'), parity 
(nulliparous, parous), gestational age at birth, 
diabetes (none, gestational diabetes treated with 
diet, gestational diabetes treated with insulin, pre-
existing diabetes), induction of labour, neonatal sex 
(indeterminate sex excluded), thick meconium 
during labour, and epidural use in labour.  Exclusion 
criteria were elective caesarean section, multiple 
gestation, malpresentation and an incomplete 
dataset.  Cases of failed induction of labour were 
classified as caesarean section for failure to 
progress, whether or not the labour established. 
To test the reliability of the database, a sample from 
our dataset was checked against the written 
medical notes including 100 births classified as a 
caesarean section for failure to progress and 100 
births not classified as a caesarean section for 
failure to progress (“other”).  These were selected 
randomly from the full dataset using a computer 
program.  The 200 medical records were mixed and 
reviewers blinded to the mode of delivery on the 
database.  One reviewer extracted data from each 
record.  Of these records, 99/100 were correctly 
classified as a caesarean section for failure to 
progress and 100/100 were correctly classified as 
“other”.  Where data was available in both the 
medical records and the database, place of birth 
was correctly classified in 190/197 (96%) database 
records.  Age was correct for 192/195 (98%), BMI 
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group for 130/137 (95%), parity for 199/199 (100%), 
previous caesarean section for 174/179 (97%), 
diabetes group for 197/199 (99%), induction of 
labour for 183/198 (92%), birthweight for 105/106 
(99%), neonatal sex for 194/194 (100%), and 
cigarette smoking for 107/109 (99%).  Birthweight 
was often recorded in the database but not the 
medical records. 
During the study period, labour was routinely 
induced at approximately 41 weeks and four days’ 
gestation. Cervical ripening was with 0.3 mg/h slow 
release intravaginal dinoprostone over 12 hours if 
Bishop’s score < 7.  Induction of labour was by 
artificial rupture of the membranes then oxytocin 
infusion commencing at 1 mU/min and adjusted 30 
minutely to a maximum of 32 mU/min. Vaginal 
examinations were performed every four hours in 
the first stage of labour, every two hours from eight 
to 10 cm dilatation, and hourly in the second stage 
of labour. The loading dose for epidural analgesia 
was 0.125% marcaine with 2μg/mL fentanyl 
followed by an infusion of 0.125% ropivacaine with 
5 ug/mL fentanyl at 6–8 mL/hour with bolus top-ups 
as required. Augmentation was considered for 
cervical dilatation of less than two centimeters in 4 
hours or poor contractions during the active phase 
of labour. Oxytocin induction or augmentation was 
not routinely used for women with a previous 
caesarean section. 
Neonatal HC was measured by a midwife at one to 
five days after birth (usually ≥ two days).  A paper 
tape measure was placed around the infant’s head 
aiming for the maximum occiptofrontal 
circumference.   
𝜒2 tests were used to compare proportions.  
Binomial logistic regression was performed for 
caesarean section overall, caesarean for failure to 
progress in labour, and for caesarean section for 
indications other than failure to progress in labour.  
Explanatory variables were selected for 
multivariable models if p < 0.25 in the univariable 
logistic regression.  The stepwise backward method 
was used, excluding variables with the highest Wald 
statistic one at a time until the remaining variables 
all had a p value < 0.01.  If a variable changed the 
point estimates for the adjusted odds ratios for HC 
quartile by > 10% then they were retained in the 
model (even if p > 0.01).  Interaction was assessed 
by creating interaction terms of HC by each of the 
other variables in the model with a cut-off of 0.005 
for inclusion of the term.  Goodness of fit was 
assessed by the Hosmer-Lemeshow test and the 
discriminatory ability of the model was measured by 
concordance, c.  All analyses were performed using 
SAS version 9.2 or 9.3. 
Ethics approval for this study was obtained from the 
Sydney Local Health District Human Ethics Review 
Committee, RPAH Zone (Protocol X09-0294). 
Results 
Nineteen thousand seven hundred and forty-three 
singleton births from January 2005 to June 2009 
were identified.  After exclusion of preterm births (< 
37 weeks’ gestation), elective caesarean sections, 
stillbirths and breech presentations, 16,226 
remained of which 11,687 contained data for all 
variables.  The most common missing variables 
were maternal BMI (n = 4,081)(25.2%) maternal 
height (n = 3,594)(22.1%), maternal weight (n = 
2,880)(17.7%), and neonatal HC (n = 559)(3.4%).  
Of the 11,687 births with complete data, there were 
8,288 normal vaginal births (70.9%), 1,720 assisted 
deliveries (14.7%) and 1,679 intrapartum caesarean 
sections (14.4%) including 961 for failure to 
progress in labour (8.2%).  Among the 4,539 
pregnancies excluded for missing data, there were 
3,144 normal vaginal births (69.3%), 740 assisted 
deliveries (16.3%) and 655 intrapartum caesarean 
sections (14.4%) including 369 for failure to 
progress in labour (8.1%).  Thus, the frequencies of 
our primary outcomes were similar for pregnancies 
with missing and non-missing data.  HC was divided 
into four quartiles. 
Table 4A.1 summarizes demographics and clinical 
characteristics by mode of birth.  The rate of 
caesarean section for failure to progress in labour 
was 4.1%, 6.4%, 8.8% and 14.3% for the first to the 
fourth quartiles respectively (𝜒2 test for trend = 186, 
1DF, p < 0.0001).  Other factors associated with 
caesarean section for failure to progress in the 
univariate analyses were maternal age, BMI, height, 
parity, completed weeks of gestation, epidural use, 
previous caesarean section, cigarette smoking, 
induction of labour, diabetes in pregnancy, 
birthweight, neonatal gender, presence of thick 
meconium in labour, and year of birth (Table 1).  
The only factor not statistically significant in the 
univariate analyses was place of maternal birth (𝜒2 
= 8.3, 4DF, p = 0.14).  All variables were associated 
with intrapartum caesarean section overall in the 
univariate analyses except for cigarette smoking (𝜒2 
= 4.8, 2DF, p = 0.09).  All variables were associated 
with caesarean section for reasons other than 
failure to progress in labour except maternal age 
(𝜒2 = 3.9, 4DF p = 0.42). 
Logistic regression on caesarean section for 
failure to progress in labour: 
Neonatal sex, gestational age, diabetes, thick 
meconium in labour, delivery year and place of birth 
were removed from the model as they were not 
confounders and not associated with caesarean  
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Table 4A.1 
Maternal and neonatal demographic and clinical characteristics 
  
 
n 
 
NVD1 
(%) 
Assisted 
deliveries 
(%) 
 
CSFTP2 
(%) 
CS-Other 
indications
3(%) 
 
Total CS4 
(%) 
p-value 
(CS-FTP 
v’s 
others) 
Total births 11,687 70.9 14.7 8.2 6.1 14.4  
HC Q1 (< 340 mm) 
      Q2 (340-346 mm) 
      Q3 (347-355 mm) 
      Q4 ( > 355 mm) 
2,736 
3,143 
3,289 
2,519 
80.3 
73.8 
67.9 
61.1 
11.0 
14.1 
16.3 
17.3 
4.1 
6.4 
8.8 
14.3 
4.6 
5.7 
7.0 
7.3 
8.7 
12.1 
15.8 
21.5 
 
 
 
<0.00015 
Maternal Age 
 <25 
  25 - 29 
  30 – 34 
  35 – 39 
  40+ 
 
976 
2,860 
4,497 
2,836 
518 
 
77.8 
71.9 
69.2 
70.9 
68.0 
 
10.1 
15.1 
15.7 
14.5 
13.3 
 
5.9 
7.1 
8.7 
8.9 
11.0 
 
6.1 
5.9 
6.4 
5.7 
7.7 
 
12.1 
13.0 
15.1 
14.6 
18.7 
 
 
 
 
 
0.00066 
BMI 
  <20 
  20 – 24 
  25 – 29 
  30 – 34 
  ≥35 
 
2,623 
6,244 
1,918 
612 
290 
 
73.2 
71.1 
68.1 
69.3 
67.9 
 
16.4 
15.1 
13.3 
10.5 
10.0 
 
5.9 
7.7 
11.3 
12.7 
11.4 
 
4.4 
6.2 
7.2 
7.5 
10.7 
 
10.3 
13.9 
18.5 
20.3 
22.1 
 
 
 
 
 
<0.00015 
Height (cm) 
  < 160 
  160 – 164 
  165 – 179 
  ≥ 180 
 
2,907 
3,102 
2,944 
2,734 
 
65.6 
69.4 
73.1 
75.9 
 
14.8 
14.8 
15.3 
14.0 
 
11.4 
9.2 
6.6 
5.6 
 
8.3 
6.5 
5.1 
4.6 
 
19.6 
15.7 
11.6 
10.2 
 
 
 
 
<0.00015 
Place of Birth 
    “Western” 
    South East Asia 
    South Asia 
    Pacific Islands 
    Other 
 
7,958 
2,336 
439 
319 
635 
 
71.3 
70.3 
58.3 
73.7 
76.2 
 
14.9 
15.2 
17.5 
10.7 
10.7 
 
7.9 
8.6 
10.5 
10.7 
7.4 
 
5.9 
5.9 
13.7 
5.0 
5.7 
 
13.8 
14.5 
24.1 
15.7 
13.1 
 
 
 
 
 
0.116 
Parity 
     Nulliparous 
     Parous 
 
6,887 
4,800 
 
57.0 
90.1 
 
22.1 
4.1 
 
12.1 
2.7 
 
8.8 
2.3 
 
20.9 
5.0 
 
 
<0.00016 
Gestation (weeks) 
    37+ 
    38+ 
    39+ 
    40+ 
    41+ 
   ≥42 
 
576 
1,528 
3,093 
3,818 
2,483 
189 
 
78.1 
75.7 
77.9 
70.6 
59.5 
51.3 
 
11.6 
13.2 
12.3 
15.9 
17.6 
14.3 
 
4.2 
5.2 
5.7 
8.0 
13.5 
21.7 
 
6.1 
5.9 
4.1 
5.4 
9.4 
12.7 
 
10.2 
11.1 
9.8 
13.4 
22.9 
34.4 
 
 
 
 
 
 
0.00065 
Epidural 
    Yes 
    No 
 
3,164 
8,523 
 
39.9 
82.4 
 
29.8 
9.1 
 
19.3 
4.1 
 
10.9 
4.4 
 
30.2 
8.5 
 
 
<0.00016 
Previous CS 
    Yes 
    No 
 
270 
11,417 
 
51.1 
71.4 
 
12.2 
14.8 
 
23.7 
7.9 
 
13.0 
6.0 
 
36.7 
13.8 
 
 
<0.00016 
Smoking 
    No 
    Yes 
    Unknown 
 
7,407 
425 
3,855 
 
69.9 
67.1 
73.3 
 
15.4 
16.5 
13.3 
 
8.7 
8.5 
7.2 
 
6.0 
8.0 
6.2 
 
14.7 
16.5 
13.5 
 
 
 
0.026 
Induction of labour 
    Yes 
    No 
 
2,947 
8,740 
 
54.9 
76.3 
 
18.4 
13.5 
 
15.7 
5.7 
 
11.1 
4.5 
 
26.7 
10.2 
 
 
<0.00016 
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section for failure to progress when adjusted for the 
other variables.  There was no interaction between 
HC quartile and any of the other variables.  Odds 
ratios and confidence intervals are reported in Table 
4A.2. 
The odds ratio (OR) for caesarean section for 
failure to progress in labour progressively increased 
from 1.33 (95% CI 1.02 – 1.73) for the second HC 
quartile to 1.93 (95% CI 1.44 – 2.57) for the fourth 
HC quartile (Table 2).  The model fit the data well 
(Hosmer-Lemeshow test p=0.38) and had good 
ability to discriminate between women who did and 
did not have a caesarean section for failure to 
progress in labour (c statistic = 0.86). 
Logistic regression on intrapartum caesarean section 
(all caesarean sections): 
Neonatal sex and delivery year were removed from 
the model as they were not confounders and not 
associated with intrapartum caesarean section.  
There was no interaction between HC quartile and 
any of the other variables.  Odds ratios and 
confidence intervals are reported in Table 4A.2. 
The OR for intrapartum caesarean section 
progressively increased from 1.52 (95% CI 1.24 – 
1.87) for the second HC quartile to 2.38 (95% CI 
1.89 – 3.00) for the fourth HC quartile (Table 4A.2).  
This model did not fit the data as well (Hosmer-
Lemeshow goodness of fit test = 0.01) but had good 
ability to discriminate between women who did and 
did not have a caesarean section for intrapartum 
caesarean section (c statistic = 0.84).  Inspection of 
the expected versus observed frequencies in the 
Hosmer-Lemeshow table showed a reasonable fit, 
suggesting that the p-value was influenced by the 
large sample size. 
Logistic regression on caesarean section for indications 
other than failure to progress: 
Diabetes group and cigarette smoking were 
removed from the model as they were not 
confounders and not associated with caesarean 
section for reasons other than failure to progress 
when adjusted for the other variables.  There was 
no interaction between HC quartile and any of the 
other variables.  Odds ratios and confidence 
intervals are reported in Table 4A.2. 
Table 4A.1 (continued) 
Maternal and neonatal demographic and clinical characteristics 
  
 
n 
 
NVD1 
(%) 
Assisted 
deliveries 
(%) 
 
CSFTP2 
(%) 
CS-Other 
indications
3(%) 
 
Total CS4 
(%) 
p-value 
(CS-FTP 
v’s 
others) 
Diabetes 
     Nil 
     GDM Diet 
     GDM Insulin 
     Pre-existing 
 
10,884 
294 
467 
42 
 
71.3 
72.1 
64.9 
35.7 
 
14.6 
13.6 
18.0 
19.0 
 
8.1 
8.5 
10.1 
26.2 
 
6.1 
5.8 
7.1 
19.0 
 
14.1 
14.3 
17.1 
45.2 
 
 
 
 
<0.00016 
Birthweight (g) 
  <2500 
  2500 - 2999 
  3000 - 3499 
  3500 – 3999 
  4000 – 4499 
  4500+ 
 
168 
1,548 
4,619 
3,847 
1,307 
198 
 
64.9 
74.5 
73.5 
68.7 
65.9 
65.2 
 
16.1 
15.0 
14.4 
15.6 
14.2 
  5.1 
 
4.2 
4.2 
5.8 
10.0 
14.5 
23.7 
 
14.9 
6.3 
6.3 
5.7 
5.4 
6.1 
 
19.0 
10.5 
12.1 
15.7 
20.0 
29.8 
 
 
 
 
 
 
<0.00016 
Neonatal sex 
    Female 
    Male 
 
5,647 
6,040 
 
73.3 
68.7 
 
13.7 
15.7 
 
7.7 
8.7 
 
5.4 
6.9 
 
13.0 
15.6 
 
 
0.036 
Thick Meconium 
    Yes 
    No 
 
887 
10,800 
 
50.6 
72.6 
 
23.2 
14.0 
 
11.5 
8.0 
 
14.7 
5.4 
 
26.2 
13.4 
 
 
<0.00016 
Year 
    2005 
    2006 
    2007 
    2008 
    2009 
 
2,173 
2,663 
2,629 
2,665 
1,557 
 
74.3 
72.9 
69.0 
69.2 
69.0 
 
13.1 
13.5 
14.2 
16.4 
15.1 
 
6.3 
7.2 
8.4 
10.2 
9.1 
 
6.3 
6.3 
5.8 
6.2 
6.0 
 
12.6 
13.6 
14.2 
16.4 
15.1 
 
 
 
 
 
<0.00016 
1) NVD = Normal vaginal delivery 
2) CSFTP = Caesarean section for failure to progress 
3) CS – other indications = Caesarean section for indications other than failure to progress  
4) Total CS = Caesarean section for any indication (ie all caesarean sections) 
5) Chi squared test for trend 
6) Chi squared test 
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Table 4A.2 
Multiple logistic regression analyses 
 
Category Adjusted OR for 
CS FTP1 (95% 
CI) 
p Adjusted OR for 
CS – Other2 
p Adjusted OR for 
Total CS3  
(95% CI) 
P 
HC (cm) 
  <34 
  34 – 34.6 
  34.7 – 35.4 
  >35.5 
 
1.0* 
1.33 (1.02 – 1.73) 
1.54 (1.18 – 2.02) 
1.93 (1.44 – 2.57) 
 
<0.0001 
 
1.0* 
1.52 (1.16 – 2.00) 
1.96 (1.49 – 2.59) 
2.05 (1.49 – 2.82) 
 
<0.0001 
 
1.0* 
1.52 (1.24 – 1.87) 
1.99 (1.62 – 2.46) 
2.38 (1.89 – 3.00) 
 
<0.0001 
Maternal Age 
 <25 
  25 - 29 
  30 – 34 
  35 – 39 
  40+ 
 
1.0* 
1.31 (0.94 – 1.81) 
1.79 (1.31 – 2.44) 
2.16 (1.56 – 2.99) 
3.05 (1.98 – 4.71) 
 
<0.0001 
 
 
1.0* 
0.98 (0.71 – 1.35) 
1.26 (0.93 – 1.70) 
1.24 (0.89 – 1.71) 
1.85 (1.19 – 2.88) 
 
0.009 
 
1.0* 
1.16 (0.90 – 1.48) 
1.65 (1.30 – 2.09) 
1.89 (1.47 – 2.44) 
2.98 (2.11 – 4.21) 
 
<0.0001 
BMI 
  <20 
  20 – 24 
  25 – 29 
  30 – 34 
  ≥35 
 
1.0* 
1.09 (0.89 – 1.34) 
1.45 (1.14 – 1.85) 
1.83 (1.31 – 2.54) 
1.54 (0.99 – 2.41) 
 
0.0002 
 
 
1.0* 
1.42 (1.13 – 1.78) 
1.57 (1.19 – 2.07) 
1.73 (1.18 – 2.54) 
2.73 (1.74 – 4.29) 
 
0.0001 
 
1.0* 
1.30 (1.10 – 1.53) 
1.73 (1.41 – 2.12) 
2.14 (1.61 – 2.84) 
2.36 (1.65 – 3.38) 
 
<0.0001 
Height (cm) 
  < 160 
  160 – 164 
  165 – 179 
  ≥ 180 
 
1.0* 
0.60 (0.50 – 0.73) 
0.38 (0.31 – 0.47) 
0.26 (0.20 – 0.33) 
 
<0.0001 
 
 
1.0* 
0.76 (0.61 – 0.93) 
0.62 (0.50 – 0.79) 
0.57 (0.44 – 0.73) 
 
<0.0001 
 
1.0* 
0.62 (0.53 – 0.73) 
0.43 (0.36 – 0.51) 
0.32 (0.26 – 0.38) 
 
<0.0001 
Place of Birth 
  ‘Western’ countries 
  South East Asia 
  South Asia 
  Pacific Islands 
  Other  
 
1.0*4 
1.21 (0.99 – 1.49) 
1.41 (0.98 – 2.04) 
1.76 (1.16 – 2.67) 
1.13 (0.80 – 1.59) 
 
0.024 
 
1.0* 
1.06 (0.85 – 1.33) 
2.04 (1.47 – 2.84) 
0.93 (0.54 – 1.59) 
1.04 (0.72 – 1.50) 
 
0.0009 
 
1.0* 
1.20 (1.02 – 1.42) 
2.06 (1.56 – 2.73) 
1.45 (1.01 – 2.07) 
1.12 (0.85 – 1.47) 
 
<0.0001 
Parity 
    Nulliparous 
    Parous 
 
1.0* 
0.11 (0.09 – 0.15) 
 
<0.0001 
 
1.0* 
0.23 (0.18 – 0.30) 
 
<0.0001 
 
1.0* 
0.13 (0.11 – 0.16) 
 
<0.0001 
Gestation 
  37+ 
  38+ 
  39+ 
  40+ 
  41+ 
  ≥42 
 
 
 
NS 
 
1.0* 
1.06 (0.69 – 1.62) 
0.77 (0.51 – 1.17) 
0.93 (0.62 – 1.41) 
1.27 (0.83 – 1.93) 
1.56 (0.85 – 2.85) 
 
0.001 
 
1.0* 
0.94  (0.66 – 1.35) 
0.85 (0.61 – 1.19) 
1.00 (0.71 – 1.40) 
1.22 (0.87 – 1.72) 
1.75 (1.08 – 2.84) 
 
0.0004 
Epidural 
    No 
    Yes 
 
1.0* 
4.78 (3.98 – 5.74) 
 
<0.0001 
 
1.0* 
2.02 (1.67 – 2.44) 
 
<0.0001 
 
1.0* 
3.90 (3.38 – 4.50) 
 
<0.0001 
Previous CS 
    Yes 
    No  
 
1.0* 
0.04 (0.02 – 0.06) 
 
<0.0001 
 
1.0* 
0.10  (0.07 – 0.16) 
 
<0.0001 
 
1.0* 
0.04 (0.03 – 0.06) 
 
<0.0001 
Smoking 
    No 
    Yes 
    Unknown 
 
1.0* 
1.04 (0.70 – 1.54) 
1.85 (1.52 – 2.25) 
 
<0.0001 
  
NS 
 
1.0* 
1.22 (0.89 – 1.66) 
1.89 (1.63 – 2.20) 
 
<0.0001 
Induction of labour 
    Yes 
    No 
 
 
 
1.0* 
2.00 (1.71 – 2.33) 
 
<0.0001 
 
1.0* 
1.87 (1.57 – 2.22) 
 
<0.0001 
 
1.0* 
2.14 (1.88 – 2.45) 
 
<0.0001 
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In this model, the OR for caesarean section for 
reasons other than failure to progress successively 
increased from 1.52 (95% CI 1.16 – 2.00) for the 
second HC quartile to 2.05 (95% CI 1.49 – 2.82) for 
the fourth HC quartile (Table 2).  The model did not 
fit the data as well (Hosmer-Lemeshow test p=0.03) 
but had a reasonable ability to discriminate between 
women who did and did not have a caesarean 
section for indications other than failure to progress 
in labour (c statistic = 0.79).  Inspection of the 
expected versus observed frequencies in the 
Hosmer-Lemeshow table showed a reasonable fit, 
suggesting that the p-value was influenced by the 
large sample size. 
Discussion: 
Our main finding was a progressive increase in the 
adjusted odds of caesarean section for failure to 
progress in labour with successive neonatal HC 
quartiles.  The unadjusted risk of caesarean section 
for failure to progress increased from 4.1% in the 
lowest to 14.3% in the highest quartile.  
Surprisingly, there was a similar adjusted odds of 
caesarean section for other indications with 
successive neonatal HC quartiles.  This latter 
association is difficult to explain although others 
have reported an association between increasing 
neonatal HC and ‘fetal distress’ in labour568. 
These findings are important because attempts to 
predict intrapartum caesarean section have been 
largely unsuccessful.  They imply that antenatal 
ultrasound measurements of neonatal HC could be 
incorporated into predictive models.  Identification of 
risk factors for intrapartum caesarean section could 
lead to improved antenatal counseling or to 
interventions to reduce the chance of operative 
delivery.  One promising intervention is induction of 
labour510. 
Several large cohort studies have reported an 
association between post-partum neonatal HC and 
caesarean section without specifically addressing 
caesarean section for failure to progress in 
labour266,568-570.  Only one of these adjusted for 
maternal age, height, BMI and birthweight, all of 
which have a known association with emergency 
caesarean section568.  We have added to these 
studies by performing separate analyses by 
indication for caesarean section and adjusting for a 
range of potential confounders. 
Table 4A.2 continued 
Multiple logistic regression analyses  
 
Category Adjusted OR for CS 
FTP1 (95% CI) 
p Adjusted OR for CS 
– Other2 
p Adjusted OR for 
Total CS3  
(95% CI) 
p 
Diabetes 
   Nil 
   GDM diet 
   GDM insulin 
   Preexisting diabetes 
 
 
 
NS 
 
 
 
 
NS 
 
1.0* 
0.89 (0.61 – 1.31) 
0.74 (0.56 – 1.00) 
3.32 (1.57 – 7.02) 
 
0.002 
Birthweight (g) 
  <2500 
  2500 - 2999 
  3000 - 3499 
  3500 – 3999 
  4000 – 4499 
  4500+ 
 
0.95 (0.41 – 2.18) 
1.0* 
1.36 (1.00 – 1.84) 
2.44 (1.77 – 3.37) 
4.41 (3.05 – 6.37) 
10.4 (6.07 – 17.8) 
 
<0.0001 
 
2.54 (1.52 – 4.26) 
1.0* 
0.84 (0.64 – 1.09) 
0.61 (0.45 – 0.83) 
0.51 (0.35 – 0.76) 
0.53 (0.26 – 1.05) 
 
<0.0001 
 
2.06 (1.28 – 3.31) 
1.0* 
1.02 (0.82 – 1.26) 
1.23 (0.96 – 1.56) 
1.75 (1.31 – 2.34) 
3.59 (2.24 – 5.75) 
 
<0.0001 
Thick meconium 
    No 
    Yes 
 
 
 
NS 
 
 
1.0* 
2.68 (2.12 – 3.39) 
 
<0.0001 
 
1.0* 
1.55 (1.28 – 1.88) 
 
<0.0001 
Neonatal sex 
   Female 
   Male 
 
 
 
NS 
 
1.0* 
1.25 (1.06 – 1.47) 
 
0.009 
 
 
 
NS 
Year 
    2005 
    2006 
    2007 
    2008 
    2009 
 
1.0*4 
0.83 (0.63 – 1.10) 
0.82 (0.60 – 1.14) 
1.09 (0.79 – 1.50) 
1.00 (0.70 – 1.44) 
 
0.044 
 
1.0* 
0.73 (0.57 – 0.94) 
0.47 (0.36 – 0.63) 
0.49 (0.37 – 0.65) 
0.49 (0.36 – 0.67) 
 
<0.0001 
 
1.0*4 
0.85 (0.68 – 1.05) 
0.71 (0.55 – 0.91) 
0.88 (0.68 – 1.15) 
0.84 (0.63 – 1.13) 
 
0.034 
1) CSFTP = Caesarean section for failure to progress 
2) CS – Other = Caesarean section for indications other than failure to progress 
3) Total CS = Caesarean section for any indication (ie all intrapartum caesarean sections) 
4) Variable not in final model but data are presented for variables with p < 0.05 before exclusion from the model 
* Referent group 
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Several other findings are noteworthy.  The 
association between maternal age and caesarean 
section was primarily due to failure to progress in 
labour.   It has been postulated that age related 
uterine factors such as fewer oxytocin receptors 
and myometrial gap junctions mediate the 
association between maternal age and caesarean 
section147.  However, the studies that have data on 
competing indications for emergency caesarean 
section provide conflicting evidence regarding the 
extent to which intrapartum dystocia mediates this 
association143,147,560,571. 
Body mass index at booking was associated with 
emergency caesarean section for both failure to 
progress in labour and for other indications.  The 
association between BMI and intrapartum 
caesarean section is well established204,448,572 
although the mechanisms are not well understood.  
Our finding of a dual association suggests that two 
mechanisms may be responsible.  Obesity does not 
appear to directly affect uterine expulsive forces573.  
Other possible mechanisms include an effect on the 
shape of the soft tissues associated with the pelvic 
inlet and an effect on placentation.  We also 
confirmed the inverse association between maternal 
height and caesarean section143,574-576 and found 
that this was primarily due to caesarean section for 
failure to progress. 
The association between induction of labour and 
caesarean section is consistent with other large 
cohorts572,577,578.  Induction of labour was more 
strongly associated with caesarean section for 
failure to progress in labour than for other 
indications.  The discrepancy between these 
studies and randomized trials which suggest 
induction of labour actually reduces caesarean 
section510 is potentially explained by confounding or 
selection bias.  The latter could occur if women who 
are induced are compared with women in 
spontaneous labour rather than all women who did 
not have a planned induction at the same gestation.  
The association between epidural use and 
caesarean section is also consistent with data from 
other cohorts143,447,560 and not supported by the 
findings from randomized trials579. 
South Asian women (born in India, Pakistan, 
Bangladesh or Sri Lanka) were more likely to have 
a caesarean section for suspected fetal 
compromise and women from the Pacific Islands 
were more likely to have a caesarean section for 
failure to progress.  Women with a previous 
caesarean section were more likely to have a 
caesarean section both for failure to progress and 
for suspected fetal compromise.  Birthweight had 
opposing influences on caesarean section for each 
indication resulting in the previously described "U" 
shaped association with caesarean section overall 
with higher rates for both low and high birthweight 
infants448,576, presumably due to higher risk of 
emergency caesarean section in the lower 
birthweight groups due to underlying placental 
insufficiency and higher rates in the higher 
birthweight groups due to CPD.  Our observation 
that gestational age was not an independent 
predictor of caesarean section for failure to 
progress in labour suggests that the strong 
association in the univariate analysis was mediated 
by birthweight and HC.  For births at 40 or more 
weeks’ gestation, there was an association between 
gestational age and caesarean section for other 
indications implying that caesarean section for fetal 
distress is more common as gestation advances 
beyond this point. 
Limitations 
Limitations include the potential for entry errors 
associated with large databases.  However, we 
checked the accuracy of the database in a random 
sample of mother-infant pairs and found a 
reasonable level accuracy for all variables.   Head 
circumference measurements were performed by 
different clinicians and measurement errors would 
have resulted in some infants being assigned to the 
incorrect HC quartile.  This would result in a non-
differential misclassification of HC quartile and bias 
our results towards the null.  That is, the true 
association between HC and caesarean section for 
suspected CPD is likely to have been 
underestimated in our study.  Finally, we have 
reported on a post-partum measure which cannot 
be used as part of an antenatal predictive model.  
Our findings should be confirmed in a population 
based cohort of women with late antenatal 
ultrasound HC measurements. 
Strengths 
The strengths of this study include the accurate 
classification of the indication for caesarean 
sections allowing inferences about the mechanisms 
of association between risk factors and mode of 
delivery to be made.  Due to our large sample size 
and range of variables, we could account for a 
range of potential confounders.  Using post-partum 
measurements of HC allowed analysis of a large 
population-based cohort of mother-infant pairs 
(most births at RPA Hospital are within a defined 
‘catchment area’) suggesting our findings are 
generalisable.  A similar cohort using ultrasound 
determined HC would have modified the observed 
association between HC and caesarean section if 
growth restricted fetuses were overrepresented.  As 
neonatal HC was measured on post-partum day 
two, it was unlikely to be influenced by moulding of 
the fetal skull during childbirth. 
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Future research 
If fetal HC is to be used as part of a model for 
predicting mode of birth, then the association 
between ultrasound determined fetal biometry and 
mode of birth should be assessed.  It has been 
suggested that the ability to predict a high risk of 
caesarean section could lead clinicians to offer 
elective caesarean section445,446.  However, a more 
productive approach might be to offer induction of 
labour before the estimated date of confinement510.  
If women at high risk of intrapartum caesarean 
section can be identified, then there is potential to 
perform a randomised trial of induction of labour in 
this group for reducing intrapartum caesarean 
section. 
Conclusions 
We conclude that there is a strong and independent 
relationship between neonatal HC and caesarean 
section for failure to progress in labour.  There is 
potential for HC to be incorporated into predictive 
models for intrapartum caesarean section.  
Identification of women at high risk of emergency 
caesarean section could lead to the opportunity to 
offer methods of reducing this intervention. 
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Part B: Cervical length 
Does cervical length predict intrapartum 
caesarean section?
Introduction 
There is a global trend of increasing caesarean 
section rates, with close to a third of all term 
pregnancies delivered in this manner580. An 
unplanned emergency Caesarean section is 
associated with significant maternal and neonatal 
morbidity581,582.  One of the most common 
indications for unplanned emergency caesarean 
sections is failure to progress in labour110. There is 
evidence that functionality of the utero-cervical unit 
during labour is pre-programmed very early in the 
pregnancy583. In pregnancies approaching term, this 
machinery is activated, preparing the utero-cervical 
unit for labour. There have been many attempts to 
quantify the risk of emergency caesarean section in 
a general obstetric population using logistic 
regression models296,446-448,560,564-566.  A model 
would need to have a high positive predictive value 
if it was to be used to select women at high enough 
risk to be offered elective caesarean section445 or 
an intervention such as induction of labour to 
improve the chances of a vaginal birth510. 
Most predictive models include certain maternal 
characteristics such as maternal BMI or height and 
some fetal characteristics such as birthweight to 
predict risk of caesarean section. Another 
omnipresent variable in these models is some 
description of the state of the utero-cervical unit in 
terms of “readiness” for labour. The Bishop score335 
for cervical status is still useful in this regard, but 
other ultrasound-based methods for assessment of 
cervical length have been found to be as predictive 
as and less inconvenient to the parturient than, the 
Bishop score584. As a screening test, ultrasound 
assessment of the cervix would therefore find 
greater acceptance among women. 
Barring a handful of workers447,585, modelling to 
predict risk of caesarean section has been based 
on studies conducted in women in whom labour 
was to be induced straightaway.  In this setting, 
while a longitudinal assessment of cervical 
“readiness” over the last few weeks of the 
pregnancy would be ideal, this would be impractical. 
The next best alternative, from a screening 
perspective, would be to assess the state of the 
cervix at 37 weeks gestation, and model 
accordingly.  
In this study, we set out to determine whether 
cervical length at 37 weeks’ gestation is associated 
with intrapartum caesarean section after adjusting 
for maternal and fetal characteristics. 
Materials and methods 
This was a prospective cohort study.  The study 
factor was cervical length and the primary outcome 
was intrapartum caesarean section.  Participants 
were pregnant women who planned a vaginal birth 
at Royal Prince Alfred Hospital (RPAH), a tertiary 
referral hospital in Sydney Australia with about 
5,000 births per year.  Written informed consent 
was obtained study from all participants.  The study 
was approved by the ethics committee of the RPAH 
(protocol number X10-0219), and funded by the 
Australasian Diabetes in Pregnancy Society 
(ADIPS). The study is reported according to 
guidance provided by the STROBE statement 
guidelines for reporting observational studies586. 
Entry criteria included singleton gestations at ≥ 37 
weeks zero days and ≤ 38 weeks zero days; 
cephalic presentation; planned vaginal birth; 
attendance at a low risk midwives' clinic or the 
gestational diabetes mellitus (GDM) clinic; and no 
indication for induction of labour at the time of 
recruitment other than GDM.  Exclusion criteria 
were: type I or II diabetes; hypertensive disease in 
pregnancy (systolic blood pressure ≥ 140 mm Hg or 
Diastolic blood pressure ≥ 90 mm Hg on at least 
two occasions at least six hours apart prior to 
recruitment); suspected fetal compromise 
(ultrasound measured abdominal circumference < 
5th centile, abnormal fetal doppler studies, 
oligohydramnios, or a non-reactive antenatal CTG 
prior to recruitment); previous caesarean section or 
other uterine surgery; and any indication for elective 
caesarean section. 
Women were recruited from the antenatal diabetes 
clinic by a consultant obstetrician and from the low 
risk midwives' antenatal clinics by the midwife 
caring for the woman. Recruitment occurred from 
2011 to 2013. 
The following data were collected at 37 weeks' 
gestation: maternal ethnicity, age, level of 
education, pre-pregnancy BMI, current BMI, height, 
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parity, GDM (diagnosed by glucose tolerance test 
with 75g load: fasting blood glucose level ≥ 5.5 mM, 
one hour level ≥ 10 mM, or two-hour level ≥ 8 mM), 
requirement for insulin; and ultrasound based fetal 
biometry, well-being parameters and cervical 
length.  The following data were collected 
retrospectively from the medical records: mode of 
birth, gestational hypertension (systolic blood 
pressure ≥ 140 mmHg or diastolic blood pressure ≥ 
90 mmHg on at least two occasions ≥ 6 hours 
apart), indication for operative delivery, birth weight, 
neonatal sex, induction of labour, and gestation at 
delivery. 
Abdominal and transvaginal ultrasounds were all 
performed at ≥ 37 weeks plus zero days and ≤ 38 
weeks plus zero days gestation.  Fetal biometry 
(biparietal diameter587, head circumference587, 
abdominal circumference587, femur length587, 
amniotic fluid index (AFI)588, umbilical artery and 
MCA Doppler waveforms338) were measured using 
standard techniques. Estimated fetal weight was 
calculated using the Hadlock IV formula589. Three 
measurements of the cervical length were taken437 
and the mean measurement used in the analysis. 
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During the study period, labor was routinely induced 
at approximately 41 weeks and four days’ gestation 
for uncomplicated pregnancies; at ≥ 39 weeks plus 
zero days and ≤ 40 weeks' gestation for gestational 
diabetes requiring insulin; and ≥ 40 weeks zero 
days and ≤ 41 weeks for gestational diabetes which 
was well controlled on diet. Cervical ripening was 
with 0.3 mg/h slow release intravaginal 
dinoprostone over 12 hours for a Bishop’s score < 
7.  Induction of labor was by artificial rupture of the 
membranes then oxytocin infusion commencing at 
one mU/min and adjusted 30 minutely to a 
maximum of 32 mU/min. Vaginal examinations were 
performed every four hours in the first stage of 
labor, every two hours from eight to ten cm 
dilatation, and hourly in the second stage of labor. 
The loading dose for epidural analgesia was 
0.125% marcaine with 2μg/mL fentanyl followed by 
an infusion of 0.125% ropivacaine with 5 ug/mL 
fentanyl at 6–8 mL/hour with bolus top-ups as 
required. Augmentation was considered for cervical 
dilatation of less than two cm in four hours or poor 
contractions during the active phase of labor.  
Continuous intrapartum electronic fetal monitoring 
was used for all women with insulin requiring 
gestational diabetes. Caesarean section was 
performed for failed induction, failure to progress in 
labour, or for non-reassuring fetal heart rate pattern 
and/or abnormal fetal scalp lactate in labour. 
 Normally distributed data were reported as means 
± standard deviations and non-normally distributed 
data were reported as medians and interquartile 
ranges.  T-tests were used to compare the means 
of two groups of normally distributed data when the 
variances were similar.  The Wilcoxon rank sum test 
was used to compare the distributions of two groups 
of non-normally distributed data.  χ2 tests were used 
to compare proportions.  Due to the small number 
of primary outcome events, multivariable models 
were fitted using semi-Bayes logistic regression and 
the Markov-chain Monte Carlo procedure as 
described by Sullivan et al590 using 100,000 
iterations.  Explanatory variables were tested for 
linear association with the logit function of the 
outcome by grouping into quartiles and plotting the 
β-coefficients against the mid-points of each group.  
Non-linearly associated variables were 
dichotomized or in the case of cervical length 
partitioned into three groups: the lowest quartile, the 
middle two quartiles, and the highest quartile on the 
basis of a similar rate of intrapartum caesarean 
section within the middle two quartiles.   For the 
semi-Bayes regression, normal priors (β) were 
constructed such that the corresponding odds ratios 
(eβ) were between l and 8 with 95% confidence for 
age, gestational diabetes, male baby, height > 164 
cm, birthweight ≥ median birthweight and BMI > 25, 
and between 4 and 15 with 95% confidence for 
nulliparity.  No priors were specified for induction of 
labour or cervical length.  Explanatory variables 
were selected for multivariable models on the basis 
of a p < 0.25 in the univariable logistic regressions.  
GDM and BMI were included in the base models on 
the basis of clinical suspicion of an association with 
caesarean section.  A sample size calculation was 
not performed because there was insufficient data 
available in the medical literature on which to base 
a calculation.  All analyses were performed using 
SAS version 9.4. 
Results: 
Figure 4B.1 summarises the number of women 
screened for eligibility.  362 consecutive patients 
attending the gestational diabetes clinic were 
screened between November 2010 and August 
2013, of whom 275 were eligible and 110 
participated. Six hundred women from the 
Midwives’ clinic were screened for eligibility of 
whom 557 were eligible and 102 participated. 
Among low risk women, 43/102 (42%) were induced 
and there were no elective caesarean sections 
(Table 4B.1).  There were 26 (25%) instrumental 
deliveries and 12 (12%) caesarean sections in 
labour.  Among women with GDM, 65/110 (59%) 
were induced and 2/110 (2%) had an elective 
caesarean section (Table 4B.1).  There were 25 
(23%) instrumental deliveries and 20 caesarean 
sections in labour (18%).  Among the 30 caesarean 
sections in labour, 14 (47%) were for failure to 
progress, 15 (50%) were for fetal distress, and 1 
(3%) was for an active genital herpes simplex virus 
infection. 
Table 4B.1 
Onset of labour by parity and gestational diabetes (GDM) 
 Induction of labour (%) Spontaneous onset of 
labour (%) 
Elective caesarean 
section (%) 
Low risk pregnancy 
   Nulliparous 
   Parous 
 
38 (48) 
5 (22) 
 
41 (52) 
18 (78) 
 
0 (0) 
0 (0) 
GDM 
   Nulliparous 
   Parous 
 
49 (62) 
16 (52) 
 
28 (35) 
15 (48) 
 
2 (3) 
0 (0) 
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Table 4B.2 shows the results of the univariable 
analysis.  The mean cervical length was 25.4mm 
(95% CI 24.0 - 26.7) for women who had a vaginal 
birth and 30.4mm (95% CI 27.8 - 33.0) for women 
who had a caesarean section, a difference which 
was statistically significant (t211 = 2.96, p = 0.003).  
Women who had a caesarean section were also 
older, shorter, more likely to have a male baby or a 
baby with a higher birthweight and had a higher 
amniotic fluid index than women who had a vaginal 
birth.  In the subgroup of 14 women who had a 
caesarean section for failed induction or failure to 
progress in labour, the mean cervical length was 
33.2mm (95% CI 29.3 – 37.1). 
 In the final model, cervical length, parity, maternal 
height, gestation at delivery, pre-pregnancy BMI 
and birthweight were independently associated with 
caesarean section in both the semi-Bayes and the 
MCMC analyses (Table 4B.3). 
Discussion: 
Our main finding was that ultrasound measured 
cervical length at 37 weeks’ gestation was 
associated with subsequent caesarean section 
among women planning vaginal birth after adjusting 
for maternal age, height, pre-pregnancy BMI, parity, 
neonatal sex and birthweight.  A cervical length of 
20 to 32 mm was associated with an odds ratio of 
4.8, and a cervical length of more than 32 mm was 
TABLE 4B.2 
Background, clinical and 37 week ultrasound characteristics of woman-infant pairs with planned vaginal 
birth who had vaginal birth or emergency caesarean section 
 Vaginal birth (n=180) Caesarean section (n=32) p 
Cervical length 25.4 (24.0-26.7)1 30.4 (27.8-33.0)1 0.0032 
Age 31.5 (29, 31.5)3 35 (30, 37)3 0.024 
Parity 
   Nulliparous 
   Parous 
  
31/158 (20%) 
1/54 (2%) 
 
0.0025 
Ethnicity  
   Caucasian 
   Asian 
   Other 
 
 
 
16/115(14%) 
10/60 (17%) 
6/37 (16%) 
 
0.87 5 
Height (cm) 164 (163-165)1 161 (159-164)1 0.042 
Prepregnancy BMI 22.9 (20.8, 25.7)3 24.2 (21.9 , 27.3)3 0.634 
Education6 
   Tertiary education 
   No tertiary education 
  
18% (28/159) 
8% (4/50) 
 
0.105 
Gestation at delivery 39+3 (38+3, 40+1)3 39+6 (39+3, 40+4)3 0.024 
Gestational HT 
   No 
   Yes 
  
30/201 (15%) 
2/11 (18%) 
 
0.677 
Gestational diabetes 
   No 
   Yes 
  
12/102 (11%) 
20/110 (18%) 
 
0.195 
Induction of labour 
   Yes 
   No 
  
18/107 (17%) 
12/102(12%) 
 
0.315,8 
Birthweight (g) 3325 (3060, 3163)3 3620 (3373, 3834)3 0.0084 
Neonatal sex 
   Female 
   Male 
  
7/106 (7%) 
25/106 (24%) 
 
0.00065 
Ultrasound parameters 
   EFW (g) 
   AC (mm) 
   HC (mm) 
   BPD (mm) 
   AFI (cm) 
 
3169 (2969, 3375)3 
337 (326, 344)3 
326 (325-328)1 
91.5 (91.0 - 92.0)1 
12.0 (10.0, 13.7)3 
 
3250 (3092, 3487)3 
341 (331, 345)3 
328 (324 - 332)1 
92.3 (91.0 - 93.6)1 
13.1 (11.0, 16.2)3 
 
0.204 
0.144 
0.322 
0.222 
0.0134 
1) Mean (95% confidence interval) 
2) Student's t test 
3) Median (interquartile range) 
4) Wilcoxon rank sum test 
5) Chi squared test 
6) Data on education missing for 3 women 
7) Fisher's exact test 
8) 2 women excluded who had elective caesarean section - one for oblique lie and one for persistently high presenting part 
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associated with an odds ratio of 9.1 for caesarean 
section compared with women in the lowest quartile 
of cervical length.  Gestational diabetes treated in a 
multidisciplinary clinic was not independently 
associated with intrapartum caesarean section. 
Our results agree with several other studies.  The 
first, a UK study, showed a positive association 
between cervical length on transvaginal ultrasound 
at 37 weeks’ gestation among 1,571 women of 
mixed parity and subsequent caesarean section, 
but did not adjust for potential confounders445.  The 
second, an Australian study, showed a positive 
association between cervical length on translabial 
ultrasound among 202 nulliparous women at 36 to 
40 weeks’ gestation and subsequent caesarean 
section, but did not adjust for fetal factors or 
maternal height446.  A third cohort study in Korea 
among 453 nulliparous women showed no 
association at all between cervical length on 
transvaginal ultrasound at 37 weeks’ gestation and 
subsequent caesarean section447.  The reason for 
the apparent discrepancy between the latter study 
and the other three (including our own) is not easily 
explained.  It is conceivable that differences in 
maternal characteristics or management practices 
modified the association between cervical length 
and route of delivery. 
The association between cervical length and 
caesarean section is physiologically plausible and 
could be mediated by a disproportion between the 
fetal presenting part and the maternal bony or soft 
tissue pelvis resulting in less downward pressure on 
the cervix and less release of endogenous 
prostaglandins and subsequent cervical change.  
Alternatively, a firmer, longer cervix could offer 
greater resistance against uterine expulsive forces 
during parturition or represent dysfunctional 
development of the uterus much earlier in the 
course of pregnancy, a possibility supported by the 
finding that the association between cervical length 
and caesarean section is already present in the 
second trimester448. 
TABLE 4B.3 
Multivariable analyses of factors predictive of emergency caesarean at 37 weeks’ gestation among 
women planning a vaginal birth 
 Number of 
caesarean 
sections / total (%) 
Data augmentation with a 
rescaled prior: posterior 
medians (95% Profile-Likelihood 
Confidence intervals)1 
MCMC: 
posterior medians 
(2.5th, 97.5th centiles)1 
Cervical length (mm) 
   0-20 
   >20 - 32 
   >32 
 
2/55 (4) 
17/101 (17) 
13/56 (27) 
 
1.0* 
6.0 (1.2, 31) 
8.6 (1.6, 48) 
 
1.0* 
7.4 (1.6, 58) 
11 (2.2, 92) 
Age (years) 
   < 35 
   ≥ 35 
 
15/150 (10) 
17/62 (27) 
 
1.0* 
4.1 (1.9, 9.1) 
 
1.0* 
3.9 (1.9, 8.0) 
Parity 
   Nulliparous 
   Parous 
 
31/158 (20) 
1/54 (2) 
 
1.0* 
13 (4.5, 37) 
 
1.0* 
9.4 (5.1, 18) 
Neonatal sex 
   Female 
   Male 
 
7/106 (7) 
25/106 (24) 
 
1.0* 
3.3 (1.4, 7.4) 
 
1.0* 
3.3 (1.6, 7.0) 
Height (cm) 
   > 164 
  ≤ 164 
 
21/106 (20) 
11/106 (10) 
 
1.0* 
3.8 (1.7, 8.6) 
 
1.0* 
3.5 (1.7, 7.3) 
Pre-pregnancy BMI 
   < 25 
   ≥ 25 
 
30/186 (16) 
2/26 (8) 
 
1.0* 
1.8 (0.82, 4.0) 
 
1.0* 
2.1 (1.01, 4.2) 
Gestational diabetes 
   No 
   Yes 
  
1.0* 
1.8 (0.79, 4.0) 
 
1.0* 
1.4 (0.52, 3.8) 
Induction of labour 
   No 
   Yes 
  
1.0* 
0.73 (0.28, 1.9) 
 
1.0* 
0.79 (0.30, 2.1) 
Birthweight (g) 
   ≥ 3643 
   < 3643 
 
24/106 (23) 
8/106 (8) 
 
1.0* 
4.9 (2.2, 11) 
 
1.0* 
4.4 (2.1, 9.2) 
1) Using the technique and SAS code described by Sullivan et al (2013)590.  Outcomes are expressed as odds ratios 
* Referent group 
BMI = body mass index; MCMC = Monte Carlo Markov Chain analysis 
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This study has limitations.  The sample size was 
small which resulted in relatively wide confidence 
intervals for our point estimates of odds ratios and 
limited the number of explanatory variables in our 
models.  Another limitation is the use of birthweight 
as a covariate which cannot be used as part of an 
antenatal predictive model as it is unknown 
antenatally.  However, as the primary aim of the 
study was to assess the impact of a single variable 
on intrapartum caesarean section we elected to 
adjust for birthweight which is a more accurate 
indicator of fetal size than ultrasound determined 
biometry. 
The study also has some strengths.  Its prospective 
nature reduced the risk of selection bias.  All 
women were followed up for the primary outcome, 
eliminating the risk of attrition bias.  By using semi-
Bayesian and MCMC techniques we were able to 
adjust for a larger range of maternal and fetal 
variables known to impact on the risk of intrapartum 
caesarean section than would have been possible 
using traditional logistic regression.  Our 
observation in the multivariable analysis that 
increasing maternal age, pre-pregnancy BMI, 
height, male fetus and increasing birthweight are 
associated with subsequent caesarean section is 
consistent with previous studies and provides 
ancillary evidence that our analyses accurately 
identified independently associated explanatory 
variables. 
Conclusions: 
Increasing cervical length at 37 weeks’ gestation is 
associated with intrapartum caesarean section after 
adjusting for maternal and fetal variables known to 
be associated with this outcome.  There is potential 
to incorporate cervical length into antenatal models 
designed to predict intrapartum caesarean section 
which will improve antenatal counselling and 
ultimately lead to identification of women who may 
benefit from interventions designed to reduce the 
probability of intrapartum caesarean section. 
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Part C: Fetal biometry 
Does fetal biometry predict caesarean section 
in labour? 
Introduction  
The rate of caesarean section is increasing globally, 
and in Australia reached 33% in 201325, which is 
more than twice the rate proposed by the World 
Health Organisation in 198580. The underlying 
cause of this increase is not fully understood, but 
changes in the prevalence of obesity, advanced 
maternal age, gestational diabetes, and obstetric 
management of conditions such as twins, breech 
presentation and mid-cavity arrest appear to play a 
role591. Caesarean section is associated with 
increased surgical risks and recovery time and has 
implications for future pregnancies such as the 
mode of future births and abnormal placentation591. 
It also has a significant impact upon the healthcare 
budget, with each caesarean being estimated to 
cost $2,850 US dollars more than a vaginal 
delivery592. 
Potential strategies to prevent caesarean section 
include increasing uptake of external cephalic 
version for breech presentation, trial of labour after 
a previous caesarean section, and elective 
induction of labour. However, while elective 
induction of labour has been shown to reduce the 
risk of caesarean section511, it is unclear which 
women will benefit from this intervention most. 
In a population based cohort, we previously found a 
strong independent relationship between both 
birthweight and neonatal head circumference and 
caesarean section for failure to progress in labour 
(CS-FTP)(see Chapter 4, Part A), suggesting that 
antenatal ultrasound determination of estimated 
fetal weight (EFW) and head circumference (HC) 
predict intrapartum caesarean section.  However, 
there is little evidence to prove such an association. 
As both small and large fetuses may be at 
increased risk of intrapartum caesarean section – 
for ‘fetal distress’ or failure to progress respectively, 
analysing these two outcomes separately may 
result in better predictive models. 
The primary aim of this study was to identify if 
ultrasound biometry measurements are associated 
with intrapartum caesarean for failure to progress, 
and secondary aims were to identify ultrasound 
factors associated with caesarean section for other 
indications and caesarean section overall. 
Methods 
This was a retrospective cohort study.  The study 
factors were ultrasound measured fetal HC, 
abdominal circumference (AC), biparietal diameter 
(BPD), femur length (FL) and EFW.  The primary 
outcome measure was CS-FTP. This was defined 
by failure of the cervix to dilate 0.5cm/hr despite 
intravenous syntocinon infusion and included cases 
of failed induction of labour, whether or not the 
labour established. Secondary outcomes were 
emergency caesarean section for any indication 
(CS-overall) and emergency caesarean section for 
indications other than FTP (CS-other), usually due 
to concern for fetal well-being. Where there was 
both failure to progress and fetal distress, the case 
was documented as CS-FTP as there was still an 
element of obstructed labour. Labour was induced 
by administering 0.3mg/h slow release intravaginal 
dinoprostone over 12 hours if a woman’s Bishop 
score was less than 7, insertion of a cervical 
ripening balloon for 12 hours if the cervix was 
subsequently closed, an artificial rupture of 
membranes and then commencement of an 
intravenous syntocinon infusion. This was 
commenced at 1mU/min and adjusted every 30 
minutes to a maxium of 32 mU/min. Vaginal 
examinations were performed 4 hourly in the first 
stage of labour and hourly in the second stage. 
Failure to establish in labour was defined by 12 
hours of intravenous syntocinon infusion without 
dilatation of the cervix. The population was all 
women who had an obstetric ultrasound from 36 
weeks 0 days to 38 weeks 6 days’ gestation at 
Royal Prince Alfred Hospital (RPAH).  Data from a 
population based cohort of consecutive births at 
RPAH, a tertiary referral hospital in Sydney 
Australia from January 2005 to June 2009 were 
linked with the institutional ultrasound database 
(see Chapter 2). 
The obstetric database included information for all 
births over 20 weeks' gestation and is 
contemporaneously updated by the midwives 
involved in the women's care.  The following known 
or potential confounding factors were extracted and 
considered for inclusion in the multivariate models: 
maternal age, booking BMI (<20 weeks' gestation), 
height, place of birth, parity, previous caesarean, 
cigarette smoking during the current pregnancy 
('yes', 'no', 'unknown'), diabetes (none, diet 
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controlled, insulin treated, or pre-existing).  The 
following factors were excluded because they are 
not available antenatally and therefore cannot be 
part of an antenatal predictive model: induction of 
labour, epidural in labour, and thick meconium 
liquor. 
We verified the accuracy of the obstetric database 
by comparing it with a random selection of the 
written medical records as described in Chapter 2.  
Clinical and demographic parameters (maternal 
age, BMI, parity, previous caesarean section, 
diabetes group, cigarette smoking and neonatal 
sex) were correct in 95% to 100% of entries except 
for induction of labour which was correct in 92%.  
CS-FTP was correctly classified in 99% of records 
(99/100) and CS-other in 100% (100/100). 
The obstetric ultrasound database which contains 
data for all pregnancy ultrasounds performed at 
RPAH was interrogated and data were extracted for 
all ultrasounds from 36 weeks 0 days’ to 38 weeks 
6 days’ gestation.  These data were linked to the 
obstetric database which contained data for 16,226 
consecutive live singleton births from January 2005 
to June 2009 after exclusion of elective caesarean 
sections, multiple pregnancies, breech 
presentations and preterm births (<37 weeks).   If 
more than one growth ultrasound was performed, 
the measurements closest to 38 weeks 0 days’ 
gestation were used.  All ultrasound measurements 
were extrapolated to 38 weeks 0 days’ gestation to 
allow for direct comparison between patients, using 
Campbell’s formulas for HC, BPD, FL and AC593, 
and the Hadlock IV formula for EFW589. Centiles 
and quartiles were determined by dividing the 
dataset into centiles and quartiles respectively, not 
standard values.   Uterine artery pulsatility index 
(UAPI), amniotic fluid index (AFI) and placental 
location were considered for inclusion in the 
multivariable models. 
Data was analysed using SAS version 9.4.  A p-
value of <0.05 was considered statistically 
significant. χ2 tests were used to compare 
proportions, T-tests were used to compare means 
for parametric data and Wilcoxon Rank Sum Tests 
to compare distributions for non-parametric data.  
Explanatory variables were tested for linear 
association with the logit function of the outcome by 
grouping into four to six clinically relevant 
categories (such as birthweight, BMI, maternal age, 
gestational age) or quartiles (such as HC, AFI) and 
plotting the beta-coefficients against the mid-points 
of each group.  Non-linearly associated variables 
were analysed by group.   Explanatory variables 
were selected for multivariable models if p < 0.25 in 
the univariable logistic regression and data were 
available antenatally.  Missing data were imputed 
using 20 iterations.   Binomial logistic regression 
was performed on each of the 20 datasets, using 
generalized estimating equations to account for 
repeat sampling among women who had more than 
one pregnancy, and summary odds ratios and 95% 
confidence intervals reported.   The stepwise 
backward method was used, excluding variables 
with the highest p value one at a time until the 
remaining variables were < 0.05.  If a variable 
changed the point estimates for the adjusted odds 
ratios (ORs) for HC, AC, BPD, FL or EFW (even if p 
> 0.05) by more than 10%, it was retained in the 
model.  Interaction was assessed by creating 
interaction terms of EFW, AC, HC, BPD or FL by 
each of the other variables and with each other, 
with a cut-off of 0.05 for inclusion of the term.  
Colinearity was considered to be present when the 
variance inflation factor was > 10.  In the 
multivariable models either a combination of HC, 
AC, BPD and FL, or EFW alone were included as 
explanatory variables because EFW is calculated 
from these. 
This study obtained ethics approval from the 
Sydney Local Health District (RPAH Zone). 
Results 
There were 19,473 singleton deliveries from 
January 2005 to June 2009 of which 16,226 
remained after exclusion of preterm births, elective 
caesareans, stillbirths and breech presentations.  
Among these, there were 2,006 pregnancies with at 
least one fetal biometry ultrasound from 36+0 to 
38+6 weeks’ gestation.  The missing variables were 
BMI (n = 317)(16%), height (n = 250)(12%), weight 
(n = 172)(9%), placental location (n = 37)(2%), and 
parity (n = 7)(0.3%). 
The caesarean section rate was 17% (341/2,006) 
overall, including 9% (182/2,006) for FTP.  These 
rates were 14% (1,993/14,220) and 9% 
(1,330/14,220) respectively, among the 14,220 
women for whom an ultrasound was not performed. 
Table 4C.1 shows demographic and clinical 
characteristics of mother-infant pairs included and 
excluded from the study.  
Univariate analyses 
Table 4C.2 summarises maternal demographic, 
clinical, intrapartum and ultrasound factors 
associated with emergency caesarean section and 
vaginal birth.  The only factors not associated with 
CS-FTP in the univariate analyses were maternal 
place of birth, cigarette smoking, thick meconium 
liquor, neonatal sex and placental location. All 
biometry values (HC, BPD, FL, AC and EFW) were 
associated with an increased risk of CS-FTP. 
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Multiple logistic regressions 
Tables 4C.3 and 4C.4 show the results of the 
multiple logistic regressions with multiple imputation 
of missing data.  There was no evidence of 
interaction between explanatory variables.  There 
was no evidence of collinearity. 
Logistic regression on caesarean section for 
failure to progress in labour 
In the model using EFW as an explanatory variable, 
the OR for CS-FTP was 2.24 (95% CI 1.76 – 2.84) 
per 500g increase in EFW after adjusting for 
maternal age, height, BMI, parity, previous 
caesarean, diabetes group, AFI and UAPI (Table 
4C.3). 
In the model using AC, HC, BPD and FL as 
explanatory variables, BPD and AC were 
associated with CS-FTP (Table 4C.4).  The OR for 
CS-FTP was 1.51 (95% CI 1.16 – 1.97) per 5mm 
increase in BPD, and the OR for AC in the 4th 
quartile (>75th centile) compared with the 10th – 
25th centile group was 2.09 (95% CI 1.13 – 3.85). 
Logistic regression on emergency caesarean 
section for any indication 
In the model using EFW as an explanatory variable, 
the odds of intrapartum caesarean section was 
increased for the third and fourth quartiles of EFW 
compared with the 10th – 25th centile group after 
adjusting for demographic, clinical and ultrasound 
parameters (Table 4C.4).     
In the model using fetal biometry as explanatory 
variables, CS-overall was associated with the 
highest quartile of BPD and the highest quartile of 
AC (Table 5).  HC and FL were not associated with 
caesarean section. 
 
Table 4C.1: 
Characteristics of woman-infant pairs included and excluded from the study 
 n† Included 
(n = 2,006) 
Excluded 
(n = 14,220) 
Age at delivery (years)(mean ± SD) 16,226 31.8 ± 5.4 32.3 ± 4.9 
BMI (kgm-2)(median, IQR) 12,149 22.5 (20.2, 26.2) 22.1 (20.2, 24.8) 
Place of birth 
   “Western” countries‡ 
   South East Asia 
   South Asia§ 
   Other 
 
11,488 
2,891 
584 
1,248 
 
1,312 (65%) 
420 (21%) 
107 (5%) 
167 (8%) 
 
10,176 (72%) 
2,471 (17%) 
477 (3%) 
1,081 (8%) 
Parity 
   Nulliparous 
   Parous 
 
9,424 
6,678 
 
1,206 (60%) 
793 (40%) 
 
8,218 (58%) 
5,885 (41%) 
Gestation at delivery (Median, IQR) 16,226 39+4 (39+2, 40+3) 40+0 (39+0, 40+6) 
Diabetes 
   No diabetes 
   Diet controlled 
   Insulin treated 
   Pre-existing 
 
15,173 
390 
596 
67 
 
1,617 (81%) 
99 (5%) 
259 (13%) 
31 (2%) 
 
13,556 (95%) 
291 (2%) 
337 (2%) 
36 (0.2%) 
Induction of labour 16,226 850 (42%) 3,318 (23%) 
Epidural 16,226 578 (29%) 3,964 (28%) 
Birthweight (g) 16,195 3,327 +/- 521 3,488 +/- 447 
Caesarean section 
   CS FTP 
   CS Other 
   Vaginal birth 
 
1,330 
1,004 
13,892 
 
182 (9%) 
159 (8%) 
1,665 (83%) 
 
1,148 (8%) 
845 (6%) 
12,227 (86%) 
CS FTP = caesarean section for failure to progress in labour; CS Other = CS for other indications; IQR = interquartile range; 
SD = standard deviation 
† Data were missing for: BMI 4,077 (25%), place of birth 15 (0.1%), parity 124 (1%), and birthweight 31 (0.2%) participants. 
‡ “Western” countries include Australia, New Zealand, European countries, the USA and Canada 
§ South Asian countries include Bangladesh, India, Pakistan and Sri Lanka 
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Table 4C.2: 
Maternal, intrapartum and neonatal factors among women planning a vaginal birth who had an ultrasound 
between 36 weeks and 38 weeks 6 days gestation. 
 n CS-FTP 
n=182 
CS-Other 
n=159 
Vaginal birth 
n=1665 
Test 
statistic† 
p 
Maternal factors       
Age (years)a 2006 32.8 ± 5.2 31.9 ± 5.6 31.6 ± 5.4 T2004=2.68 0.007 
Height (cm)a 1756 162.5 ± 7.0 162.1 ± 7.3 163.9 ± 7.2 T1754=2.03 0.04 
Weight (kg)b 1834 65 (56, 75) 60 (54, 74) 60 (53, 70) T1832=3.73 0.0002 
BMI (kgm-2)a 1689 25.7 ± 6.2 24.7 ± 6.0 23.5 ± 5.2 T1687=3.73 0.0002 
Place of birth 
   “Western”‡  
   South East Asia 
   South Asia§ 
   Other 
 
1312 
420 
107 
167 
 
116 (9%) 
38 (9%) 
8 (7%) 
20 (12%) 
 
104 (8%) 
27 (6%) 
16 (15%) 
12 (7%) 
 
1092 (83%) 
355 (85%) 
83 (78%) 
135 (81%) 
 
χ2 (3 DF)  
= 2.12 
 
0.55 
Antenatal factors       
GA at USb 2006 37+2 
(36+4, 38+0) 
37+1  
(36+4, 37+6) 
37+2 
(36+4, 38+0) 
|Z| = 2.59 0.009 
GA at delivery 2006 39+6 ± 9 39+5 ± 9 39+4 ± 8 T2006=2.6 0.01 
Parity 
   Nulliparous 
   Parous 
   Unknown 
 
1206 
793 
7 
 
158 (13%) 
24 (3%) 
 
 
137 (11%) 
20 (3%) 
 
911 (76%) 
749 (94%) 
 
χ2 (1 DF)  
= 58.7 
 
<0.0001 
Previous CS: Yes 
                      No 
41 
1965 
12 (29%) 
170 (9%) 
6 (15%) 
153 (8%) 
23 (56%) 
1642 (84%) 
χ2 (1 DF)  
= 24.8 
<0.0001 
Diabetes 
   No diabetes 
   Diet controlled 
   Insulin treated 
   Pre-existing 
 
1617 
99 
259 
31 
 
138 (9%) 
6 (6%) 
25 (10%) 
13 (42%) 
 
121 (7%) 
9 (9%) 
23 (9%) 
6 (19%) 
 
1358 (84%) 
84 (85%) 
211 (81%) 
12 (39%) 
 
χ2 (3 DF) 
= 52.1 
 
<0.0001 
Intrapartum factors 
Induction of labour 
   No 
   Yes 
 
1156 
850 
 
53 (5%) 
129 (15%) 
 
56 (5%) 
103 (12%) 
 
1047 (91%) 
618 (73%) 
 
χ2 (1 DF)  
= 66.6 
 
<0.0001 
Epidural:   No 
                 Yes 
1428 
578 
72 (5%) 
110 (19%) 
82 (6%) 
77 (13%) 
1274 (89%) 
381 (68%) 
χ2 (1 DF)  
= 97.6 
<0.0001 
Thick meconium 
   No 
   Yes 
 
1897 
109 
 
169 (9%) 
13 (12%) 
 
136 (7%) 
23 (21%) 
 
1592 (84%) 
73 (67%) 
 
χ2 (1 DF)  
= 1.14 
 
0.29 
Fetal factors       
Birthweighta 2000 3630 ± 553 3297 ± 561 3297 ± 503 T1998=8.37 <0.0001 
Birth HC¶a 1922 35.0 ± 1.3 34.7 ± 1.5 34.3 ± 1.5 T1920=5.06 <0.0001 
CS-FTP = caesarean section for failure to progress in labour; CS-Other = caesarean section in labour for indications other 
than failure to progress (usually for “fetal distress”); DF = degrees of freedom; CS = caesarean section; GA = gestational age 
in weeks; gestation at US = gestation at the time of antenatal ultrasound; HC = head circumference 
† All comparisons are for caesarean section for failure to progress in labour (CS-FTP) versus all other births.  T-statistic 
shown for Student’s t-test, 2 sided |Z| statistic for Wilcoxon rank sum test, and χ2 test for comparing proportions 
a) mean ± standard deviation 
b) median (interquartile range) 
‡ “Western” countries include Australia, New Zealand, European countries, the USA and Canada 
§ South Asian countries include Bangladesh, India, Pakistan and Sri Lanka 
¶ Measured post-natally 
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Logistic regression on emergency caesarean 
section for indications other than failure to 
progress 
In the model using EFW as an explanatory variable, 
the odds of intrapartum caesarean section for 
indications other than failure to progress was 
increased for EFW < 10th centile and EFW > 75th 
centile after adjusting for demographic, clinical and 
ultrasound parameters (Table 4C.3).  In the model 
using fetal biometry as explanatory variables, none 
of the four measurements (HC, AC, FL or BPD) 
were associated with caesarean section for other 
indications.  The only two variables in the final 
model were parity and previous caesarean section. 
Discussion 
Our main finding was that EFW, BPD and AC at 38 
weeks’ gestation predicts emergency caesarean for 
failure to progress after adjusting for demographic, 
clinical and ultrasound factors. The odds 
approximately doubled for every 500g increase in 
EFW; or increased by about 50% for every 5mm 
increase in BPD and doubled if the AC was above 
the 75th centile. We also found a potentially 
predictive association between fetal biometry and 
caesareans for other indications, primarily fetal 
distress, with an increase in these caesareans by 
Table 4C.3: 
Multiple imputation and logistic regression for caesarean section in labour (models including estimated fetal weight) † 
 CS-FTP 
OR (95% CI) 
CS-overall 
OR (95% CI) 
CS-other 
Age (years) 
   < 25 
   25 - 29 
   30 – 34 
   35 – 39 
   40+ 
 
1.00 
0.89 (0.56 – 2.08) 
1.54 (0.83 – 2.85) 
2.27 (1.19 – 4.33) 
3.44 (1.50 – 7.89) 
 
1.00 
0.89 (0.55 – 1.43) 
1.39 (0.89 – 2.18) 
1.69 (1.03 – 2.76) 
2.61 (1.37 – 4.95) 
 
Not in final model 
Height (cm) 
   < 160 
   160 – 164 
   165 – 169 
   170+ 
 
0.79 (0.69 – 0.92) 
per 5cm increase 
 
1.00 
0.78 (0.54 – 1.13) 
0.60 (0.41 – 0.88) 
0.48 (0.31 – 0.74) 
 
NS but kept in model 
BMI (kgm-2) 
   < 25 
   25 – 29 
   30 – 34 
   35+ 
 
NS but kept in the 
final model 
 
1.00 
1.36 (0.93 – 1.99) 
1.58 (1.00 – 2.49) 
2.31 (1.37 – 3.88) 
 
NS but kept in model 
Nulliparity 13.4 (7.58 – 23.8) 11.0 (7.29 – 16.5) 6.16 (3.64 – 10.4) 
Previous caesarean section 26.6 (9.24 – 76.6) 19.9 (8.67 – 45.8) 7.11 (2.61 – 19.4) 
Diabetes 
   No diabetes 
   GDM diet controlled 
   GDM insulin treated 
   Pre-existing 
 
1.00 
0.53 (0.22 – 1.24) 
0.84 (0.50 – 1.41) 
6.29 (2.36 – 16.7) 
 
1.00 
0.84 (0.46 – 1.52) 
0.83 (0.56 – 1.23) 
7.28 (2.81 – 18.8) 
 
Not in final model 
US EFW adjusted to 38 wks 
   ≤ 10th centile 
   10th – < 25th centile 
   25th - < 50th centile 
   50th - < 75th centile 
   75th centile +    
 
2.24 (1.76 – 2.84) 
per 500g increase 
 
1.45 (0.78 – 2.71) 
1.00 
1.56 (0.95 – 2.56) 
1.72 (1.04 – 2.84) 
3.77 (2.25 – 6.31) 
 
2.33 (1.12 – 4.84) 
1.00 
1.74 (0.92 – 3.31) 
1.53 (0.79 – 2.97) 
2.19 (1.11 – 4.29) 
CI = confidence interval; CS-other = caesarean section in labour for indications other than failure to progress (usually 
concern for fetal wellbeing); CS overall = caesarean section in labour 
EFW = estimated fetal weight  
† all models were adjusted for BMI group, height or height group, multiparity, and previous caesarean section. CS-FTP 
model also adjusted for age group, diabetes type, UAPI quartile and AFI. CS-overall model also adjusted for age group, 
diabetes type, and AFI quartile. 
Figure 4C.1: 
Odds ratio of caesarean section by centile group 
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two-fold with an estimated EFW less than the 10th 
centile. 
Only two studies to our knowledge have assessed 
the association between fetal biometry and 
caesarean section for failure to progress in labour, 
both of which had a far smaller sample size than 
our study594,595. Kim et al (2008) found both 
increased EFW and AC to be associated with CS-
FTP after adjusting for maternal height, age, AFI, 
epidural analgesia and induction of labour594.  We 
screened for a larger number of potential 
confounders and additionally adjusted our models 
for BMI and gestational diabetes which are known 
to be associated with intrapartum caesarean 
section143,187,202,296,419,446,448,560,566,575,596-598.  
Furthermore, we excluded induction of labour and 
epidural analgesia which are unknown at the time of 
an antenatal ultrasound and therefore cannot be a 
part of a predictive model.  In an older study by 
Saunders (1992) et al595, increased AC was 
associated with CS-FTP in a small cohort of women 
undergoing induction of labour without adjusting for 
potential confounders. 
Other studies which have assessed the association 
between fetal biometry and caesarean section 
overall have found variable results369,436,447,565,599,600 
and only two found a positive association447,599.  
These discrepancies may be because caesarean 
for “fetal distress” is performed on the basis of 
presumed fetal hypoxaemia which has a different 
set of risk factors than CS-FTP.  Other possible 
explanations include restriction to women 
undergoing induction of labour369,436,600 or restriction 
to women admitted to the delivery ward565,599.  In 
one study it was not clear which women were 
eligible to have an ultrasound or when it was 
performed 565.  Furthermore, many of these studies 
are limited by the assumption that continuous 
biometric measurements are linearly related to the 
overall risk of caesarean sections which is likely to 
be incorrect, given that growth restricted and 
macrosomic fetuses are both at increased risk 
(Figure 4C.1).  
Meta-analyses of randomised controlled trials have 
shown that induction of labour reduces the risk of 
intrapartum caesarean section510,511. Whilst the 
literature on such benefit for inducing macrosomic 
infants is limited, promising evidence is emerging, 
with a recent randomised control trial by Boulvain 
(2015) revealing a trend towards a reduction in 
caesareans105. A well-designed large retrospective 
cohort study of 132,112 women by Cheng (2012) 
has also revealed a statistically significant reduction 
in caesareans with induction at 39 weeks compared 
Table 4C.4 
Multiple imputation and logistic regression for caesarean section in labour (models including fetal biomtery) ‡ 
 CS-FTP 
OR (95% CI) 
CS-overall 
OR (95% CI) 
CS-other 
US measured HC at 38 weeks (mm) 
   1st quartile (< 325.6) 
   2nd quartile (325.6 – 339.0) 
   3rd quartile (339.1 – 352.6) 
   4th quartile (≥ 352.7) 
 
Not in final model 
 
Not in final model 
 
Not associated 
US measured BPD at 38 weeks (mm)    
   1st quartile (< 89.4) 
   2nd quartile (89.4 – 91.8) 
   3rd quartile (91.9 – 94.4) 
   4th quartile (≥ 94.5) 
1.51 (1.16 – 1.97) 
per 5mm increase 
1.00 
1.14 (0.76 – 1.70) 
1.26 (0.85 – 1.87) 
2.15 (1.45 – 3.21) 
Not associated 
US measured AC at 38 weeks    
   ≤ 10th centile 
   10th – < 25th centile 
   25th - < 50th centile 
   50th - < 75th centile 
   ≥ 75th centile 
0.32 (0.09 – 1.12) 
1.00 
0.84 (0.46 – 1.56) 
0.98 (0.53 – 1.81) 
2.09 (1.13 – 3.85) 
1.20 (0.66 – 2.18) 
1.00 
0.94 (0.59 – 1.50) 
1.22 (0.77 – 1.94) 
1.96 (1.22 – 3.16) 
Not associated 
US measured FL at 38 weeks (mm) 
   1st quartile (< 69.9) 
   2nd quartile (69.9 – 71.7) 
   3rd quartile (71.8 – 73.7) 
   4th quartile (≥ 73.7) 
 
Not in final model 
 
Not in final model 
 
Not associated 
AC = abdominal circumference; BPD = biparietal diameter; CI = confidence interval; CS-FTP = caesarean section for failure to 
progress; CS-other = caesarean section in labour for indications other than failure to progress (usually concern for fetal 
wellbeing); CS overall = caesarean section in labour; FL = femur length; HC = head circumference; OR = odds ratio; UAPI = 
umbilical artery pulsatility index; US = ultrasound  
‡ models were adjusted for age group, BMI group, height or height group, diabetes type, multiparity, previous caesarean 
section, and AFI or AFI quartile. CS-overall model also adjusted for UAPI quartile. 
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with conservative management with a rate of 35.2% 
from 40.9%  (OR 1.25, 95% CI 1.17-1.33) 515. 
Our study adds to the existing literature on the 
association between fetal biometry and caesarean 
section for failure to progress by (i) describing the 
association of biometry with the specific caesarean 
indication of failure to progress, (ii) addressing a 
substantially larger sample size than previous 
studies, (iii) extrapolating biometric measurements 
to a standardised and practical gestation of 38 
weeks, (iv) accounting for a larger number of 
potential confounders, and (v) addressing EFW and 
other components of biometry in separate analyses. 
We propose that either EFW or BPD and AC may 
be incorporated into a risk model with other 
antenatal factors well known to be associated with 
CS-FTP such as maternal age 447,560,564,565, BMI 
187,446,564,566, parity446,560,564,566,601, height 
447,576,601,602(24, 34-36), and Bishop score 447,565, 
which may identify patients who will benefit most 
from induction of labour to prevent operative 
delivery.  
Limitations 
There are several limitations of this study. Being 
reliant on the databases allows for the possibility of 
database entry errors, although we have previously 
shown high levels of accuracy for the clinical and 
demographic variables used in this study (see 
Chapter 2). The accuracy of fetal biometry is 
sonographer-dependent and varies according to 
factors such as maternal BMI and degree of 
descent of the presenting part, and the 
extrapolation of measurements to 38 weeks 
assumes normal growth patterns.  However, these 
measurements were collected in a real antenatal 
setting and are likely to reflect the type of data that 
would be used in practice for predictive modelling. 
The retrospective use of ultrasound data could 
impact on the generalisability of our findings 
because the ultrasound indications were not 
available and ultrasounds are preferentially 
performed when a risk factor such as gestational 
diabetes, suspected fetal macrosomia or growth 
restriction is present. However as discussed in the 
methods, diabetes which was the only antenatally 
known risk factor that was found to be different 
between the included and excluded cohorts was 
adjusted for in multivariate analysis. Also the rate of 
CS-FTP was similar between the women in this 
study and all women who delivered in the defined 
time period (9% for both groups), suggesting that 
the results for this outcome are generalizable. 
Finally, regardless of the differences between the 
included and excluded cohorts, differences 
identified between centile groups within the study 
population are still clinically meaningful. 
Strengths 
A major strength of this study is the large sample 
size, far exceeding the numbers in similar studies in 
the literature.  We also extrapolated US 
measurements to a set gestation of 38 weeks to 
standardise these measurements improving our 
ability to detect associations between fetal biometry 
and intrapartum caesarean section. Another major 
strength of our study was distinguishing between 
different indications for caesarean section, and the 
relationship of each with biometric measurements 
which enabled us for example to describe a linear 
association between some components of fetal 
biometry (EFW and BPD) and CS-FTP.  Finally, we 
were able to adjust for a substantial range of 
potential confounders and limit explanatory 
variables to those which are available in the 
antenatal setting when predictive modelling is 
possible. 
Future research 
The findings of this study provide a basis from 
which a prospective study can be performed, 
investigating the association between ultrasound, 
clinical and demographic parameters, and 
intrapartum caesarean. We hope to perform a 
randomised control trial whereupon all patients 
have an ultrasound at 38 weeks’ gestation, and 
those at high risk of CS-FTP are randomised to 
induction of labour at 39 weeks versus standard 
care. Our research group’s ultimate aim is to 
formulate a predictive model or scoring system 
incorporating both clinical and sonographic risk 
factors of CS-FTP, to identify patients that can be 
induced at 39 weeks with the aim of reducing their 
risk of intrapartum caesarean section. 
Conclusions 
BPD, AC and EFW at 38 weeks are associated with 
intrapartum caesarean for failure to progress after 
adjusting for confounding factors. Routine biometry 
at 38 weeks may help identify patients whose 
intrapartum caesarean risk could be reduced by 
elective induction at 39 weeks. These findings need 
to be further validated with a prospective 
investigation of the same ultrasound parameters, 
and a study of whether induction of such high risk 
patients actually reduces the caesarean rate. 
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SYNOPSIS 
Chapter 5: Birthweight standards. 
This Chapter is divided into two parts.  Part A has been published and Part B will be submitted to a 
peer reviewed journal.   
Part A is a descriptive study which produces birthweight standards by excluding inductions of labour 
and caesarean sections before labour.  The standards were similar to ultrasound based fetal growth 
charts and can be produced from routinely collected local data. 
Reference: Joseph FA, Hyett JA, McGeechan K, Schluter PJ, Gordon A, McLennan A, de Vries BS.  
Fetal Diagn Ther  doi: 10.1159/000475662, Epub ahead of print, 2017. 
Contributions to Part A: 
Dr Farmey Joseph: Final analysis and drafting the manuscript. 
Professor Jon Hyett: Primary supervision and contributions to the writing the manuscript 
Dr Kevin McGeechan: Statistics advice, study design, and contribution to writing the manuscript. 
Dr Philip Schluter: Statistics advice and contribution to writing the manuscript. 
Dr Adrienne Gordon: Data collection and contribution to writing the manuscript. 
Dr Andrew McLennan: Contribution to writing the manuscript. 
Dr Brad de Vries: Study concept and design, initial analysis, major contributions to the manuscript. 
Part B uses a modified version of the methods described Part A to produce birthweight standards 
based on national data for the United States. 
Contributions to Part B: 
The authors and their relative contributions are the same as for Part A. 
Relevance: 
There is strong evidence that induction of labour reduces perinatal mortality, and potential to 
conduct a randomised trial of induction of labour at 39 weeks’ gestation for women with pregnancies 
at risk of adverse perinatal outcomes for improving these outcomes.   This trial could be conducted 
using the same ultrasound and clinical screening process at 37 weeks used to predict caesarean 
section for slow progress in labour, in parallel with the trial described in Chapter 6, Part B.  The 
birthweight standards described in this chapter could be part of a predictive model for adverse 
perinatal outcomes. 
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Chapter 5: Birthweight standards 
Part A: A new method 
 
Introduction 
Centile growth reference charts of estimated fetal 
weight, or birth weight versus gestational age, are 
widely used to identify high-risk pregnancies and to 
monitor fetal growth. Small for gestational age 
(SGA) infants are typically defined using the 10th 
centile for fetal weight, a threshold associated with 
adverse perinatal and long-term outcomes603-605. 
Therefore, the accurate estimation of these centile 
curves is important for diagnosis of abnormal fetal 
growth and for antepartum obstetric management. 
Data to construct centile curves generally arise from 
two sources: ultrasound estimates of fetal weight 
42,606,607 or actual birth weights of infants608-610. Each 
approach has its limitations. Ultrasound estimates 
are susceptible to measurement error, even in the 
hands of a skilled operator611-613. But use of actual 
birth weights of premature infants is problematic, as 
past research has demonstrated that many preterm 
births are not the result of “normal” pregnancies, but 
rather are associated with a pre-existing growth 
abnormality614-617. Inclusion of these pregnancies 
therefore causes a skewed distribution of birth 
weights and inaccurate reference charts. 
Preterm births may be divided into “spontaneous” 
and “iatrogenic” categories, the latter resulting from 
medical or surgical intervention to interrupt the 
pregnancy. Common indications for iatrogenic 
delivery include maternal disorders (e.g., pre-
eclampsia or insulin-dependent diabetes) or fetal 
disorders (suspicion of fetal compromise due to 
intrauterine growth restriction or genetic 
syndromes). All such disorders are frequently 
associated with growth disturbance, and therefore 
inclusion of iatrogenic preterm infants in 
construction of growth charts likely introduces bias. 
In contrast, the aetiology of spontaneous preterm 
birth is poorly understood, but there is a significant 
association with acute chorioamnionitis618-621. In 
these pregnancies, the duration from onset of 
infection to labour, and thus the duration of impaired 
placental function, may be too short for significant 
fetal growth restriction to occur. While spontaneous 
preterm birth is abnormal and is still associated with 
fetal growth restriction (especially at earlier 
gestations)615, the association has been found to be 
considerably weaker than with iatrogenic birth614.  
It is therefore both physiologically plausible, and 
consistent with previous published data, that 
preterm infants born following spontaneous birth are 
likely to be more representative of the overall 
population of normal fetuses. Therefore, we aim to 
confirm that preterm infants born following 
spontaneous birth have a higher birth weight and 
follow different 10th centile growth curves as 
compared with preterm infants born following 
induction of labour or pre-labour caesarean section 
(defined here as iatrogenic preterm birth). We then 
aim to use these results to develop new and more 
accurate birth weight charts by excluding iatrogenic 
births. 
Methods 
Design 
The study was a single-centre retrospective 
observational study.  
Population and Setting 
The study population consisted of all singleton live-
born infants born from 1989 to 2014 at Royal Prince 
Alfred Hospital, an inner city, tertiary maternity 
centre in Sydney, NSW, Australia. This hospital is a 
major obstetric tertiary referral centre which covers 
an inner-city, multicultural population, and currently 
averages approximately 5,500 deliveries per year. 
The hospital accepts in-utero and ex-utero transfers 
from around the state and overseas. The Neonatal 
Intensive Care Unit averages approximately 900 
admissions each year. Exclusion criteria comprised 
multiple births, still births, records with 
indeterminate sex or zero birth weights, and 
incomplete records missing critical fields relating to 
gestation or labour onset. 
This study involved no human experimentation. 
Permission to analyse de-identified data for 
purposes of this project was granted by the Ethics 
Review Committee of the Sydney Local Health 
District. 
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Procedure 
Study data were collected from the electronic 
obstetric database populated by midwifery staff 
from 1989 to 2014. The birth record was completed 
after each delivery and included fields such as birth 
weight, sex, and the date of birth for each birth 
during this period. 
Each record also included the estimated date of 
confinement (EDC), calculated by adding 280 days 
to the date of the last menstrual period (LMP). In 
circumstances where the LMP was unknown or 
where the 1st trimester ultrasound showed a 
disparity of 5 days or greater in dates, the EDC was 
recalculated based on this crown-rump length.  
The electronic birth record included detail of 
gestational age at delivery, manually calculated and 
recorded by the accoucheur. If the gestational age 
field was inconsistent with gestational age implied 
by the EDC and date of birth, and the discrepancy 
was sufficiently small to be likely the result of data 
entry error on the part of the accoucheur (less than 
3 weeks), then the latter method was used. 
Each birth was classified as being “spontaneous” or 
“iatrogenic.” Classification was based on the data 
fields reporting the type of labour and the timings of 
events in labour (such as the time labour was 
defined and the time of artificial rupture of 
membranes). Iatrogenic birth included induction 
of labour and pre-labour Caesarean section.  
For the purposes of this study, it is important to 
note that onset of labour was the only criterion 
for classification. For example, in the case of 
preterm premature rupture of membranes, the 
birth was classified as spontaneous only if 
labour contractions and cervical dilatation 
subsequently commenced without intervention. 
In the case of Caesarean section, the birth was 
classified as iatrogenic only if there was no 
spontaneous labour prior to the procedure.  
Statistical Analysis 
Analysis and reporting were informed by the 
STROBE guidelines (www.strobe-
statement.org). Statistical analysis was 
performed using SAS version 9.3 for Windows 
(SAS Institute Inc., Cary, NC, USA). Centile 
curves for fetal weight were constructed using 
quantile regression, a statistical technique 
previously used in the construction of growth 
charts622, with the explanatory variables of 
gestational age, sex, labour onset (spontaneous 
vs. iatrogenic), and the interaction term of 
labour onset × gestational age.  
Regressions were fitted to polynomials of maximum 
order 4, given the absence of substantial theoretical 
or empirical evidence to support the employment of 
more complex or higher-order models623. Student’s t 
test was used to determine the significance of 
regression terms, conducted in a hierarchical 
fashion, whereby the highest order term was 
considered first, and eliminated if non-significant 
and the model re-run. Once the final, most 
parsimonious model was identified, a visual 
inspection followed to ascertain whether predicted 
estimates from this model were consistent with the 
general patterns observed within the empirical data. 
Sensitivity analyses were performed with outliers 
removed using Tukey’s method624. The resulting 
centile curves were compared with the original 
curves (outliers included), and the differences 
reviewed. A p value of 0.05 was used to define 
significance. 
Results 
The database contained a total of 124,240 births, of 
which 96% remained after applying the exclusion 
criteria (Figure 5A.1). A further 1,327 (1.1%) of the 
remainder were excluded due to a significant 
discrepancy between manual and automated 
means of calculating gestational age. Analysis was 
Table 5A.1: 
Study population sex, gestation, and birth weight 
distributions 
 Spontaneous Iatrogenic 
 n %  n % 
Total 80,550 100.0  35,162 100.0 
Sex      
Female 38,893 048.3  16,903 048.1 
Male 41,657 051.7  18,259 051.9 
Gestation (weeks+days)     
26+0 to 29+6 00.516 000.6  00.493 001.4 
30+0 to 36+6 04,630 005.7  02,982 008.5 
37+0 to 42+0 75,404 093.6  31,687 090.1 
Birth weight, g      
0.<500 000.11 000.0  000.13 000.0 
0.<500–999 00.146 000.2  00.277 000.8 
<1,000–1,499 00.475 000.6  00.633 001.8 
<1,500–1,999 00.836 001.0  00.771 002.2 
<2,000–2,499 02,316 002.9  01,540 004.4 
<2,500–2,999 12,750 015.8  05,319 015.1 
<3,000–3,499 31,756 039.4  11,784 033.5 
<3,500–3,999 24,268 030.1  10,346 029.4 
<4,000–4,499 6,954 008.6  03,731 010.6 
<4,500–4,999 00.942 001.2  00.655 001.9 
≥5,000 000.96 000.1  000.93 000.3 
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limited to infants born from 26 to 42 weeks of 
gestation due to small numbers born prior to 26 
weeks (0.3% of total) as well as a hospital policy of 
induction prior to 42 weeks. The final total of births 
for analysis was 115,712. 
Of these births, 80,550 (69.6%) were assessed as 
spontaneous onset of labour and 35,162 (30.4%) as 
iatrogenic. Other characteristics of the study 
population are shown in Table 5A.1. 
Quantile regression modelling of birth weight on 
gestational age, sex, labour onset group, and the 
labour onset group × gestational age interaction 
term revealed that all main effects and interactions 
were significant for both the 10th centile and 
median birth weight curves (p < 0.001). That is, the 
observed relationship between gestational age and 
birth weight was different for spontaneous versus 
iatrogenic onset of labour for the 10th and 50th 
centiles. However, there was no evidence of a 
difference in the relationship between gestational 
age and birth weight for the 90th centile curve (p = 
0.07 for the interaction term).  
Figure 5A.2 shows a comparison of the centile 
curves, demonstrating that preterm infants born 
following iatrogenic onset of labour generally have 
lower birth weights. The difference changes with 
gestational age, being most marked at 
approximately 30–32 weeks of gestation. Compared 
with the iatrogenic births, the spontaneous births 
more closely approximate ultrasound estimates 
published by Hadlock et al42 in 1991. 
Figure 5A.3 compares the 10th, 50th, and 90th 
centile curves from the spontaneous population 
against the same centiles from a commonly used 
reference based on national birth weight data609. In 
comparison to the unselected national cohort, the 
10th centile curve lies noticeably higher at preterm 
gestations but converges around 38 weeks.  
Figures 4 and 5 show male and female centile 
curves using the spontaneous cohort only. The 
regression equations for the birth weight in grams of 
the 10th centile for spontaneous births as a function 
of gestational age (GA) were: 
Female: – 14524.63 +  2087.97 ×  GA –  112.927 ×
 GA2  +  2.73430 ×  GA3 –  0.023592 ×  GA4 
Male: – 61436.50 +  7763.86 ×  GA –  367.562 ×
 GA2  +  7.75998 ×  GA3 –  0.060402 ×  GA4 
Removing outliers (as defined by Tukey’s method) 
and repeating the quantile regressions yielded a 
negligible difference of estimated birth weight. The 
maximum difference for the 10th centile estimates 
was only 3 g, which occurred at 26 weeks of 
gestation for female births.  
Finally, quantile regression was performed on the 
entire population including spontaneous and 
iatrogenic births (the usual approach to creating 
birth weight charts). The resulting 10th centile for all 
births was compared with the spontaneous birth 
population. For spontaneous births prior to 34 
weeks of gestation, only 1.9% of female and 2.3%  
Figure 5A.1 
Participant flow chart 
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Figure 5A.2: 
Tenth centile and median for birth weights of spontaneous versus iatrogenic births. Corresponding 
centiles from an ultrasound estimate (Hadlock, 1991)
439
 are shown for comparison. 
Figure 5A.3: 
Tenth, median, and 90th centiles for RPA Hospital spontaneous births versus a 
commonly used Australian birth weight-based reference (Dobbins, 2012)
506
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of male spontaneous births lay below the 10th 
centiles for all female and male births, respectively.  
Discussion 
We have demonstrated that growth centiles derived 
from spontaneous births are remarkably similar to 
those created from ultrasound42 and may represent 
a more suitable proxy for normally grown fetuses. 
In our large cohort, iatrogenic preterm infants were 
more likely to be SGA and had a lower 10th centile 
and median birth weight than infants born following 
spontaneous labour. The difference varied 
according to gestational age and was most marked 
at 30–32 weeks of gestation, likely reflecting the 
generally good prognosis for fetuses born after 30 
weeks and thus the decision to deliver many SGA 
fetuses at around this gestation. The quantile 
regression analysis also demonstrated that the 10th 
centile and median birth weights of our 
spontaneous labour population closely approximate 
the ultrasound-based centile curves published by 
Hadlock et al42 in 1991. 
These findings confirm that infants delivered for 
iatrogenic indications are often affected by 
pathologies that impact intrauterine growth, 
consistent with previously published results614. In 
contrast, pathologies leading to spontaneous onset 
of labour appear less likely to have an impact on 
growth potential.  
As an additional consequence, growth curves 
based on birth weights of all deliveries from an 
unselected population likely result in significant 
underdiagnosis of SGA in the preterm population, 
as demonstrated by comparing the 10th centile 
curves for our spontaneous births against the 
national unselected cohort (Fig. 3). Within our 
hospital, only approximately 2% of spontaneous 
births prior to 34 weeks of gestation had birth 
weights below the 10th centile for the entire hospital 
population.  
The strengths of this study include the use of a 
large data set comprising more than 115,000 births 
after exclusions. Centile curves were constructed 
using quantile regression, a method with significant 
advantages over traditional least squares 
regression. Quantile regression makes no 
assumptions about the distribution of the error 
process and produces centile curves with greater 
robustness to outliers625,626, as demonstrated in this 
case by application of Tukey’s method. Thus, there 
was no need to exclude outliers using an arbitrary 
methodology with the associated risk of introducing 
a new source of error. Furthermore, consecutive 
births were included in the study, and only about 
1% were excluded due to missing data or uncertain 
EDC, reducing the risk of selection bias.  
As with all database analyses, these results are 
dependent on the accuracy of the recorded birth 
data. A discrepancy in the reported gestational age 
at delivery could have a significant impact on 
analysis, and we took steps to exclude cases where 
there was doubt about the veracity of these data. 
Misclassification of “iatrogenic” births as 
“spontaneous” could cause a slight downward shift 
in our 10th centile curve. In particular, for cases in 
which the labour is described as “augmented” only 
(suggesting spontaneous onset), it was necessary 
to review the timing of events in labour to confirm 
that onset of labour did indeed commence before 
the administration of oxytocin.  
A second limitation concerns the paucity of data at 
the extreme of prematurity with potential impact on 
the process of fitting the data to a smoothed curve. 
In this series, only 59 infants (31 male, 28 female) 
were born after spontaneous labour at 26 weeks of 
gestation; only 1 (3.2%) male and 2 (7.1%) female 
infants lie below the respective 10th centile, and it is 
difficult to have statistical confidence in the fitted 
curve at this gestation. Confidence in these data 
could be improved by using larger state or national 
data sets.  
Finally, while iatrogenic births are excluded, there is 
still some potential for bias in the spontaneous 
preterm population. There may be circumstances 
where pathologies that disrupt growth also cause 
preterm spontaneous labour. For example, even 
preterm labour resulting from acute infection may 
be associated with a short period of reduced 
growth. Thus, there likely exists a residual level of 
systematic error in our charts that would act to 
make our centile curves slightly lower than the 
“true” curves. 
Many clinicians use charts based on actual birth 
weights to monitor and assess fetal growth as well 
as to define rates of postnatal growth in preterm 
infants627. The ideal such growth chart would be 
constructed by randomly assigning fetuses to be 
delivered at preterm gestations and then weighing 
them at birth, but that is not possible for obvious 
reasons.  
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Figure 5A.4: 
Centile growth curves of females for all eligible births, constructed from the subset of 
spontaneous births: 10th, 50th, and 90th centiles 
  
Figure 5A.5: 
Centile growth curves of males for all eligible births, constructed from the subset of 
spontaneous births: 10th, 50th, and 90th centiles 
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The potential for bias in these data has been 
recognised previously, but few attempts have been 
made to retrospectively remove an anomalous 
cohort whose birth weight is impacted by pregnancy 
pathology. In the preterm setting, these charts 
based on actual birth weights underestimate the 
true 10th and lower centiles because the preterm 
infants were far more likely to be growth restricted 
than fetuses at an equivalent gestational 
age617,627,628. 
The use of charts that have not excluded this 
“pathological” cohort provides two potential sources 
of misinterpretation when applied to the preterm 
population. First, individual “normal” fetuses will be 
deemed to be of a higher centile than is truly the 
case, as preterm centile curves are biased 
downwards by early delivery of SGA fetuses. 
Second, at later preterm gestations individual 
“normal” fetuses will appear to grow at a slower rate 
than anticipated, as the centile curve growth 
velocities reflect the dropout of SGA fetuses who 
have been delivered early. 
Implementation of the approach described in this 
paper would likely result in increased diagnosis of 
SGA fetuses if charts based on actual birthweights 
were used previously. It may eventuate that the 
threshold for diagnosis and potential intervention is 
altered accordingly (e.g., from the 10th centile to a 
lower centile) to avoid unnecessary intervention. On 
the other hand, we expect little difference in the 
diagnosis of SGA if ultrasound based charts were 
previously used. 
A recent systematic review found 104 birth weight 
charts published since 1990610. One example of 
birth weight charts in use today is the Fenton charts 
517, which were derived from a meta-analysis of six 
large population-based charts including about 4 
million infants. The major advantage of these charts 
is the large population size enabling construction of 
smoothed growth curves down to 22 weeks of 
gestation. However, only one of the six charts 
underlying the meta-analysis attempted to exclude 
high-risk pregnancies, and thus the preterm growth 
curves are likely heavily influenced by pregnancies 
with abnormal fetal growth.  
Recognising the limitations of birth weight charts, 
the authors of other charts have made efforts to 
identify a low-risk cohort from which to collect data 
and thus minimise the inherent bias. The 
INTERGROWTH-21st project629 represents the 
most comprehensive such effort to date. Eight study 
sites were chosen on the basis of socioeconomic, 
health, and nutritional status. Within those centres, 
inclusion criteria were designed to select a maternal 
population at low risk of fetal growth impairment, 
including strict universal criteria relating to age, 
height, BMI, smoking, medical history, and obstetric 
history. Pregnancies of uncertain gestational age 
were excluded. Standardised anthropometric 
measures were taken of all newborn infants. One 
disadvantage of this project is the resulting small 
number of early preterm births, and as a 
consequence the growth curves published in 2014 
were limited to 33 weeks of gestation and above610. 
Furthermore, it is not possible to prospectively 
exclude all pregnancies with fetal growth 
abnormalities, and therefore there is likely some 
residual level of bias in the preterm portion of these 
charts. 
Another group has produced charts with 
retrospective exclusion of infants born to women 
with maternal diseases known to impact on birth 
weight630,631. The limitation of this approach is that 
many infants are delivered for fetal indications in the 
absence of significant maternal disease, and 
therefore the residual bias in these charts likely 
remains substantial. 
An alternative approach to assessing fetal growth 
involves construction of charts of estimated fetal 
weight based on ultrasound measurements of fetal 
biometry. This method allows charts to be 
constructed using data from a large cohort of 
pregnancies with no limitation on gestation, but has 
the disadvantage that the formulas used to 
calculate an estimated fetal weight are susceptible 
to ultrasound measurement error613. A systematic 
review in 2012 found 83 such studies published 
from 1971 to 2008632. 
One such example is the widely used Hadlock 
charts based on single antenatal ultrasound 
examination of 392 middle-class white women from 
Texas, USA42. Other examples of ultrasound-based 
charts include the Fetal Growth Longitudinal 
Study606(part of the INTERGROWTH-21st project) 
and the NICHD Fetal Growth Studies607. Unlike the 
Hadlock charts, these studies used longitudinal 
ultrasound data and from a significantly larger and 
more diverse patient population.  
The approach described in this study calculates 
birth weight centiles using data sets restricted to 
pregnancies that delivered spontaneously. This 
approach may be considered complementary with 
the Intergrowth project which also attempts to 
exclude “pathological” pregnancies. While the 
Intergrowth approach is to identify a low-risk cohort 
prospectively, our approach is to exclude these 
pregnancies retrospectively by using iatrogenic birth 
as a proxy for pathological pregnancy. This 
approach may be a suitable alternative for 
constructing growth charts for institutions or regions 
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where the patient population cannot be easily 
characterised with reference to universal growth 
curves, provided birth data are available to 
distinguish iatrogenic versus spontaneous labour.  
Using this study as a proof of concept, future 
researchers could apply this approach to other birth 
data sets. Many maternity centres maintain detailed 
records of all births including appropriate data fields 
to differentiate the spontaneous from the iatrogenic 
births. It would be a relatively simple matter using 
this approach to construct customised centile 
curves by institution, region, or country. Larger data 
sets will enable production of growth curves which 
extend to earlier gestations. These charts are likely 
to be more accurate than existing birth weight 
charts for the identification of individual fetuses at 
risk of being SGA. 
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Part B: Birthweight standards for the 
United States 
 
Introduction: 
A new method of defining birthweight standard 
centiles was developed in Chapter 5 Part A.  The 
method relies on identifying labour onset as either 
iatrogenic (induction of labour or prelabour 
caesarean section) or spontaneous.  Excluding 
iatrogenic births resulted in birthweight standards 
derived from a population of relatively normally 
grown fetuses.  Using data from a single institution, 
the 10th centile closely approximated the ultrasound 
based fetal growth standards described by Hadlock 
in 199142. 
Ideally, population based standards would include 
the birthweights of all delivered infants plus the in 
utero weights of all unborn fetuses at any given 
gestational age.  Birthweights of preterm infants 
following spontaneous onset of labour approximate 
this ideal because iatrogenic births represent only a 
very small proportion of all ongoing pregnancies 
and removing them therefore has a minimal impact 
on centile curves.  However, the situation may be 
different in term pregnancies.  For example, 
induction of labour may be performed for fetal 
macrosomia or gestational diabetes105,331,332, 
potentially increasing the higher centiles around 39 
to 40 weeks’ gestation or decreasing them in post-
dates pregnancies.  We considered that it may be 
possible to develop a method to include iatrogenic 
births in birthweight standards by adjusting them in 
a way that prevented them from being 
overrepresented at any given gestational age. 
The aim of this study was to develop large 
population based birthweight standards using two 
cohorts: (1) Only infants born following spontaneous 
onset of labour; and (2) Infants born following 
spontaneous labour, and by iatrogenic delivery after 
adjusting for timing of birth and expected growth 
over time.  Data from births in the United States 
was used because it is freely accessible to the 
public. 
Methods 
This was a retrospective observational study of all 
live births in the United States in 2015.  Study data 
were collected from the US Centers for Disease 
Control and Prevention website available at: 
http://www.nber.org/data/vital-statistics-natality-
data.html.  The study was performed on publicly 
available de-identified data and did not require 
approval from an ethics committee. 
The study population comprised all singleton live 
births in the United States in 2015.  Iatrogenic births 
were defined as those where the labour was 
induced or where the final route of delivery was 
caesarean section and a trial of labour was not 
attempted.  Spontaneous births were defined as all 
other births.  Exclusion criteria included gestational 
age less than 20 or at least 43 completed weeks 
(22+0/7 to 42+6/7), multiple gestation, or congenital 
anomaly. Records missing data for any of these 
exclusion criteria, gestational age, birthweight, and 
insufficient data to determine if the birth was 
iatrogenic were also excluded.    We confirmed 
earlier observations that there is a bivariate 
birthweight distribution with a second peak at very 
high birthweights for some gestational ages28, and 
excluded infants with unrealistic birthweights using 
criteria suggested by Alexander et al (1996)28.  The 
obstetric estimation of gestational age was used as 
it is considered the most accurate for US data633. 
Preliminary analysis revealed anomalies in the 
higher centiles for preterm births (described in the 
results) and consequently a post hoc exclusion was 
applied to the data: infants above the 90th centile 
regression curve for all births after other exclusions, 
from 26 to 34 weeks’ gestation and not admitted to 
the neonatal intensive care unit were excluded as 
their gestational age was considered likely to be 
misclassified. 
Centile curves were produced using two datasets: 
(1) All eligible births with spontaneous onset of 
labour. 
(2) All eligible births including iatrogenic births 
adjusted to an expected gestational age had 
intervention not occurred, and assuming continued 
growth on the same centile for gestational age.  The 
method used to adjust iatrogenic births was as 
follows: 
• The distribution of all spontaneous births later 
than the week of intervention and before 43 
completed weeks was used.  For an iatrogenic 
birth at 30 completed weeks this was the 
number of spontaneous births at any given 
week from 31 to 42 completed weeks’ gestation 
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divided by all spontaneous births from 31 to 42 
completed weeks’ gestation. 
• An expected gestational age at delivery was 
assigned randomly and weighted according to 
the distribution in the previous step.  For 
example, an iatrogenic birth at 30 weeks, had a 
34% chance of being assigned to 39 weeks as 
34% of all spontaneous births from 31 to 42 
completed weeks’ gestation occurred at this 
gestation. 
• The birthweight centile for any given iatrogenic 
birth was calculated with respect to all 
spontaneous births at the same gestational age 
and assumed to remain unchanged had the 
pregnancy progressed.  For example, an 
iatrogenic birth at 30 weeks on the 4th centile 
for all spontaneous births at 30 weeks that was 
assigned to an expected delivery at 39 weeks, 
was assigned a birthweight corresponding with 
the 4th centile for all spontaneous births at 39 
weeks. 
• The combination of actual birthweights for 
spontaneous births and adjusted birthweights 
and gestational ages for iatrogenic births were 
used to develop centile charts. 
Analysis and reporting were informed by the 
STROBE guidelines (www.strobe-statement.org).  
Statistical analysis was performed using SAS 
version 9.4 for Windows (SAS Institute Inc., 
Cary, NC, USA).  Centile curves for fetal 
weight were constructed using quantile 
regression634 for boys and girls in separate 
analyses. 
Results 
There were 3,988,733 reported births in United 
States in 2015 of which 3,832,657 (96%) 
remained after applying the initial exclusion 
criteria (Figure 5B.1).  Of these, 152,242 (4%) 
were excluded for missing data and 1,526 
(0.04%) were excluded due to unrealistic 
birthweight using criteria described by 
Alexander et al in 199628. 
Exploration of the data showed that preterm 
infants above the 90th centile for birth weight at 
26 to 34 weeks’ pregnancy were less likely to 
be admitted to the intensive care unit than 
infants below the 90th centile.  We 
hypothesised that this was due to 
misclassification of more advanced gestational 
age.  As most infants were admitted to the 
neonatal intensive care unit from 26 to 34 
weeks’ gestation, we decided to exclude 1,685 
infants whose birthweight was above the 90th centile 
at these gestational ages but not admitted to the 
neonatal intensive care unit from further analysis, 
representing 0.05% of the included births.  Figure 
5B.2 shows actual centiles per gestational age for 
spontaneous births with fourth order polynomial 
trendlines, before and after exclusion of unrealistic 
birth weights using Alexander’s criteria28 and after 
the additional exclusions for suspected 
misclassification of gestational age. 
The final dataset used to describe centile curves for 
all births included 2,016,303 (55%) spontaneous 
and 1,660,901 (45%) iatrogenic births.  Other 
characteristics of the study population are shown in 
Table 5B.1. 
Figure 5B.3 shows the results of quantile regression 
of birth weight on gestational age for spontaneous 
and iatrogenic births from 24 to 42 completed 
weeks’ gestation.  In general, iatrogenic preterm 
births had lower birth weights than births following 
spontaneous onset of labour and iatrogenic term 
births had higher birth weights.  The pattern was 
similar to that observed for births at Royal Prince 
Alfred Hospital (Chapter 5, Part A).  Iatrogenic 
births showed characteristic sigmoid curves 
whereas those for births following spontaneous 
onset of labour were straighter. 
TABLE 5B.1: 
Study population sex, gestation, and birth weight distributions 
 Spontaneous  Iatrogenic 
 n %  n % 
Total 2,016,303 100.0  1,660,901 100.0 
Sex      
Female     984,744 048.8  811,451 048.9 
Male 1,033,236 051.2  849,458 051.1 
Gestation (weeks+days)     
20+0 to 25+6 0,006,459 000.2  0,004,564 000.3 
26+0 to 29+6 0,006,394 000.3  0,009,995 000.6 
30+0 to 36+6 0,132,171 006.6  0,121,513 007.3 
37+0 to 42+6 1,871,279 092.9  1,524,829 091.8 
Birth weight, g      
0.<500 002,481 000.1  001,130 000.1 
0.<500–999 005,975 000.3  008,820 000.5 
<1,000–1,499 007,128 000.4  012,504 000.8 
<1,500–1,999 016,636 000.8  023,469 001.4 
<2,000–2,499 075,697 003.8  075,908 004.6 
<2,500–2,999 380,884 018.9  276,734 016.7 
<3,000–3,499 842,162 041.8  625,515 037.7 
<3,500–3,999 543,554 027.0  474,113 028.5 
<4,000–4,499 125,668 006.2  137,465 008.3 
<4,500–4,999 014,959 000.7  022,286 001.3 
≥5,000 001,159 000.1  002,957 000.2 
Source: National Center for Health Statistics 
 For Health  
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Figure 5B.4 shows the results of quantile regression 
of spontaneous births and all births of birthweight 
on gestational age where the iatrogenic birth 
weights were extrapolated to an expected gestation 
at delivery.  Although the two sets of curves were 
similar, the latter were slightly straighter, particularly 
for the higher quantiles. 
Figure 5B.5 shows a comparison between birth 
weights for all births (with iatrogenic extrapolated) 
and the Intergrowth43 and commonly used 
Hadlock42 fetal weight standards.  In general, the 
birth weight standards showed similar gradients and 
were located between these two standards. 
Figures 5B.6 to 5B.8 show the final birthweight 
standards for all births, girls, and boys using 
quantile regression of birthweight (extrapolated for 
iatrogenic births) on gestational age (extrapolated 
for iatrogenic births).  The standards include 
1,881,768 boys 1,795,436 girls after the exclusions 
outlined in Figure 5B.1, from 24 to 42 completed 
weeks’ gestation. 
Discussion 
We have demonstrated that spontaneous birth 
weight standards for nationwide US data are similar 
to those created from ultrasound42,43, confirming our 
previous observation in a single tertiary hospital in 
Sydney, Australia (Chapter 5 Part A).  This is likely 
because spontaneous onset of labour is less 
associated with abnormal fetal growth than 
obstetrically initiated births614.  The method 
approximates fetal weight standards without the 
need for serial ultrasounds in pregnancy. 
Additionally, we used an adjustment for iatrogenic 
births which prevented their over-representation at 
some gestations.  For example, at 30 weeks’ 
gestation, 60% of births were iatrogenic but they 
represented only 0.1% of pregnancies which went 
to this gestation or beyond, which strongly biased 
the growth weight standard downwards at this 
gestation.  Over-representation of iatrogenic births 
results in marked “S”-shaped birth weight standards 
with lower birth weights for preterm births (Chapter 
5, Part A).  Assuming that in pregnancies resulting 
in an iatrogenic birth, labour would have occurred at 
the same time as for other births and that fetuses 
would stay on the same centile had the pregnancy 
continued, allowed all births to be included.  The 
resultant birth weight standards were similar to 
those produced using spontaneous births alone, but 
may represent a slight improvement.  For example, 
inductions of labour for macrosomia or gestational 
diabetes are excluded when only  
3,988,733 reported births in US in 2015 
3,832,657 potentially eligible births 
Exclusions: 
   1,397 gestational age < 20 weeks 
   4,294 gestational age ≥ 43 weeks 
   137,267 multiple pregnancies 
   13,118 congenital abnormality 
Missing data: 
   2,014 unknown birthweight 
   71,197 unknown if congenital abnormality 
   79,031 unknown if iatrogenic or spontaneous birth 
 3,680,415 births with complete data  
Figure 5B.1: 
Participant flow chart 
Unrealistic birthweight:28 
   1,426 Birthweight too high 
   100 Birthweight too low 
    3,678,889 births for exploratory analysis: 
3,677,204 births for analysis: 
   1,660,901 iatrogenic 
   2,016,303 spontaneous 
   1,881,768 boys 
   1,795,436 girls 
 
Suspected incorrect birth weight: 1,685  
(weight > 90th centile, 26 to 34 weeks’ gestation, not 
admitted to neonatal intensive care unit) 
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Figure 5.2B: 
Actual centiles and trend lines before and after 1,526 exclusions for ‘unrealistic’ birthweights28,29 
and 1,685 exclusions for suspected misclassified gestational ages 
After exclusions for ‘unrealistic birthweights’ (n = 3,678,889): 
After exclusions for ‘unrealistic birthweight’ and suspected incorrect gestational age: 
(n = 3,677,204) 
 Before exclusions (n = 3,680,415): 
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The regression curves for US birthweights were straighter for spontaneous compared with iatrogenic births.  
The greatest differences were in the lower centiles from 26 to 36 weeks gestational age 
Figure 5B.3: 
Spontaneous versus iatrogenic births: 10
th
, 50
th
 and 90
th
 centiles using quantile regression on US 
natality data, 2015 
  
Spontaneous  Iatrogenic  
Figure 5B.4: 
Spontaneous versus all births (including iatrogenic extrapolated to expected gestational age): 10
th
, 
50
th
 and 90
th
 centiles using quantile regression on US natality data, 2015 
  
Spontaneous  All births (iatrogenic extrapolated)  
The regression curves for US birthweights were similar for spontaneous and all births, when iatrogenic births were 
assigned a gestational age the woman would have reached had intervention not occurred, and growth along centile 
lines was assumed.  For all births, there was a slight straightening of the curve for the higher centiles. 
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spontaneous births are used which could result in 
an apparent flattening or deceleration of fetal 
growth after term, especially in the higher centiles. 
However, given that the adjustment is complex and 
the difference between the two sets of curves is 
relatively small, it would be reasonable to only 
include spontaneous births if the method is applied 
to other populations in the future. 
Although the birth weight standards for 
spontaneous births were similar to Intergrowth43 
and Hadlock42 ultrasound based fetal weight 
standards, the similarity was stronger in a previous 
study in a single tertiary hospital in Sydney, 
Australia (Chapter 5, Part A).  This could be due to 
the different definition of spontaneous onset of 
labour.  In the Sydney cohort, onset of labour was 
specifically recorded but in the current study, if a 
trial of labour was not allowed, the woman was 
assumed to be in the iatrogenic group even if labour 
started spontaneously.  However, there is no clear 
reason that this would alter the birthweight 
standards in the spontaneous group, and the 
difference may be due to accuracy of the large US 
national natality dataset. 
The Intergrowth-21st project was a rigorously 
designed and executed project which produced fetal 
weight and birth weight standards by performing 
serial ultrasounds in women who met strict criteria 
to be considered as low risk43,610,629,635.  The 
philosophy was that global standards could be 
produced such that centiles would represent the 
distribution of normal, healthy fetuses.  Thus, unlike 
other standards, the Intergrowth-21st standards are 
prescriptive rather than descriptive or population 
based and may represent the preferred method for 
comparison in international studies.  However, it 
has not been shown if the Intergrowth-21st 
standards perform any better for predicting adverse 
perinatal and longer term outcomes. 
The strengths of this study include its large sample 
size which allowed birth weight standards to be 
produced from 24 to 42 weeks’ gestation.  As 
quantile regression is non-parametric, no 
assumption about the distribution of residuals is 
required and quantiles are estimated directly.  The 
method is robust to outliers636.  Further, less than 
0.1% of the data was excluded due to unrealistic 
birthweight or suspicion of misclassification. 
In general, the regression curves for US birthweights fell somewhere between the estimated fetal weight centiles 
developed by Hadlock and those developed as part of the intergrowth project.  They were slightly more “S shaped” 
for the lower centiles. 
Figure 5B.5: 
10th, 50th, and 90th centiles for all births (including iatrogenic extrapolated to expected gestational 
age) using quantile regression on US natality data, 2015 versus intergrowth and Hadlock estimated 
fetal weight centiles42,43 
  
US birthweight,  all births  Hadlock, estimated fetal weight  Intergrowth, estimated fetal weight  
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Figure 5B.6: 
All births (including iatrogenic extrapolated to expected gestational age) using quantile regression on US natality data, 2015 
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Figure 5B.7: 
Girls (including iatrogenic extrapolated to expected gestational age) using quantile regression on US natality data, 2015 
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Figure 5B.8: 
Boys (including iatrogenic extrapolated to expected gestational age) using quantile regression on US natality data, 2015 
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The limitations of the study include reliance on a 
large national dataset with multiple individuals 
contributing to data entry leading to possible 
misclassification and bias.  Indeed, post-hoc 
analysis of birthweight and neonatal intensive care 
unit admission suggested misclassification of 
gestational age, leading to exclusion of 1,685 cases 
where gestational age was considered likely to have 
been underestimated.  It is also possible that the 
‘flattening’ of birth weight curves at the lower 
centiles of post-dates pregnancies represents a ‘tail’ 
of lower birthweights created by overestimation of 
gestational age in some pregnancies.  Thus, it may 
be reasonable to restrict future birth weight 
standards to pregnancies less than 42 completed 
weeks’ gestation.  Four percent births were 
excluded due to missing data (in most cases for 
congenital abnormality or spontaneous versus 
iatrogenic birth).  If missingness is related to birth 
weight centile, this could introduce bias into the 
birth weight standards, but as this is a small 
percentage, bias is likely to be small. 
Future research should aim to develop customised 
birth weight standards using the methods in this 
paper.  There is also a need for comparisons of the 
predictive performance of different birth weight and 
fetal weight standards such as those produced as 
part of the Intergrowth-21st project and other 
commonly used standards such as the 
metaanalysis of birth weight standards by Fenton et 
al 517, for important adverse perinatal outcomes and 
longer term outcomes such as serious disability. 
In conclusion, we have produced sex specific birth 
weight standards using US natality data and a 
technique which includes births following 
spontaneous onset of labour and an adjusted 
gestation and birth weight for iatrogenic births.  
These standards are more similar to fetal weight 
standards than existing population birth weight 
standards.  They are potentially customisable and 
can be produced from large datasets using data 
which is routinely collected in most settings. 
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SYNOPSIS 
Chapter 6: Consolidation and future directions. 
This Chapter is divided into four parts.  Part A will be submitted for publication in a different format. Part B will be 
submitted for publication, and Parts C and D consolidate and discuss the findings in this thesis.   
Part A develops a logistic regression model to predict caesarean section for slow progress in labour using data from 
the fetal biometry study in Chapter 4 (Part A), and temporal validation.  The intention is to develop a model based on 
a larger dataset from 2009 to 2016 and use bootstrap validation to estimate optimism-corrected performance. 
Authors: de Vries BS, McGeechan K, Phipps H, Hyett JA. 
Contributions to Part A: 
Dr Brad de Vries: Study concept and design, analysis, drafted the Chapter. 
Dr Kevin McGeechan: Statistics advice and general supervision. 
Dr Hala Phipps: General supervision. 
Professor Jon Hyett: Primary supervision. 
 
Part B is a protocol for a randomised controlled trial of induction of labour at 39 weeks’ gestational age among 
women at high risk of caesarean section for slow progress in labour, for reducing caesarean section in labour. 
Authors: de Vries BS, Phipps H, Barratt A, McGeechan K, Gordon A, Hyett JA. 
Contributions to Part B: 
Dr Brad de Vries: Protocol concept and design, drafted the manuscript. 
Dr Hala Phipps: General supervision, contributed to writing the manuscript 
Prof Alexandra Barratt: Contribution to writing the manuscript. 
Dr Kevin McGeechan: Contribution to writing the manuscript. 
Dr Adrienne Gordon: Contribution to writing the manuscript. 
Professor Jon Hyett: Primary supervision and contribution to the writing the manuscript. 
 
Part C is a general discussion about the works in this thesis. 
Author: de Vries BS. 
Contributions to Part C: 
Part C was written by Dr Brad de Vries with general advice and feedback from Prof Jon Hyett and Dr Hala Phipps. 
 
Part D is a summary of this thesis and its conclusions. 
Contributions to Part D: 
Part D was written by Dr Brad de Vries with general advice and feedback from Prof Jon Hyett and Dr Hala Phipps. 
 
Relevance: 
The chapter brings the original works in this thesis together and discusses their relevance and future directions. 
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Chapter 6: 
Consolidation and future directions 
Part A: A model for predicting intrapartum caesarean 
section 
Introduction 
This chapter is based on data from Chapter 4C.  
2,006 women who had an ultrasound from 36(+0/7) to 
38(+6/7) weeks' gestational were included.  The aim 
was to create a tool which could be used to screen 
women for inclusion in a pilot randomised controlled 
trial of induction of labour at 38(+5/7) to 39(+2/7) weeks' 
gestational age, for reducing the risk of caesarean 
section among women at high risk of caesarean 
section for slow progress in labour. 
Methods 
The dataset described in Chapter 4 (Part C) was 
divided chronologically into two sets: (1) A model 
building set using the first 1,000 women; and (2) a 
model validation set.  Predicted probabilities derived 
from the first dataset were applied to the second, 
the area under the receiver operating characteristic 
curve calculated, and false positive rates 
determined for given sensitivities.  Finally, the entire 
dataset was used to develop a new predictive 
model.  Multiple imputation was used for all models. 
Results 
The model from the first 1,000 women was applied 
to the remaining 771 whose BMI was known.  The 
area under the receiver operator characteristic 
curve was 0.82 with a sensitivity of 70% for a 20% 
false positive rate.  The final equation was: 
𝑙𝑝 = −0.3916 − 0.1988 ×  𝐴𝑔𝑒1 + 0.2636 ×  𝐴𝑔𝑒2 +
0.6054 ×  𝐴𝑔𝑒3 + 0.8037 ×  𝐴𝑔𝑒4 + 0.06330 ×
 𝐴𝐹𝐼 − 0.5066 ×  𝐺𝐷𝑀𝐷 − 0.2511 ×  𝐺𝐷𝑀𝐼 +
1.9748 ×  𝐺𝐷𝑀𝑃 − 2.6650 ×  𝑀𝑈𝐿𝑇 − 0.05020 ×
 𝐻𝑇 + 1.6171 ×  𝐸𝐹𝑊 + 0.09156 ×  𝐵𝑀𝐼1 +
0.4049 ×  𝐵𝑀𝐼2 + .7570 ×  𝐵𝑀𝐼3    
𝑃 =
𝑒𝑙𝑝
1 + 𝑒𝑙𝑝
 
𝑊ℎ𝑒𝑟𝑒:    𝑙𝑝 = 𝑙𝑖𝑛𝑒𝑎𝑟 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑜𝑟 
𝑃 = 𝑝𝑟𝑜𝑏𝑎𝑏𝑙𝑖𝑡𝑦 𝑜𝑓 𝑐𝑎𝑒𝑠𝑎𝑟𝑒𝑎𝑛 𝑠𝑒𝑐𝑡𝑖𝑜𝑛 𝑓𝑜𝑟 𝑠𝑙𝑜𝑤 𝑝𝑟𝑜𝑔𝑟𝑒𝑠𝑠 
𝐴𝑔𝑒1 = 1 𝑖𝑓 𝑎𝑔𝑒 25 − 29; 
𝐴𝑔𝑒2 = 1 𝑖𝑓 𝑎𝑔𝑒 30 − 34; 
𝐴𝑔𝑒3 = 1 𝑖𝑓 𝑎𝑔𝑒 35 − 39; 
𝐴𝑔𝑒4 = 1 𝑖𝑓 𝑎𝑔𝑒 ≥ 40; 
𝑎𝑙𝑙 𝑎𝑔𝑒 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑠 = 0 𝑖𝑓 𝑎𝑔𝑒 < 25  
𝐴𝐹𝐼 = 𝑎𝑚𝑛𝑖𝑜𝑡𝑖𝑐 𝑓𝑙𝑢𝑖𝑑 𝑖𝑛𝑑𝑒𝑥 (𝑐𝑚) 
𝐺𝐷𝑀𝐷 = 1 𝑖𝑓𝐺𝐷𝑀 𝑜𝑛 𝑑𝑖𝑒𝑡; 
𝐺𝐷𝑀𝐼 = 1 𝑖𝑓 𝐺𝐷𝑀 𝑜𝑛 𝑖𝑛𝑠𝑢𝑙𝑖𝑛; 
𝐺𝐷𝑀𝑃 = 1 𝑖𝑓 𝑝𝑟𝑒 − 𝑒𝑥𝑖𝑠𝑡𝑖𝑛𝑔 𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠; 
𝑎𝑙𝑙 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑠 = 0 𝑖𝑓 𝑛𝑜 𝐺𝐷𝑀   
(GDM = gestational diabetes mellitis) 
𝑀𝑈𝐿𝑇 = 1 𝑖𝑓 𝑝𝑎𝑟𝑜𝑢𝑠; 𝑀𝑈𝐿𝑇 = 0 𝑖𝑓 𝑛𝑢𝑙𝑙𝑖𝑝𝑎𝑟𝑜𝑢𝑠 
𝐻𝑇 = 𝑚𝑎𝑡𝑒𝑟𝑛𝑎𝑙 ℎ𝑒𝑖𝑔ℎ𝑡 𝑖𝑛 𝑐𝑚 
𝐸𝐹𝑊 = 𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒𝑑 𝑓𝑒𝑡𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡 𝑖𝑛 𝑘𝑔 
𝐵𝑀𝐼1 = 1 𝑖𝑓 𝐵𝑀𝐼 20 − 24; 
𝐵𝑀𝐼2 = 1 𝑖𝑓 𝐵𝑀𝐼 25 − 29; 
𝐵𝑀𝐼3 = 1 𝑖𝑓 𝐵𝑀𝐼 ≥ 30; 
𝑎𝑙𝑙 𝐵𝑀𝐼 𝑣𝑎𝑟𝑖𝑎𝑏𝑙𝑒𝑠 = 0 𝑖𝑓 𝐵𝑀𝐼 < 20 
Discussion 
The data from Chapter 4, Part C are promising for 
the prediction of caesarean section for slow 
progress in labour and are suitable for applying to a 
pilot randomised controlled trial induction of labour 
for reducing caesarean section.  We intend to 
develop a predictive model using a larger dataset 
(from 2009 to 2016) and bootstrapping to obtain 
optimism-corrected parameter estimates.  This 
method provides more accurate parameter 
estimates than the type of split sample temporal 
external validation used in this chapter (see 
Literature Review, page 30).  
 
114 Chapter 6: Consolidation and future directions 
 
 
 
Part B: Protocol for a randomised trial 
Induction of labour for preventing caesarean 
section in labour 
 
Background and rationale: 
There is global concern about rising caesarean 
section caesarean section rates throughout the 
world and ongoing debate about the causes.  In 
Australia, the rate increased from 3% in 1963 to 
18% in 1991 and 33% in 201422,29,64.  Contributing 
factors include maternal demographics (increasing 
maternal age, maternal body mass index (BMI)); 
gestational diabetes; changes in obstetric practices 
such as a reluctance to perform midcavity 
instrumental deliveries, changing attitudes towards 
the management of breech and twin births; and the 
perceived safety of caesarean section and risk of 
litigation85-89.  Strategies to counteract this trend 
such as promoting vaginal birth after caesarean 
section and external cephalic version for breech 
presentation focus on prelabour caesarean section, 
but little has been done to address caesarean 
section in labour637. 
Caesarean section in labour is associated with 
maternal and perinatal complication rates which are 
higher than for vaginal birth or elective caesarean 
section638-642, and accounts for about 40% of all 
caesarean sections1,97.  Most of these are due to 
slow progress representing about 8% of all births.  
Slow progress is the most common cause of 
caesarean section in labour97(Chapter 2, Part A). 
Caesarean section for slow progress in labour is 
presumed to be secondary to cephalopelvic 
disproportion and/or insufficient uterine expulsive 
forces567.  However, strategies to deal with this 
condition have changed little in the last 40 years.  
Since the 1960s, it has been assumed that the only 
accurate way to predict cephalopelvic disproportion 
is through a trial of labour with a standardised 
approach to oxytocin augmentation373, and this 
approach remains the basis of obstetric 
management of labour today. 
There has never been a diagnostic test to predict 
caesarean section for slow progress in labour with 
enough accuracy to offer elective caesarean 
section, but third trimester screening and predictive 
modelling could identify women who might benefit 
from preventative measures.  Randomised trials 
consistently show that induction of labour reduces 
the risk of caesarean section overall, most likely by 
preventing caesarean section for slow progress in 
labour (Chapter 3, Part C).  Meta-analyses have 
reported relative rates of caesarean section overall 
ranging from 0.82 to 0.89510-512, but most trials were 
performed in the post-term setting and the relative 
risk reduction may be higher for women specifically 
at high risk of caesarean section for slow progress. 
The recently published ARRIVE Trial, a large 
randomised trial of nulliparous women with low risk 
pregnancies showed a relative rate of caesarean 
section of 0.84 (95% CI 0.76 – 0.93) with planned 
induction of labour at 39(+0/7) to 39(+4/7) weeks’ 
pregnancy.  In this trial the absolute risk reduction 
was 3.6% (from 22.2% to 18.6%) which may be 
insufficient to lead to a major change in practice535. 
We have recently developed a predictive model 
using third trimester ultrasound, demographic, and 
clinical factors with a sensitivity of 70% and a false 
positive rate of 20% for predicting caesarean 
section for slow progress in labour (Chapter 6, Part 
A).  Used as a screening tool, this model has the 
potential to identify women at high risk of caesarean 
section in labour, who may be the women most 
likely to benefit from induction. 
Hypotheses: 
Among women planning a normal vaginal birth, with 
a cephalic presenting fetus, who are at high risk of 
caesarean section for slow progress in labour, 
induction of labour at 39 weeks’ gestation reduces 
the risk of caesarean section for slow progress in 
labour from 28% to 21%, compared with routine 
antenatal care. 
Trial design 
The trial is designed as a superiority, unblinded, 
multicentre, randomised controlled clinical trial with 
two parallel groups and primary endpoints of 
caesarean section for failure to progress in labour 
and caesarean section for any indication. 
Randomization will be performed as block 
randomization with a 1:1 allocation. 
Study settings 
Hospitals in Australia with 2,000 or more deliveries 
per year including Royal Prince Alfred Hospital, 
NSW. 
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Eligibility criteria 
Inclusion criteria 
1. Age ≥ 18 years 
2. Singleton pregnancy 
3. Planned vaginal birth 
4. Cephalic presentation 
5. First trimester ultrasound 
6. Screening ultrasound at 36+0 to 37+6 weeks 
gestation for fetal biometry, amniotic fluid index 
and fetal Doppler studies 
7. Positive risk screen for caesarean section for 
failure to progress in labour.  The screening 
tool described in Chapter 6 (Part A) will be 
used. 
(Potential participants with a risk of caesarean 
section for slow progress in labour of ≥ 20% will 
be eligible to participate). 
Exclusion criteria 
1. Planned induction of labour before the 
estimated date of confinement 
2. Previous caesarean section or uterine incision 
3. Any indication for elective caesarean section 
4. Known major anatomic fetal abnormality 
Intervention 
The intervention is planned artificial rupture of the 
membranes and/or intravenous oxytocin infusion.  
Cervical priming with the use of methods such as 
administration of vaginal prostaglandins and/or 
insertion of a cervical catheter may occur the day 
before in accordance with local hospital policies. 
Comparator 
The comparator will be the care the woman would 
have received had she not been enrolled into the 
trial. 
Explanation for choice of comparators: 
The comparator was chosen because it is not 
feasible to impose a single care protocol to 
midwives and doctors from different institutions.  
Using usual care as the comparator will help make 
the results of the trial generalisable. 
The timing of the intervention 
Women allocated to the treatment arm of the trial 
will have planned artificial rupture of the obstetric 
membranes and/or intravenous oxytocin infusion at 
any time from 38 weeks’ and five days’ gestation to 
39 weeks and two days’ gestation. 
The intervention in current practice 
Induction of labour is a common intervention and 
was performed in 28% of all pregnancies in 
Australia in 201325 for indications such as post-
dates pregnancy, gestational diabetes, gestational 
hypertension, suspected fetal compromise or 
placental insufficiency, suspected macrosomia, 
prelabour ruptured membranes and social 
indications. 
The efficacy of the intervention 
RCTs consistently show that IOL reduces the risk of 
CS overall but the efficacy of IOL for preventing CS 
for slow progress is unknown.  Meta-analyses and a 
large randomised trial in low-risk nulliparous women 
reported relative risks of 0.82 to 0.89510-512,535, but 
most trials were performed in the post-term setting, 
and the relative risk reduction may be higher for 
women at high risk of caesarean section for slow 
progress in labour, or if the induction is performed 
earlier in the pregnancy. 
The safety of the intervention 
Induction of labour at 39 weeks’ gestation is 
generally considered to be a safe procedure, but is 
associated with increased maternal pain and 
restricted mobility which may be more marked than 
for spontaneous onset of labour577.  Specific 
complications include uterine hyperstimulation, 
umbilical cord prolapse, and unsuccessful induction 
attempt539.  Advantages include a reduction in 
perinatal mortality and a decrease in severe 
perineal trauma510,514(see Chapter 3, Part B). 
Criteria for discontinuing or modifying the 
allocated intervention 
The intervention will be modified or discontinued if 
there is a clinical need to do so.  For example, 
induction of labour may be offered for post-dates 
pregnancy, gestational diabetes, gestational 
hypertension or other clinical or social indications.  
This will occur at the discretion of the woman’s 
usual carer and the woman herself in the same way 
as other clinical decisions. 
All interventions and usual care provided by doctors 
and midwives looking after the participant will be 
allowed. However, if the doctor is intending to offer 
induction of labour or advise against induction of 
labour, the woman will not be recruited. 
Strategies to improve adherence to trial 
protocols and monitor compliance 
Study investigators will perform site visits about four 
times per year to promote recruitment, provide 
education for clinical staff and site investigators and 
to audit centre medical records and monitor 
compliance. 
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Concomitant interventions permitted or 
prohibited 
All the care the woman normally receives during 
pregnancy will be permitted and there will be no 
specific prohibitions.  For example, a clinical 
decision for induction of labour or elective 
caesarean section may be made. 
Outcomes 
Primary outcomes: 
1. Caesarean section for slow progress in labour  
This outcome was chosen because the evidence 
suggests that induction of labour prevents 
caesarean section by preventing slow progress in 
labour (Chapter 3, Part C). 
2. Caesarean section for any indication 
This outcomes was chosen because it is clinically 
important.  It is associated with adverse outcomes 
including infection, venous thromboembolism, 
maternal death, anaesthetic complications, serious 
adverse impact on future pregnancies such as 
infertility, future caesarean sections and death due 
to an abnormally adherent placenta. 
Secondary outcomes: 
1. Serious maternal morbidity or mortality 
(combined outcome), which includes the following: 
post-partum and/or intrapartum haemorrhage 
requiring blood transfusion, third or fourth degree 
perineal trauma; dilatation and curettage for 
bleeding or retained placental tissue; cervical 
laceration; vertical uterine incision; ruptured uterus; 
vulvar or perineal haematoma; pneumonia; venous 
thromboembolism requiring anticoagulation; wound 
infection requiring hospital stay more than 7 days; 
readmission to hospital for obstetric-related causes; 
wound dehiscence; maternal fever of at least 
38.5°C on two occasions at least 24 hours apart not 
including the first 24 hours; bladder, ureter or bowel 
injury requiring repair; genital-tract fistula; bowel 
obstruction; or admission to intensive care unit. This 
will be reported as a proportion of participants with 
serious morbidity or mortality. 
This outcome was chosen to assess the short-term 
harm to the mother of the intervention.  A combined 
outcome was chosen to increase the power to 
detect this harm. 
2. Serious perinatal/neonatal morbidity or mortality 
within 6 weeks of birth (combined outcome), which 
will include the following: shoulder dystocia 
requiring manouvres other than McRoberts or 
suprapubic pressure or resulting in neonatal injury, 
5-minute Apgars < 4; arterial cord pH <7.0 or lactate 
>10 or base excess < −15; seizures < 24 hours of 
age, intubation/ventilation >24 hours, tube feeding 
>4 days, admission to neonatal intensive care >4 
days, meconium aspiration, neonatal sepsis, 
neonatal jaundice requiring phototherapy, neonatal 
fracture, intraventricular/intracranial haemorrhage, 
subgaleal haemorrhage, neonatal blood transfusion, 
hypoxic ischaemic encephalopathy, or neuropraxia. 
This will be reported as a proportion of participants 
with serious morbidity or mortality. 
This outcome was chosen to assess the short-term 
harm to the fetus/infant of the intervention.  A 
combined outcome was chosen to increase the 
power to detect this harm. 
Other outcomes 
Other outcomes will be assessed during delivery 
admission and at 6-weeks, 6-months, and 1-year 
postpartum. 
The following outcomes will be assessed during the 
delivery admission: 
1. Length of first stage of labour: time from the first 
vaginal examination where the cervix was ≥ 4cm 
dilatation to the first examination where the cervix 
was fully dilated or the time of birth, whichever 
comes first (median) 
2. Length of second stage of labour: time from the 
first vaginal examination where the cervix was fully 
dilated to the time of birth (median) 
3. Length of the expulsive phase of the second 
stage of labour: time from the onset of maternal 
pushing to the time of birth (median) 
4. Analgesia required in labour: epidural, opiates, 
nitrous oxide, other (proportions) 
5. Instrumental delivery: forceps or vacuum birth 
(proportion) 
6. Estimated blood loss at delivery (median: visual 
estimation by midwife or doctor) 
7. Any perineal/vaginal trauma requiring suturing 
(proportion) 
8. Episiotomy (proportion) 
8. Length of hospital stay (median) 
9. 5 minute Apgar score (median, and proportion) 
10. Admission to neonatal intensive care unit 
(proportion) 
11. Breast feeding at discharge (proportion) 
12. Gestational age at birth (median) 
13. Place of birth (proportion) 
14. Neonatal resuscitation required (proportion) 
15. Number of births with spontaneous onset, no 
augmentation, and no epidural (proportion) 
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16. Epidural analgesia, other analgesia 
(proportions) 
17. Oxytocin use in labour (proportion) 
18. Gestational hypertension, pre-eclampsia 
(includes post-natal) (proportions) 
19. Puerperal psychosis (proportion) 
20. Congenital anomaly (proportion) 
21. Birthweight (mean) 
 
 
The following outcomes will be assessed at 6 
weeks: 
1. Still breast feeding (proportion) 
2. Satisfaction with birth (visual analogue scale) 
(median) 
3. Satisfaction with care in hospital (visual analogue 
scale)(median) 
4. Saw a health professional for depression since 
delivery (proportion) 
5. Health-related quality of life (SF-12) (median) 
6. Infant mortality or admission to hospital 
 
The following outcomes will be assessed at 6 
months: 
1. Still breast feeding (proportion) 
2. Saw a health professional for depression since 
delivery (proportion) 
3. health-related quality of life (SF-12) (median) 
4. Infant mortality or admission to hospital 
The following outcomes will be assessed at one 
year: 
1. Still breast feeding (proportion) 
2. Saw a health professional for depression since 
delivery (proportion) 
3. Health-related quality of life (SF-12) (median) 
4. Pelvic floor function (bowel, urinary, prolapse, 
and sexual function domains - using the Australian 
pelvic floor function questionnaire643 (medians) 
5. ‘Ages and Stages’ 12 month questionnaire (ASQ-
3TM)644(medians) 
Participants’ timeline 
See table 7.1. 
Table 6B.1 
Time-line for enrolment, allocation and follow-up 
 Enrolment 
(weeks GA) 
Allocation 
(weeks GA) 
Intervention 
(weeks GA) 
Birth After birth 
 32-36  36-37 38(+0/7)-38(+4/7) 38(+5/7)-39(+2/7)  0-7 days  6 weeks 6 months 1 year 
1st Eligibility screen X         
Informed consent X         
2nd eligibility screen  X        
Allocation   X       
Intervention: 
   Planned IOL  
   No planned IOL 
    
X 
<---------------- 
 
 
----> 
    
   Assessments:          
Primary outcomes: 
(caesarean section) 
     X    
Delivery outcomes:      X    
   Early postnatal   
 outcomes 
     X    
   Maternal mortality 
 and serious morbidity 
      X   
Perinatal mortality and 
serious morbidity 
      X   
Satisfaction with birth       X   
Satisfaction with 
antenatal care 
      X   
Depression       X X X 
Health related QOL       X X X 
Pelvic floor outcomes         X 
GA = gestational age          
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Sample size 
The sample size calculation will be based on the 
primary outcome. The power calculation was based 
on our local data which showed a rate of caesarean 
section for slow progress of 28% among women 
with a high-risk screen.  We are currently surveying 
obstetricians, midwives and pregnant women in 
Australia and New Zealand.  Assuming they 
indicate they would choose induction of labour if 
their relative risk reduction in caesarean section 
was 25% (absolute risk reduction of 8%): then to 
detect a reduction in the rate of operative delivery 
from 28% in the control group to 21% in the 
intervention group, a sample size of 620 women in 
each group (total = 1,240) will be required to have 
80% power of finding a result, for α = 0.05 (2-tailed), 
β= 0.20 (Epi-Info version 7.2.1.0). 
Recruitment 
Women will be approached at the time of their usual 
antenatal clinic appointment at any time from 32 to 
37 weeks’ gestation, but aiming for 32 weeks.  
Recruitment will occur at 5 to 10 major tertiary 
hospitals in Australia.  Strategies to maximise 
recruitment will include: 
The presence of a recruitment officer in the 
antenatal clinics at each participating centre who 
will provide information about the risk assessment 
and the trial, and obtain informed consent. 
• Each participant will be given the contact 
details of a research officer who will be able to 
answer any queries or concerns she may have 
about the trial. 
• The recruitment officer will be available to 
attend the ultrasound clinic immediately after 
• The risk assessment – women at both high and 
low risk of intrapartum caesarean section for 
failure to progress in labour will be informed of 
the results of the risk assessment and for 
women at high risk, willingness to participate 
will be confirmed. 
• The recruitment officer will help arrange the 
next clinic appointment and randomise the 
woman at 38+0 to 38+4 weeks’ gestation. 
Randomisation 
Randomisation will be stratified by parity and 
hospital site due to the potentially strong 
association between intrapartum caesarean section 
(a primary outcome) and each of these factors.  
Randomization will be centrally controlled using 
computerized sequence generation, which can be 
accessed 24 hours per day using a toll-free 
telephone line.  Randomisation will occur from 38 
weeks and zero days’ gestation to 38 weeks and 
four days’ gestation and treatment allocation will 
occur with the aim of performing artificial rupture of 
the membranes and commencing oxytocin infusion 
from 38 weeks and five days’ gestation to 39 weeks 
and two days’ gestation. 
Allocation concealment 
Participants will be enrolled and randomized by a 
recruitment officer or a health care professional 
(doctor or midwife) responsible for their antenatal 
care.  Due to the nature of the intervention, 
treatment allocation will not be masked to 
participants, clinicians or outcome assessors.  Data 
analysts will be masked to treatment allocation for 
data which does not make the treatment allocation 
obvious (such as gestational age, induction of 
labour or oxytocin during labour). 
Data collection, management, and 
analysis 
Data collection methods 
The following data fields will be collected from the 
medical records: 
• Caesarean section for failure to progress in 
labour 
• Caesarean section for any indication 
• Caesarean section for failure to progress in 
labour (according to the clinician who made the 
decision to perform the caesarean section) – if 
this is not clear from the notes, the clinician will 
be contacted within one week of the delivery 
• Forceps or vacuum delivery 
• Maternal mortality and serious morbidity 
• Perinatal mortality and serious morbidity 
• Length of labour, analgesia in labour, estimated 
blood loss, perineal or vaginal trauma, 
episiotomy, length of hospital stay, Apgar 
scores, admission to neonatal intensive care 
unit, breast feeding at discharge, gestational 
age at birth, place of birth, neonatal 
resuscitation, onset of labour, augmentation 
(commencement of oxytocin infusion after 
spontaneous onset of labour), maternal 
hypertensive disease, puerperal psychosis, 
infant birthweight, congenital anomaly 
The following data will be collected by paper or 
internet based questionnaire, facilitated by phone 
call if required: 
• Still breast feeding after discharge, satisfaction 
with birth, saw a health professional for 
depression since delivery, health related quality 
of life. 
• Perinatal mortality or morbidity, maternal 
mortality or morbidity (for example, the 
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participant may have been readmitted at a 
different hospital after discharge). 
• Pelvic floor function 
Data management 
Data collected will be entered into a registered 
electronic database by research staff blinded to 
treatment allocation and who are not involved in the 
clinical care of the participants. Hardcopies of 
participants’ data will be stored in a locked office. 
The electronic database will include the study 
identification number but no directly identifying data 
such as medical record number, date of birth or 
personal address. The de-identified database will 
be backed up on a server at Royal Prince Alfred 
Hospital. Data linking identifying details to the study 
number will be kept at a separate location in a 
locked filing cabinet. At the end of the study, data 
will be kept in a locked filing cabinet, and de-
identified electronic data will be kept on a portable 
medium such as a USB drive in a separate secure 
location at Royal Prince Alfred Hospital. All 
electronic data will be checked for accuracy by a 
second member of the research team and any 
apparent data entry errors will be discussed by the 
primary investigators and investigated/corrected as 
required. 
Analysis 
Analysis will be by intention-to-treat (according to 
treatment allocation), including withdrawals and 
losses to follow-up. Losses to follow-up for the 
primary outcome are expected to be low because 
randomisation will occur late in the third trimester 
and the primary outcome is caesarean section. 
The results will be reported according to CONSORT 
guidelines. 
Demographics and other potential confounders will 
be compared by treatment allocation in a univariate 
analysis. Categorical outcome measures will be 
compared by proportions (chi-squared test), means 
for normally distributed data (t-test), or rank order 
for non-normally distributed data (Wilcoxon rank 
sum test). 
A logistic regression analysis of treatment allocation 
and other variables on the primary outcome 
measure, caesarean section for failure to progress, 
will be performed. The following variables will be 
considered for the logistic regression model: 
maternal body mass index, maternal age, maternal 
height, gestational diabetes, neonatal gender, and 
estimated fetal weight on screening ultrasound 
adjusted to 38 weeks’ gestation. Parity, study site 
and the presence of epidural for intrapartum 
analgesia at the time of randomisation will not be 
included because randomisation is stratified for 
these variables. Only variables where P <0.25 in the 
univariate regression will be included in the 
multivariate model. Continuous variables that do not 
show a linear association with the logit function will 
be categorised. Interaction terms will be considered 
for treatment allocation versus each of the other 
variables and where clinically appropriate between 
non-treatment variables. P <0.01 will be considered 
evidence of interaction. Terms will be excluded from 
the model in a stepwise backward manner until all 
remaining terms are both statistically significant (P 
<0.05) and clinically significant (that is, removal of 
the term results in a clinically significant change in 
the estimate of the odds ratio of treatment allocation 
for the primary outcome). Multiple imputation of 
missing data will be used.  The analysis will be 
performed using SAS 9.4 (or a more recent version 
of SAS). 
Monitoring: 
Data safety monitoring committee 
Draft terms of reference for a data and safety 
monitoring committee provide for potential 
cessation of the trial if significant safety concerns 
are raised. The data and safety monitoring 
committee will consist of three people who are not 
involved in the study and do not have a working 
relationship with the primary investigators. Adverse 
events will be reported to the committee. 
Interim analysis and stopping rules There will be no 
interim analysis. The Data Safety Monitoring 
Committee may advise that the trial be stopped if 
significant concerns about the safety of induction of 
labour are found. 
Harms: 
Complications will be reported to the Data 
Monitoring Committee. 
Auditing 
There will be no external auditing of the trial. 
Research ethics approval 
Approval will be sought from the Ethics Review 
Committee (RPAH Zone) of the Sydney Local 
Health District, Sydney, Australia. 
Protocol amendments 
If modification to the study protocol is considered 
necessary, then permission will be sought from the 
ethics committee and the changes will be described 
in the final report. 
Consent 
Participants will be provided with written information 
via information pamphlets, posters and the trial 
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website. Informed consent will be obtained by 
research midwives or midwives/medical staff 
involved in potential participants’ care. A detailed 
information sheet will be provided to all participants. 
Participants will be informed of the potential risks of 
induction of labour (and the potential risks of not 
inducing the labour), given the opportunity to ask 
questions and informed that they have the right to 
change their mind at any time. 
Confidentiality 
All the information collected from the study will be 
treated confidentially, and only the researchers will 
have access to it. Hard copies of data collection 
forms will be stored in a locked office. The 
electronic database will be de-identified and stored 
at a different location to codes linking identifying 
data to study identification numbers. The electronic 
database will be on Microsoft Access, password-
protected, and only accessible by research staff. 
Declaration of interests 
The investigators have no competing interests to 
declare 
Access to data 
Only the data manager and data entry clerks under 
the direct supervision of the data manager will 
routinely have access to study data.  The data 
manager will run data queries designed to provide 
reports to the data safety monitoring committee.  
The data safety monitoring committee will be 
masked to treatment allocation – the frequencies 
and nature of adverse events will be provided in two 
groups randomly labelled as ‘group A’ and ‘group 
B’. 
Ancillary and post-trial care 
All participants will have access to the same 
medical care they would have had access to had 
they not been recruited to the trial.  No additional 
care will be routinely offered.  If an investigator 
becomes aware of a medical issue which the team 
caring for the woman is unaware of, then the 
investigator will ask the participants’ permission to 
inform the medical team. 
Anticipated date of first enrolment: 
1st March, 2019 
Trial management committee 
The committee consists of [insert names] who are 
responsible for the following: 
1. Study planning 
2. Organisation of Steering Committee meetings 
3. Randomisation 
4. Reporting of any serious adverse events to the 
Data Monitoring Committee 
5. Budget administration and organising contracts 
with individual centres 
6. Providing advice for site investigators 
7. Auditing and visiting sites 
8. Data verification 
9. Following up of study participants 
Steering committee 
The Steering Committee will be chaired by Brad de 
Vries, and all lead investigators will be steering 
committee members and are responsible for the 
following: 
1. Recruitment of pregnant women on the study and 
liaising with principal investigators [insert initials] 
2. Reviewing progress of study and facilitating the 
smooth running of the trial. 
3. Reporting the results of the trial. 
[no endpoint adjudication committee] 
Site investigators 
In each participating centre, a lead investigator 
(obstetrician) will be responsible for identification, 
recruitment data collection and completion of 
relevant trial forms, along with adherence with study 
protocol. Each lead investigator will be a steering 
committee member. 
Data manager 
The data manager will be responsible for 
maintenance of the trial IT system, data entry and 
data verification.  
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Part C: General discussion 
 
Main findings 
The main findings from this thesis are that induction 
of labour prevents caesarean section for slow 
progress in labour, and that slow progress in labour 
can be predicted.  A more detailed outline is shown 
in Figure 6C.1. 
Caesarean section for slow progress 
The most original contribution from this thesis 
pertains to slow progress in labour.  Almost no 
previous work on induction of labour accounts for 
why caesarean sections were performed, though it 
would be evident to almost anyone that the 
biological underpinnings of ‘slow progress’ and ‘fetal 
distress’ must be vastly different.  There are 
exceptions.  Some randomised trials, such as the 
Digitat Trial519 have reported on slow progress in 
labour as have some observational studies518, but 
the distinction and its implications have not been 
emphasised. 
In Chapter 2 we showed that the biggest 
contributors to increases in primary and nulliparous 
caesarean section rates were slow progress in 
labour and fetal malpresentations.  Much of the 
increase was explained by changes in the 
distribution of previous caesarean section, maternal 
age and body mass index and not just changes in 
obstetric practice.  This implied that maternal 
demographics are part of the aetiology of slow 
progress.  Concurrent increases in elective repeat 
caesarean sections appeared to have magnified the 
impact that slow progress in labour has on the 
caesarean section rate. 
It is not clear how older maternal age or higher BMI 
might cause slow progress in labour.  It is easy to 
equate ‘failure to progress’ or ‘slow progress’ with 
absolute or relative cephalopelvic disproportion but 
this relies on attributing the phenomenon to “the 
passenger” (the size and position of the baby) 
and/or the “the passages” (the dimensions and 
composition of the pelvis) and ignoring “the forces”.  
In the case of BMI there is in vitro evidence that 
increased BMI is related to an intrinsic reduction in 
contraction strength and frequency233.  In the case 
of maternal age, there is little evidence to support 
an increase in cephalopelvic disproportion, which 
would have to involve a significant increase in 
birthweight and/or a decrease in maternal pelvic 
dimensions.  Thus, for both maternal age and BMI, 
it would be reasonable to suspect that the efficiency 
of uterine expulsion is a mechanism of association. 
In Chapter 3 we showed that the indications for 
induction of labour before 40 weeks are associated 
with both caesarean section rates and their 
indication.   For example, induction of labour for 
suspected fetal compromise was associated with 
low overall caesarean section rates despite high 
rates for ‘fetal distress’, and induction for suspected 
macrosomia with high overall rates despite low 
rates for ‘fetal distress’.  The implication is that 
caesarean sections and their indications depend on 
clinical factors, which could contribute to 
heterogeneity in the finding of randomised 
controlled trials of induction of labour for preventing 
caesarean section. 
Critically, induction of labour at 39 weeks’ 
pregnancy was associated with an increase in 
caesarean section for ‘fetal distress’ and a decrease 
for slow progress in labour (Chapter 3, Part A).  We 
suspected the effect was mediated by reduced 
cephalopelvic disproportion, but the efficiency of 
uterine forces probably plays a role.  For example, a 
larger baby is expected to encounter more 
resistance from the birth canal and require greater 
forces over a longer period for a vaginal birth to be 
achieved.  Combining our findings in Chapters 2B 
and 3C, we could speculate that older or more 
obese women are more likely to experience slow 
progress in labour and this likelihood could be 
modified by inducing the labour and creating a 
scenario where the uterus has less resistance to 
overcome. 
In Chapter 4, we examined risk factors for 
caesarean section in labour for slow progress and 
other indications.  Neonatal head circumference, 
ultrasound measured biparietal diameter plus 
abdominal circumference, and estimated fetal 
weight were associated with caesarean section for 
slow progress in labour; and cervical length was 
associated with caesarean section overall.  These 
studies were important because we need to identify 
individual factors to predict caesarean section in 
labour.  They were not all incorporated into the 
predictive model, but this could be achieved by 
recalibrating the existing model and considering 
additional predictors645 or by prospectively 
collecting data in the control group of our proposed 
randomised trial (Chapter 6B). 
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Rise in CS for slow progress (1995-2009): 
• 3% to 7% (primary)  
• 5% to 11% (nulliparous)  
Model to predict CS for 
slow progress in labour 
Slow progress in labour is a major 
driver of the rising CS rate 
Could explain heterogeneity of 
results in RCTs of IOL for reducing 
caesarean section (eg Digitat Trial) 
Figure 6C.1: 
Overview of original studies in this thesis 
Protocol for a randomised controlled 
trial for preventing CS in women at 
high risk of CS for slow progress 
Methods of developing 
birthweight standards 
 
Potential to use in the prediction 
of adverse perinatal outcomes 
    
Rise in elective repeat CSs (2000-2016) 
• 5% to 9% of all births 
Much of the rise in caesarean section 
rates can be explained by changes in 
maternal demographics  
CS rates for slow progress and ‘fetal 
distress’ following induction of labour at 
38-39 weeks varied markedly by IOL 
indication 
IOL at 38 to 39 weeks was associated 
with lower rates of CS for slow progress 
and higher rates of other CSs 
Very likely that IOL prevents CS 
by reducing CS for slow 
progress in labour 
• Neonatal HC 
• Cervical length 
• EFW  
• AC and BPD 
 
} Potential predictors  
 
4
  
  
  
  
  
2A 
3C 
3A 
2B 
Is this a 
mechanism of 
association? 
    
 
5
  
6A 
6B 
Parallel trial? 
    
  = Chapter 
AC = abdominal circumference; BPD = biparietal diameter; CS = caesarean section; EFW = estimated fetal weight;  
HC = head circumference; IOL = induction of labour; RCT = randomised controlled trial 
2A 
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In Chapter 5 we described a new method for 
deriving local birthweight standards, which could be 
customised using multiple quantile regression.  
They could be used as part of an algorithm to 
predict adverse perinatal outcomes, leading to a 
randomised trial of induction of labour for improving 
these outcomes.  These charts were instrumental in 
reducing bias when assessing the association 
between induction of labour and caesarean section 
in labour as described in Chapter 3 (Part C). 
Finally, in Chapter 6 (Part A), we developed a 
model for predicting caesarean section for slow 
progress in labour, because we understand from 
Chapter 3 that it is caesarean section for slow 
progress and not ‘fetal distress’ which is prevented 
by induction of labour.  Finally, in Chapter 6 (Part 
B), we used the model as a screening tool to enrol 
women into a proposed randomised trial of 
induction of labour for preventing caesarean section 
for slow progress in labour. 
Thus, preliminary work, led to caesarean section for 
slow progress becoming the key outcome for our 
proposed trial.  However, many might consider that 
caesarean section itself is the women-centred 
outcome of importance, not its underlying cause.  
We would agree, but an analogy can be drawn 
outside of obstetrics.  In general medicine, death is 
an important patient outcome, but subdividing this 
outcome has led to the use of aspirin for preventing 
stroke, and anti-hypertensives for preventing 
myocardial infarction.  This does not undermine the 
importance of death, but uses knowledge of specific 
causes of death to tailor preventative measures.  In 
a similar manner, knowledge of the cause of 
caesarean section is the key to its prevention. 
It is important to recognise that caesarean section 
for slow progress in labour is at best an imprecise 
indicator of causation.  A next step would be to 
consider the relative roles of uterine contractions 
and the resistance to them.  Simplistically, we could 
ask if the caesarean section was primarily due to 
insufficient uterine contractions or cephalopelvic 
disproportion.  In this thesis, we considered 
differences in caesarean section for slow progress 
and for other indications, but slow progress could 
be further subdivided, leading to further insights into 
the management of labour. 
Finally, any research can lead to unexpected 
insights, as implied by the quote at the start of this 
thesis (by an excellent science fiction author).  We 
found in Chapter 3C that induction of labour for 
younger women is associated with caesarean 
section for ‘other indications’ (ie ‘fetal distress’) and 
speculated that more efficient uterine contractions 
in younger women led to uterine hyperstimulation 
and umbilical cord/placental compression.  We 
might ask if care in labour in terms of factors such 
as analgesia, maternal positions, mobility, 
hydration, and use of oxytocin could be guided by 
improved knowledge of uterine forces, uterine 
reserve, and/or evidence of relative cephalopelvic 
disproportion; and speculate that understanding 
these factors could improve women’s experiences 
of labour or reduce obstetric interventions. 
Induction of labour 
This thesis was written because induction of labour 
prevents caesarean section and we believed this 
knowledge could be better utilised.  However, it is 
an obstetric intervention that many women and their 
carers want to avoid. 
In Chapter 3 we demonstrated that induction of 
labour probably exerts its protective effect by 
preventing slow progress in labour.  Randomised 
trials510,520, and a well conducted observational 
study555, show that induction of labour before 40 
weeks’ pregnancy reduces caesarean section.  We 
demonstrated that the results of observational 
studies are very sensitive to the method of analysis 
and that inappropriate inclusion of birthweight 
and/or gestational age in regression models could 
explain heterogeneous findings514,518. 
Predictive model 
We showed that it was possible to create a model to 
predict caesarean section for slow progress in 
labour using logistic regression.  For a false positive 
rate of 20%, the sensitivity was 70%.  Thus, most 
women who went on to have a caesarean section 
for slow progress were predicted and only one in 
five women would be unnecessarily offered 
induction of labour.  There is potential to improve on 
this model by analysing a larger dataset and adding 
new variables645 and to test new predictors 
prospectively, although its predictive properties 
already show promise. 
Randomised controlled trial 
There are many randomised controlled trials of 
induction of labour and strong evidence that it 
prevents caesarean section511 and another large 
trial soon to be published535, so it could be asked 
“Why undertake another one?” 
Our response would be that our trial (Chapter 6, 
Part B) is different to the others.  Firstly, the 
outcome and inclusion criteria are based on 
knowledge that induction of labour prevents 
caesarean section for slow progress, and only 
women already at high risk of that outcome will be 
recruited, leading to a smaller sample size.  Some 
trials may have found no difference in caesarean 
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section rates due to a low background risk of 
caesarean section for slow progress519.  A definitive 
trial, enrolling those women most likely to benefit, 
would clarify the reasons for different findings 
among randomised trials. 
Secondly, it is not standard practice to induce 
labour to prevent caesarean section, because many 
eligible women would otherwise have a 
spontaneous labour and normal birth.  If selected 
women at high risk of preventable caesarean 
section could be identified (Chapter 6, Part A), and 
the relative risk reduction did not change, then the 
number needed to treat would fall and most women 
would not be induced. As an example, if 20% of 
women screened as high risk, 30% of these women 
had a caesarean section for slow progress, and the 
relative risk reduction was 20%, then their rate of 
caesarean section would fall to 24%, and the 
number needed to treat would be 17. 
Thirdly, most trials recruit women beyond 40 weeks’ 
gestational age and less is known about the impact 
of earlier induction of labour on caesarean section 
rates. 
Other studies 
Over the past three and a half years, this thesis and 
its aims were dynamic.  Studies were commenced 
with the intention that they would be included and 
others were added later.  There are several works 
in progress, including a survey of obstetricians in 
Australia and New Zealand, a survey of midwives in 
Australia, and a survey of recently and currently 
pregnant women about attitudes towards induction 
of labour.  These have been developed and in the 
case of obstetricians, ethics approval has been 
obtained.  Their aim is to determine if induction of 
labour would be considered for preventing 
caesarean section, and the size of the treatment 
effect that would prompt a decision to be induced.  
The information will help us to decide what would 
be a clinically important reduction in the risk of 
caesarean section or adverse perinatal outcomes 
and further inform our power calculation.  Another 
prospective observational study involves measuring 
differences in maternal flexibility (using the Beighton 
score) and external pelvic measurements in women 
who had a caesarean section for slow progress and 
those who had a caesarean section for other 
indications, and could add risk factors to our risk 
prediction model.  At the time of writing, 30 women 
have been recruited and the planned sample size is 
200.  We have also submitted an ethics application 
for a pilot randomised trial of induction of labour to 
assess the feasibility of our proposed trial. 
Controversy 
The work in this thesis is controversial because it 
investigates the use of one intervention (induction of 
labour) to prevent another (caesarean section).  
There is a risk that investigations in a low-risk 
population will lead to unnecessary procedures.  On 
the other hand, induction of labour reduces the risk 
of caesarean section which is a policy goal of many 
health care organisations. 
There is a perceived conflict between professional 
groups, particularly midwives and obstetricians, with 
respect to interventions in pregnancy and labour 
(see Figure 1.3, page 3).  This is sometimes fuelled 
by a few outspoken individuals with strong opinions, 
and in this setting, it is hard to know what the 
benefits of an intervention need to be for it to gain 
acceptance.  Despite evidence of objective 
‘medical’ benefit from interventions such as 
induction of labour, relatively little is known about 
the views of health care professionals and the 
general community. 
In my opinion, the future needs to be navigated 
carefully.  Any major change in the way we care for 
women needs to be the subject of rigorous 
investigation before being introduced into clinical 
practice.  That is, we need to prove we are 
improving outcomes.  Secondly, the process needs 
to be widely collaborative.  Pregnancy and childbirth 
is an integral part of the human experience and the 
opinions of the entire community should take 
precedence over that of professional groups.  
Finally, the concepts of autonomy and freedom of 
choice - basic human rights - are more important 
than specific clinical outcomes.  If we keep these 
tenets in mind then hopefully, as a community, we 
can navigate the apparent discord when it comes to 
caring for women during pregnancy and childbirth. 
Future directions 
The main purpose of this thesis was to describe 
preliminary work which will lead to the randomised 
trial described in Chapter 6 (Part B).  However, 
induction of labour is only one strategy to address 
the rise in primary caesarean sections.  Other 
possibilities include: 
(1) Using proposed changes in the definitions of the 
onset and normal progress of the first stage of 
labour533 based on a recent description of births to 
women with spontaneous labour leading to a 
vaginal birth97. 
(2) Using strategies in labour such as changing 
maternal positions, hydration, one-on-one midwifery 
care, and different approaches to analgesia. 
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(3) Using different timing for artificially rupturing the 
membranes and commencing (or stopping) oxytocin 
in labour. 
(4) Using different rates of oxytocin infusion, with 
changes based on criteria such as different 
frequencies or strengths of contractions.  For 
example, our finding in Chapter 3 (Part C) that 
younger women whose labour is induced are more 
susceptible to caesarean section for ‘fetal distress’ 
suggests that incrementing infusion rates more 
slowly should be considered in this group.  Use of a 
more judicious oxytocin protocol was associated 
with a reduction in caesarean sections in one centre 
646.  Cessation of oxytocin in the active phase of 
induced labours has also been associated with 
fewer caesarean sections 647.  
(5) Using proposed changes in the definitions of 
normal progress in the second stage of labour533. 
(6) Considering the seniority of the obstetrician who 
is present for operative vaginal births. 
The increase in caesarean sections for slow 
progress in labour is poorly understood and these 
are just a few possibilities. 
More research is also required on how to 
individualise management of labour based on 
factors such as maternal age and BMI which appear 
to be contributing to the rise in caesarean section 
rates (Chapter 2, Part B).  Understanding the 
underlying causes could lead to tailored 
management strategies. 
Finally, there is much that we don’t understand 
about the causes of slow progress in labour.  
Should we manage cephalopelvic disproportion and 
inefficient uterine contractions differently and, if so, 
can we diagnose these conditions separately?  Can 
apparently ‘inadequate’ uterine contractions have 
different underlying causes?  Perhaps we should 
use oxytocin for ‘inco-ordinate’ contractions or avoid 
oxytocin when the uterus is ‘fatigued’.  It has been 
50 years since we started plotting cervical dilatation 
to time the onset of oxytocin infusion, and future 
research should be directed towards finding new 
strategies.    
Strengths and limitations 
Specific strengths and limitations have been 
discussed in individual chapters.  The database 
used for many of the studies could contain data 
entry errors, but these would tend to dilute 
associations rather than cause systematic bias.    
Basing our predictive model on indicated 
ultrasounds could limit its generalisability.  In 
general, the use of appropriate statistical 
methodology was a strength of this thesis.  The 
planned, interlinking nature of the studies made it 
possible to build a coherent picture of the status of 
slow progress in labour and design a trial based on 
these findings.  
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Part D: Conclusions 
Slow progress in labour and the changing nature of 
the obstetric population are major drivers of the 
increasing caesarean section rates.  Induction of 
labour appears to prevent caesarean section for 
slow progress in labour.  As observational studies of 
the association between induction of labour and 
caesarean section are sensitive to changes in 
methodology, randomised controlled trials are 
required.  It is possible to predict caesarean section 
for slow progress in labour, and a randomised 
controlled trial of induction of labour at 39 weeks’ 
gestation for preventing caesarean section in 
women at high risk of this outcome could reduce the 
caesarean section rate.  There is potential to 
conduct a parallel randomised trial of induction of 
labour in high risk pregnancies for reducing 
perinatal mortality. 
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